| 藥理分類碼 名 稱
|
| (A) ALIMENTARY TRACT AND METABOLISM |
| (A01) STOMATOLOGICAL PREPARATIONS |
| (A01A) STOMATOLOGICAL PREPARATIONS |
| (A01AA) Caries prophylactic agents |
| (A01AA01) Sodium fluoride |
| (A01AA02) Sodium monofluorophosphate |
| (A01AA03) Olaflur |
| (A01AA04) Stannous fluoride |
| (A01AA30) Combinations |
| (A01AA51) Sodium fluoride, combinations |
| (A01AB) Antiinfectives and antiseptics for local oral treatment |
| (A01AB02) Hydrogen peroxide |
| (A01AB03) Chlorhexidine |
| (A01AB04) Amphotericin B |
| (A01AB05) Polynoxylin |
| (A01AB06) Domiphen |
| (A01AB07) Oxyquinoline |
| (A01AB08) Neomycin |
| (A01AB09) Miconazole |
| (A01AB10) Natamycin |
| (A01AB11) Various |
| (A01AB12) Hexetidine |
| (A01AB13) Tetracycline |
| (A01AB14) Benzoxonium chloride |
| (A01AB15) Tibezonium iodide |
| (A01AB16) Mepartricin |
| (A01AB17) Metronidazole |
| (A01AB18) Clotrimazole |
| (A01AB19) Sodium perborate |
| (A01AB21) Chlortetracycline |
| (A01AB22) Doxycycline |
| (A01AB23) Minocycline |
| (A01AC) Corticosteroids for local oral treatment |
| (A01AC01) Triamcinolone |
| (A01AC02) Dexamethasone |
| (A01AC03) Hydrocortisone |
| (A01AC54) Prednisolone, combinations |
| (A01AD) Other agents for local oral treatment |
| (A01AD01) Epinephrine |
| (A01AD02) Benzydamine |
| (A01AD05) Acetylsalicylic acid |
| (A01AD06) Adrenalone |
| (A01AD07) Amlexanox |
| (A01AD11) Various |
| (A02) DRUGS FOR ACID RELATED DISORDERS |
| (A02A) ANTACIDS |
| (A02AA) Magnesium compounds |
| (A02AA01) Magnesium carbonate |
| (A02AA02) Magnesium oxide |
| (A02AA03) Magnesium peroxide |
| (A02AA04) Magnesium hydroxide |
| (A02AA05) Magnesium silicate |
| (A02AA10) Combinations |
| (A02AB) Aluminium compounds |
| (A02AB01) Aluminium hydroxide |
| (A02AB02) Algeldrate |
| (A02AB03) Aluminium phosphate |
| (A02AB04) Dihydroxialumini sodium carbonate |
| (A02AB05) Aluminium acetoacetate |
| (A02AB06) Aloglutamol |
| (A02AB07) Aluminium glycinate |
| (A02AB10) Combinations |
| (A02AC) Calcium compounds |
| (A02AC01) Calcium carbonate |
| (A02AC02) Calcium silicate |
| (A02AC10) Combinations |
| (A02AD) Combinations and complexes of aluminium, calcium and magnesium compounds |
| (A02AD01) Ordinary salt combinations |
| (A02AD02) Magaldrate |
| (A02AD03) Almagate |
| (A02AD04) Hydrotalcite |
| (A02AD05) Almasilate |
| (A02AF) Antacids with antiflatulents |
| (A02AF01) Magaldrate and antiflatulents |
| (A02AF02) Ordinary salt combinations and antiflatulents |
| (A02AG) Antacids with antispasmodics |
| (A02AH) Antacids with sodium bicarbonate |
| (A02AX) Antacids, other combinations |
| (A02B) DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD) |
| (A02BA) H2-receptor antagonists |
| (A02BA01) Cimetidine |
| (A02BA02) Ranitidine |
| (A02BA03) Famotidine |
| (A02BA04) Nizatidine |
| (A02BA05) Niperotidine |
| (A02BA06) Roxatidine |
| (A02BA07) Ranitidine bismuth citrate |
| (A02BA08) Lafutidine |
| (A02BA51) Cimetidine, combinations |
| (A02BA53) Famotidine, combinations |
| (A02BB) Prostaglandins |
| (A02BB01) Misoprostol |
| (A02BB02) Enprostil |
| (A02BC) Proton pump inhibitors |
| (A02BC01) Omeprazole |
| (A02BC02) Pantoprazole |
| (A02BC03) Lansoprazole |
| (A02BC04) Rabeprazole |
| (A02BC05) Esomeprazole |
| (A02BD) Combinations for eradication of Helicobacter pylori |
| (A02BD01) Omeprazole, amoxicillin and metronidazole |
| (A02BD02) Lansoprazole, tetracycline and metronidazole |
| (A02BD03) Lansoprazole, amoxicillin and metronidazole |
| (A02BD04) Pantoprazole, amoxicillin and clarithromycin |
| (A02BD05) Omeprazole, amoxicillin and clarithromycin |
| (A02BD06) Esomeprazole, amoxicillin and clarithromycin |
| (A02BX) Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD) |
| (A02BX01) Carbenoxolone |
| (A02BX02) Sucralfate |
| (A02BX03) Pirenzepine |
| (A02BX04) Methiosulfonium chloride |
| (A02BX05) Bismuth subcitrate |
| (A02BX06) Proglumide |
| (A02BX07) Gefarnate |
| (A02BX08) Sulglicotide |
| (A02BX09) Acetoxolone |
| (A02BX10) Zolimidine |
| (A02BX11) Troxipide |
| (A02BX12) Bismuth subnitrate |
| (A02BX13) Alginic acid |
| (A02BX51) Carbenoxolone, combinations excl. psycholeptics |
| (A02BX71) Carbenoxolone, combinations with psycholeptics |
| (A02BX77) Gefarnate, combinations with psycholeptics |
| (A02X) OTHER DRUGS FOR ACID RELATED DISORDERS |
| (A03) DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS |
| (A03A) DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| (A03AA) Synthetic anticholinergics, esters with tertiary amino group |
| (A03AA01) Oxyphencyclimine |
| (A03AA03) Camylofin |
| (A03AA04) Mebeverine |
| (A03AA05) Trimebutine |
| (A03AA06) Rociverine |
| (A03AA07) Dicycloverine |
| (A03AA08) Dihexyverine |
| (A03AA09) Difemerine |
| (A03AA30) Piperidolate |
| (A03AB) Synthetic anticholinergics, quaternary ammonium compounds |
| (A03AB01) Benzilone |
| (A03AB02) Glycopyrronium |
| (A03AB03) Oxyphenonium |
| (A03AB04) Penthienate |
| (A03AB05) Propantheline |
| (A03AB06) Otilonium bromide |
| (A03AB07) Methantheline |
| (A03AB08) Tridihexethyl |
| (A03AB09) Isopropamide |
| (A03AB10) Hexocyclium |
| (A03AB11) Poldine |
| (A03AB12) Mepenzolate |
| (A03AB13) Bevonium |
| (A03AB14) Pipenzolate |
| (A03AB15) Diphemanil |
| (A03AB16) (2-benzhydryloxyethyl)diethyl-methylammonium iodide |
| (A03AB17) Tiemonium iodide |
| (A03AB18) Prifinium bromide |
| (A03AB19) Timepidium bromide |
| (A03AB21) Fenpiverinium |
| (A03AB53) Oxyphenonium, combinations |
| (A03AC) Synthetic antispasmodics, amides with tertiary amines |
| (A03AC02) Dimethylaminopropionylphenothiazine |
| (A03AC04) Nicofetamide |
| (A03AC05) Tiropramide |
| (A03AD) Papaverine and derivatives |
| (A03AD01) Papaverine |
| (A03AD02) Drotaverine |
| (A03AD30) Moxaverine |
| (A03AE) Drugs acting on serotonin receptors |
| (A03AE01) Alosetron |
| (A03AE02) Tegaserod |
| (A03AX) Other drugs for functional bowel disorders |
| (A03AX01) Fenpiprane |
| (A03AX02) Diisopromine |
| (A03AX03) Chlorbenzoxamine |
| (A03AX04) Pinaverium |
| (A03AX05) Fenoverine |
| (A03AX06) Idanpramine |
| (A03AX07) Proxazole |
| (A03AX08) Alverine |
| (A03AX09) Trepibutone |
| (A03AX10) Isometheptene |
| (A03AX11) Caroverine |
| (A03AX12) Phloroglucinol |
| (A03AX13) Silicones |
| (A03AX30) Trimethyldiphenylpropylamine |
| (A03AX58) Alverine, combinations |
| (A03B) BELLADONNA AND DERIVATIVES, PLAIN |
| (A03BA) Belladonna alkaloids, tertiary amines |
| (A03BA01) Atropine |
| (A03BA03) Hyoscyamine |
| (A03BA04) Belladonna total alkaloids |
| (A03BB) Belladonna alkaloids, semisynthetic, quaternary ammonium compounds |
| (A03BB01) Butylscopolamine |
| (A03BB02) Methylatropine |
| (A03BB03) Methylscopolamine |
| (A03BB04) Fentonium |
| (A03BB05) Cimetropium bromide |
| (A03C) ANTISPASMODICS IN COMBINATION WITH PSYCHOLEPTICS |
| (A03CA) Synthetic anticholinergic agents in combination with psycholeptics |
| (A03CA01) Isopropamide and psycholeptics |
| (A03CA02) Clidinium and psycholeptics |
| (A03CA03) Oxyphencyclimine and psycholeptics |
| (A03CA04) Otilonium bromide and psycholeptics |
| (A03CA05) Glycopyrronium and psycholeptics |
| (A03CA06) Bevonium and psycholeptics |
| (A03CA07) Ambutonium and psycholeptics |
| (A03CA08) Diphemanil and psycholeptics |
| (A03CA30) Emepronium and psycholeptics |
| (A03CA34) Propantheline and psycholeptics |
| (A03CB) Belladonna and derivatives in combination with psycholeptics |
| (A03CB01) Methylscopolamine and psycholeptics |
| (A03CB02) Belladonna total alkaloids and psycholeptics |
| (A03CB03) Atropine and psycholeptics |
| (A03CB04) Methylhomatropine and psycholeptics |
| (A03CB31) Hyoscyamine and psycholeptics |
| (A03CC) Other antispasmodics in combination with psycholeptics |
| (A03D) ANTISPASMODICS IN COMBINATION WITH ANALGESICS |
| (A03DA) Synthetic anticholinergic agents in combination with analgesics |
| (A03DA01) Tropenzilone and analgesics |
| (A03DA02) Pitofenone and analgesics |
| (A03DA03) Bevonium and analgesics |
| (A03DA04) Ciclonium and analgesics |
| (A03DA05) Camylofin and analgesics |
| (A03DA06) Trospium and analgesics |
| (A03DA07) Tiemonium iodide and analgesics |
| (A03DB) Belladonna and derivatives in combination with analgesics |
| (A03DB04) Butylscopolamine and analgesics |
| (A03DC) Other antispasmodics in combination with analgesics |
| (A03E) ANTISPASMODICS AND ANTICHOLINERGICS IN COMBINATION WITH OTHER DRUGS |
| (A03EA) Antispasmodics, psycholeptics and analgesics in combination |
| (A03ED) Antispasmodics in combination with other drugs |
| (A03F) PROPULSIVES |
| (A03FA) Propulsives |
| (A03FA01) Metoclopramide |
| (A03FA02) Cisapride |
| (A03FA03) Domperidone |
| (A03FA04) Bromopride |
| (A03FA05) Alizapride |
| (A03FA06) Clebopride |
| (A04) ANTIEMETICS AND ANTINAUSEANTS |
| (A04A) ANTIEMETICS AND ANTINAUSEANTS |
| (A04AA) Serotonin (5HT3) antagonists |
| (A04AA01) Ondansetron |
| (A04AA02) Granisetron |
| (A04AA03) Tropisetron |
| (A04AA04) Dolasetron |
| (A04AA05) Palonosetron |
| (A04AD) Other antiemetics |
| (A04AD01) Scopolamine |
| (A04AD02) Cerium oxalate |
| (A04AD04) Chlorobutanol |
| (A04AD05) Metopimazine |
| (A04AD10) Dronabinol |
| (A04AD11) Nabilone |
| (A04AD51) Scopolamine, combinations |
| (A04AD54) Chlorobutanol, combinations |
| (A05) BILE AND LIVER THERAPY |
| (A05A) BILE THERAPY |
| (A05AA) Bile acid preparations |
| (A05AA01) Chenodeoxycholic acid |
| (A05AA02) Ursodeoxycholic acid |
| (A05AB) Preparations for biliary tract therapy |
| (A05AB01) Nicotinyl methylamide |
| (A05AX) Other drugs for bile therapy |
| (A05AX01) Piprozolin |
| (A05AX02) Hymecromone |
| (A05AX03) Cyclobutyrol |
| (A05B) LIVER THERAPY, LIPOTROPICS |
| (A05BA) Liver therapy |
| (A05BA01) Arginine glutamate |
| (A05BA03) Silymarin |
| (A05BA04) Citiolone |
| (A05BA05) Epomediol |
| (A05BA06) Ornithine oxoglurate |
| (A05BA07) Tidiacic arginine |
| (A05C) DRUGS FOR BILE THERAPY AND LIPOTROPICS IN COMBINATION |
| (A06) LAXATIVES |
| (A06A) LAXATIVES |
| (A06AA) Softeners, emollients |
| (A06AA01) Liquid paraffin |
| (A06AA02) Docusate sodium |
| (A06AA51) Liquid paraffin, combinations |
| (A06AB) Contact laxatives |
| (A06AB01) Acetphenolisatin |
| (A06AB02) Bisacodyl |
| (A06AB03) Dantron |
| (A06AB04) Phenolphthalein |
| (A06AB05) Castor oil |
| (A06AB06) Senna glycosides |
| (A06AB07) Cascara |
| (A06AB08) Sodium picosulfate |
| (A06AB09) Bisoxatin |
| (A06AB20) Contact laxatives in combination |
| (A06AB30) Contact laxatives in combination with belladonna alkaloids |
| (A06AB52) Bisacodyl, combinations |
| (A06AB53) Dantron, combinations |
| (A06AB56) Senna glycosides, combinations |
| (A06AB57) Cascara, combinations |
| (A06AB58) Sodium picosulfate, combinations |
| (A06AC) Bulk producers |
| (A06AC01) Ispaghula (psylla seeds) |
| (A06AC02) Ethulose |
| (A06AC03) Sterculia |
| (A06AC05) Linseed |
| (A06AC06) Methylcellulose |
| (A06AC07) Triticum (wheat fibre) |
| (A06AC08) Polycarbophil calcium |
| (A06AC51) Ispaghula, combinations |
| (A06AC53) Sterculia, combinations |
| (A06AC55) Linseed, combinations |
| (A06AD) Osmotically acting laxatives |
| (A06AD01) Magnesium carbonate |
| (A06AD02) Magnesium oxide |
| (A06AD03) Magnesium peroxide |
| (A06AD04) Magnesium sulfate |
| (A06AD10) Mineral salts in combination |
| (A06AD11) Lactulose |
| (A06AD12) Lactitol |
| (A06AD13) Sodium sulfate |
| (A06AD14) Pentaerithrityl |
| (A06AD15) Macrogol |
| (A06AD16) Mannitol |
| (A06AD17) Sodium phosphate |
| (A06AD18) Sorbitol |
| (A06AD19) Magnesium citrate |
| (A06AD21) Sodium tartrate |
| (A06AD61) Lactulose, combinations |
| (A06AD65) Macrogol, combinations |
| (A06AG) Enemas |
| (A06AG01) Sodium phosphate |
| (A06AG02) Bisacodyl |
| (A06AG03) Dantron, incl. combinations |
| (A06AG04) Glycerol |
| (A06AG06) Oil |
| (A06AG07) Sorbitol |
| (A06AG10) Docusate sodium, incl. combinations |
| (A06AG11) Laurilsulfate, incl. combinations |
| (A06AG20) Combinations |
| (A06AX) Other laxatives |
| (A06AX01) Glycerol |
| (A06AX02) Carbon dioxide producing drugs |
| (A07) ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS |
| (A07A) INTESTINAL ANTIINFECTIVES |
| (A07AA) Antibiotics |
| (A07AA01) Neomycin |
| (A07AA02) Nystatin |
| (A07AA03) Natamycin |
| (A07AA04) Streptomycin |
| (A07AA05) Polymyxin B |
| (A07AA06) Paromomycin |
| (A07AA07) Amphotericin B |
| (A07AA08) Kanamycin |
| (A07AA09) Vancomycin |
| (A07AA10) Colistin |
| (A07AA11) Rifaximin |
| (A07AA51) Neomycin, combinations |
| (A07AA54) Streptomycin, combinations |
| (A07AB) Sulfonamides |
| (A07AB02) Phthalylsulfathiazole |
| (A07AB03) Sulfaguanidine |
| (A07AB04) Succinylsulfathiazole |
| (A07AC) Imidazole derivatives |
| (A07AC01) Miconazole |
| (A07AX) Other intestinal antiinfectives |
| (A07AX01) Broxyquinoline |
| (A07AX02) Acetarsol |
| (A07AX03) Nifuroxazide |
| (A07AX04) Nifurzide |
| (A07B) INTESTINAL ADSORBENTS |
| (A07BA) Charcoal preparations |
| (A07BA01) Medicinal charcoal |
| (A07BA51) Medicinal charcoal, combinations |
| (A07BB) Bismuth preparations |
| (A07BC) Other intestinal adsorbents |
| (A07BC01) Pectin |
| (A07BC02) Kaolin |
| (A07BC03) Crospovidone |
| (A07BC04) Attapulgite |
| (A07BC05) Diosmectite |
| (A07BC30) Combinations |
| (A07BC54) Attapulgite, combinations |
| (A07C) ELECTROLYTES WITH CARBOHYDRATES |
| (A07CA) Oral rehydration salt formulations |
| (A07D) ANTIPROPULSIVES |
| (A07DA) Antipropulsives |
| (A07DA01) Diphenoxylate |
| (A07DA02) Opium |
| (A07DA03) Loperamide |
| (A07DA04) Difenoxin |
| (A07DA05) Loperamide oxide |
| (A07DA52) Morphine, combinations |
| (A07DA53) Loperamide, combinations |
| (A07E) INTESTINAL ANTIINFLAMMATORY AGENTS |
| (A07EA) Corticosteroids acting locally |
| (A07EA01) Prednisolone |
| (A07EA02) Hydrocortisone |
| (A07EA03) Prednisone |
| (A07EA04) Betamethasone |
| (A07EA05) Tixocortol |
| (A07EA06) Budesonide |
| (A07EA07) Beclometasone |
| (A07EB) Antiallergic agents, excl. corticosteroids |
| (A07EB01) Cromoglicic acid |
| (A07EC) Aminosalicylic acid and similar agents |
| (A07EC01) Sulfasalazine |
| (A07EC02) Mesalazine |
| (A07EC03) Olsalazine |
| (A07EC04) Balsalazide |
| (A07F) ANTIDIARRHEAL MICROORGANISMS |
| (A07FA) Antidiarrheal microorganisms |
| (A07FA01) Lactic acid producing organisms |
| (A07FA02) Saccharomyces boulardii |
| (A07FA51) Lactic acid producing organisms, combinations |
| (A07X) OTHER ANTIDIARRHEALS |
| (A07XA) Other antidiarrheals |
| (A07XA01) Albumin tannate |
| (A07XA02) Ceratonia |
| (A07XA03) Calcium compounds |
| (A07XA04) Racecadotril |
| (A07XA51) Albumin tannate, combinations |
| (A08) ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| (A08A) ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS |
| (A08AA) Centrally acting antiobesity products |
| (A08AA01) Phentermine |
| (A08AA02) Fenfluramine |
| (A08AA03) Amfepramone |
| (A08AA04) Dexfenfluramine |
| (A08AA05) Mazindol |
| (A08AA06) Etilamfetamine |
| (A08AA07) Cathine |
| (A08AA08) Clobenzorex |
| (A08AA09) Mefenorex |
| (A08AA10) Sibutramine |
| (A08AA56) Ephedrine, combinations |
| (A08AB) Peripherally acting antiobesity products |
| (A08AB01) Orlistat |
| (A09) DIGESTIVES, INCL. ENZYMES |
| (A09A) DIGESTIVES, INCL. ENZYMES |
| (A09AA) Enzyme preparations |
| (A09AA01) Diastase |
| (A09AA02) Multienzymes (lipase, protease etc.) |
| (A09AA03) Pepsin |
| (A09AA04) Tilactase |
| (A09AB) Acid preparations |
| (A09AB01) Glutamic acid hydrochloride |
| (A09AB02) Betaine hydrochloride |
| (A09AB03) Hydrochloric acid |
| (A09AB04) Citric acid |
| (A09AC) Enzyme and acid preparations, combinations |
| (A09AC01) Pepsin and acid preparations |
| (A09AC02) Multienzymes and acid preparations |
| (A10) DRUGS USED IN DIABETES |
| (A10A) INSULINS AND ANALOGUES |
| (A10AB) Insulins and analogues, fast-acting |
| (A10AB01) Insulin (human) |
| (A10AB02) Insulin (beef) |
| (A10AB03) Insulin (pork) |
| (A10AB04) Insulin lispro |
| (A10AB05) Insulin aspart |
| (A10AB30) Combinations |
| (A10AC) Insulins and analogues, intermediate-acting |
| (A10AC01) Insulin (human) |
| (A10AC02) Insulin (beef) |
| (A10AC03) Insulin (pork) |
| (A10AC04) Insulin lispro |
| (A10AC30) Combinations |
| (A10AD) Insulins and analogues, intermediate-acting combined with fast-acting |
| (A10AD01) Insulin (human) |
| (A10AD02) Insulin (beef) |
| (A10AD03) Insulin (pork) |
| (A10AD04) Insulin lispro |
| (A10AD05) Insulin aspart |
| (A10AD30) Combinations |
| (A10AE) Insulins and analogues, long-acting |
| (A10AE01) Insulin (human) |
| (A10AE02) Insulin (beef) |
| (A10AE03) Insulin (pork) |
| (A10AE04) Insulin glargine |
| (A10AE05) Insulin detemir |
| (A10AE30) Combinations |
| (A10B) ORAL BLOOD GLUCOSE LOWERING DRUGS |
| (A10BA) Biguanides |
| (A10BA01) Phenformin |
| (A10BA02) Metformin |
| (A10BA03) Buformin |
| (A10BB) Sulfonamides, urea derivatives |
| (A10BB01) Glibenclamide |
| (A10BB02) Chlorpropamide |
| (A10BB03) Tolbutamide |
| (A10BB04) Glibornuride |
| (A10BB05) Tolazamide |
| (A10BB06) Carbutamide |
| (A10BB07) Glipizide |
| (A10BB08) Gliquidone |
| (A10BB09) Gliclazide |
| (A10BB10) Metahexamide |
| (A10BB11) Glisoxepide |
| (A10BB12) Glimepiride |
| (A10BB31) Acetohexamide |
| (A10BC) Sulfonamides (heterocyclic) |
| (A10BC01) Glymidine |
| (A10BD) Combinations of oral blood glucose lowering drugs |
| (A10BD01) Phenformin and sulfonamides |
| (A10BD02) Metformin and sulfonamides |
| (A10BD03) Metformin and rosiglitazone |
| (A10BF) Alpha glucosidase inhibitors |
| (A10BF01) Acarbose |
| (A10BF02) Miglitol |
| (A10BF03) Voglibose |
| (A10BG) Thiazolidinediones |
| (A10BG01) Troglitazone |
| (A10BG02) Rosiglitazone |
| (A10BG03) Pioglitazone |
| (A10BH) Dipeptidyl peptidase 4 (DPP-4) inhibitors |
| (A10BH01) Sitagliptin |
| (A10BH02) Vildagliptin |
| (A10BH03) Saxagliptin |
| (A10BH04) Alogliptin |
| (A10BX) Other oral blood glucose lowering drugs |
| (A10BX01) Guar gum |
| (A10BX02) Repaglinide |
| (A10BX03) Nateglinide |
| (A10X) OTHER DRUGS USED IN DIABETES |
| (A10XA) Aldose reductase inhibitors |
| (A10XA01) Tolrestat |
| (A11) VITAMINS |
| (A11A) MULTIVITAMINS, COMBINATIONS |
| (A11AA) Multivitamins with minerals |
| (A11AA01) Multivitamins and iron |
| (A11AA02) Multivitamins and calcium |
| (A11AA03) Multivitamins and other minerals, incl. combinations |
| (A11AA04) Multivitamins and trace elements |
| (A11AB) Multivitamins, other combinations |
| (A11B) MULTIVITAMINS, PLAIN |
| (A11BA) Multivitamins, plain |
| (A11C) VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO |
| (A11CA) Vitamin A, plain |
| (A11CA01) Retinol (vit A) |
| (A11CA02) Betacarotene |
| (A11CB) Vitamin A and D in combination |
| (A11CC) Vitamin D and analogues |
| (A11CC01) Ergocalciferol |
| (A11CC02) Dihydrotachysterol |
| (A11CC03) Alfacalcidol |
| (A11CC04) Calcitriol |
| (A11CC05) Colecalciferol |
| (A11CC06) Calcifediol |
| (A11CC20) Combinations |
| (A11D) VITAMIN B1, PLAIN AND IN COMBINATION WITH VITAMIN B6 AND B12 |
| (A11DA) Vitamin B1, plain |
| (A11DA01) Thiamine (vit B1) |
| (A11DA02) Sulbutiamine |
| (A11DB) Vitamin B1 in combination with vitamin B6 and/or vitamin B12 |
| (A11E) VITAMIN B-COMPLEX, INCL. COMBINATIONS |
| (A11EA) Vitamin B-complex, plain |
| (A11EB) Vitamin B-complex with vitamin C |
| (A11EC) Vitamin B-complex with minerals |
| (A11ED) Vitamin B-complex with anabolic steroids |
| (A11EX) Vitamin B-complex, other combinations |
| (A11G) ASCORBIC ACID (VITAMIN C), INCL. COMBINATIONS |
| (A11GA) Ascorbic acid (vitamin C), plain |
| (A11GA01) Ascorbic acid (vit C) |
| (A11GB) Ascorbic acid (vitamin C), combinations |
| (A11GB01) Ascorbic acid (vit C) and calcium |
| (A11H) OTHER PLAIN VITAMIN PREPARATIONS |
| (A11HA) Other plain vitamin preparations |
| (A11HA01) Nicotinamide |
| (A11HA02) Pyridoxine (vit B6) |
| (A11HA03) Tocopherol (vit E) |
| (A11HA04) Riboflavin (vit B2) |
| (A11HA05) Biotin |
| (A11HA06) Pyridoxal phosphate |
| (A11HA07) Inositol |
| (A11HA30) Dexpanthenol |
| (A11HA31) Calcium pantothenate |
| (A11HA32) Pantethine |
| (A11J) OTHER VITAMIN PRODUCTS, COMBINATIONS |
| (A11JA) Combinations of vitamins |
| (A11JB) Vitamins with minerals |
| (A11JC) Vitamins, other combinations |
| (A12) MINERAL SUPPLEMENTS |
| (A12A) CALCIUM |
| (A12AA) Calcium |
| (A12AA01) Calcium phosphate |
| (A12AA02) Calcium glubionate |
| (A12AA03) Calcium gluconate |
| (A12AA04) Calcium carbonate |
| (A12AA05) Calcium lactate |
| (A12AA06) Calcium lactate gluconate |
| (A12AA07) Calcium chloride |
| (A12AA08) Calcium glycerylphosphate |
| (A12AA09) Calcium citrate lysine complex |
| (A12AA10) Calcium glucoheptonate |
| (A12AA11) Calcium pangamate |
| (A12AA12) Calcium acetate anhydrous |
| (A12AA20) Calcium (different salts in combination) |
| (A12AA30) Calcium laevulate |
| (A12AX) Calcium, combinations with other drugs |
| (A12B) POTASSIUM |
| (A12BA) Potassium |
| (A12BA01) Potassium chloride |
| (A12BA02) Potassium citrate |
| (A12BA03) Potassium hydrogentartrate |
| (A12BA04) Potassium hydrogencarbonate |
| (A12BA05) Potassium gluconate |
| (A12BA30) Combinations |
| (A12BA51) Potassium chloride, combinations |
| (A12C) OTHER MINERAL SUPPLEMENTS |
| (A12CA) Sodium |
| (A12CA01) Sodium chloride |
| (A12CA02) Sodium sulfate |
| (A12CB) Zinc |
| (A12CB01) Zinc sulfate |
| (A12CB02) Zinc gluconate |
| (A12CB03) Zinc protein complex |
| (A12CC) Magnesium |
| (A12CC01) Magnesium chloride |
| (A12CC02) Magnesium sulfate |
| (A12CC03) Magnesium gluconate |
| (A12CC04) Magnesium citrate |
| (A12CC05) Magnesium aspartate |
| (A12CC06) Magnesium lactate |
| (A12CC07) Magnesium levulinate |
| (A12CC08) Magnesium pidolate |
| (A12CC09) Magnesium orotate |
| (A12CC10) Magnesium oxide |
| (A12CC30) Magnesium (different salts in combination) |
| (A12CD) Fluoride |
| (A12CD01) Sodium fluoride |
| (A12CD02) Sodium monofluorophosphate |
| (A12CD51) Fluoride, combinations |
| (A12CE) Selenium |
| (A12CE01) Sodium selenate |
| (A12CE02) Sodium selenite |
| (A12CX) Other mineral products |
| (A13) TONICS |
| (A13A) TONICS |
| (A14) ANABOLIC AGENTS FOR SYSTEMIC USE |
| (A14A) ANABOLIC STEROIDS |
| (A14AA) Androstan derivatives |
| (A14AA01) Androstanolone |
| (A14AA02) Stanozolol |
| (A14AA03) Metandienone |
| (A14AA04) Metenolone |
| (A14AA05) Oxymetholone |
| (A14AA06) Quinbolone |
| (A14AA07) Prasterone |
| (A14AA08) Oxandrolone |
| (A14AA09) Norethandrolone |
| (A14AB) Estren derivatives |
| (A14AB01) Nandrolone |
| (A14AB02) Ethylestrenol |
| (A14AB03) Oxabolone cipionate |
| (A14B) OTHER ANABOLIC AGENTS |
| (A15) APPETITE STIMULANTS |
| (A16) OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| (A16A) OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS |
| (A16AA) Amino acids and derivatives |
| (A16AA01) Levocarnitine |
| (A16AA02) Ademetionine |
| (A16AA03) Levoglutamide |
| (A16AA04) Mercaptamine |
| (A16AA05) Carglutamic acid |
| (A16AA06) Betaine |
| (A16AB) Enzymes |
| (A16AB01) Alglucerase |
| (A16AB02) Imiglucerase |
| (A16AB03) Agalsidase alfa |
| (A16AB04) Agalsidase beta |
| (A16AB05) Laronidase |
| (A16AX) Various alimentary tract and metabolism products |
| (A16AX01) Tioctic acid |
| (A16AX02) Anethole trithione |
| (A16AX03) Sodium phenylbutyrate |
| (A16AX04) Nitisinone |
| (A16AX05) Zinc acetate |
| (A16AX06) Miglustat |
| (B) BLOOD AND BLOOD FORMING ORGANS |
| (B01) ANTITHROMBOTIC AGENTS |
| (B01A) ANTITHROMBOTIC AGENTS |
| (B01AA) Vitamin K antagonists |
| (B01AA01) Dicoumarol |
| (B01AA02) Phenindione |
| (B01AA03) Warfarin |
| (B01AA04) Phenprocoumon |
| (B01AA07) Acenocoumarol |
| (B01AA08) Ethyl biscoumacetate |
| (B01AA09) Clorindione |
| (B01AA10) Diphenadione |
| (B01AA11) Tioclomarol |
| (B01AB) Heparin group |
| (B01AB01) Heparin |
| (B01AB02) Antithrombin III |
| (B01AB04) Dalteparin |
| (B01AB05) Enoxaparin |
| (B01AB06) Nadroparin |
| (B01AB07) Parnaparin |
| (B01AB08) Reviparin |
| (B01AB09) Danaparoid |
| (B01AB10) Tinzaparin |
| (B01AB11) Sulodexide |
| (B01AB12) Bemiparin |
| (B01AB51) Heparin, combinations |
| (B01AC) Platelet aggregation inhibitors excl. heparin |
| (B01AC01) Ditazole |
| (B01AC02) Cloricromen |
| (B01AC03) Picotamide |
| (B01AC04) Clopidogrel |
| (B01AC05) Ticlopidine |
| (B01AC06) Acetylsalicylic acid |
| (B01AC07) Dipyridamole |
| (B01AC08) Carbasalate calcium |
| (B01AC09) Epoprostenol |
| (B01AC10) Indobufen |
| (B01AC11) Iloprost |
| (B01AC13) Abciximab |
| (B01AC14) Anagrelide |
| (B01AC15) Aloxiprin |
| (B01AC16) Eptifibatide |
| (B01AC17) Tirofiban |
| (B01AC18) Triflusal |
| (B01AC19) Beraprost |
| (B01AC30) Combinations |
| (B01AD) Enzymes |
| (B01AD01) Streptokinase |
| (B01AD02) Alteplase |
| (B01AD03) Anistreplase |
| (B01AD04) Urokinase |
| (B01AD05) Fibrinolysin |
| (B01AD06) Brinase |
| (B01AD07) Reteplase |
| (B01AD08) Saruplase |
| (B01AD09) Ancrod |
| (B01AD10) Drotrecogin alfa (activated) |
| (B01AD11) Tenecteplase |
| (B01AD12) Protein C |
| (B01AE) Direct thrombin inhibitors |
| (B01AE01) Desirudin |
| (B01AE02) Lepirudin |
| (B01AE03) Argatroban |
| (B01AE04) Melagatran |
| (B01AE05) Ximelagatran |
| (B01AX) Other antithrombotic agents |
| (B01AX01) Defibrotide |
| (B01AX04) Dermatan sulfate |
| (B01AX05) Fondaparinux |
| (B02) ANTIHEMORRHAGICS |
| (B02A) ANTIFIBRINOLYTICS |
| (B02AA) Amino acids |
| (B02AA01) Aminocaproic acid |
| (B02AA02) Tranexamic acid |
| (B02AA03) Aminomethylbenzoic acid |
| (B02AB) Proteinase inhibitors |
| (B02AB01) Aprotinin |
| (B02AB02) Alfa1 antitrypsin |
| (B02AB03) C1-inhibitor |
| (B02AB04) Camostat |
| (B02B) VITAMIN K AND OTHER HEMOSTATICS |
| (B02BA) Vitamin K |
| (B02BA01) Phytomenadione |
| (B02BA02) Menadione |
| (B02BB) Fibrinogen |
| (B02BB01) Human fibrinogen |
| (B02BC) Local hemostatics |
| (B02BC01) Absorbable gelatin sponge |
| (B02BC02) Oxidized cellulose |
| (B02BC03) Tetragalacturonic acid hydroxymethylester |
| (B02BC05) Adrenalone |
| (B02BC06) Thrombin |
| (B02BC07) Collagen |
| (B02BC08) Calcium alginate |
| (B02BC09) Epinephrine |
| (B02BC10) Fibrinogen, human |
| (B02BC30) Combinations |
| (B02BD) Blood coagulation factors |
| (B02BD01) Coagulation factor IX, II, VII and X in combination |
| (B02BD02) Coagulation factor VIII |
| (B02BD03) Factor VIII inhibitor bypassing activity |
| (B02BD04) Coagulation factor IX |
| (B02BD05) Coagulation factor VII |
| (B02BD06) Von Willebrand factor and coagula-tion factor VIII in combination |
| (B02BD07) Coagulation factor XIII |
| (B02BD08) Eptacog alfa (activated) |
| (B02BD09) Nonacog alfa |
| (B02BD30) Thrombin |
| (B02BX) Other systemic hemostatics |
| (B02BX01) Etamsylate |
| (B02BX02) Carbazochrome |
| (B02BX03) Batroxobin |
| (B03) ANTIANEMIC PREPARATIONS |
| (B03A) IRON PREPARATIONS |
| (B03AA) Iron bivalent, oral preparations |
| (B03AA01) Ferrous glycine sulfate |
| (B03AA02) Ferrous fumarate |
| (B03AA03) Ferrous gluconate |
| (B03AA04) Ferrous carbonate |
| (B03AA05) Ferrous chloride |
| (B03AA06) Ferrous succinate |
| (B03AA07) Ferrous sulfate |
| (B03AA08) Ferrous tartrate |
| (B03AA09) Ferrous aspartate |
| (B03AA10) Ferrous ascorbate |
| (B03AA11) Ferrous iodine |
| (B03AB) Iron trivalent, oral preparations |
| (B03AB01) Ferric sodium citrate |
| (B03AB02) Saccharated iron oxide |
| (B03AB03) Sodium feredetate |
| (B03AB04) Ferric hydroxide |
| (B03AB05) Dextriferron |
| (B03AB06) Ferric citrate |
| (B03AB07) Chondroitin sulfate-iron complex |
| (B03AB08) Ferric acetyl transferrin |
| (B03AB09) Ferric proteinsuccinylate |
| (B03AC) Iron trivalent, parenteral preparations |
| (B03AC01) Dextriferron |
| (B03AC02) Saccharated iron oxide |
| (B03AC03) Iron-sorbitol-citric acid complex |
| (B03AC05) Ferric sorbitol gluconic acid complex |
| (B03AC06) Ferric oxide dextran complex |
| (B03AC07) Ferric sodium gluconate complex |
| (B03AD) Iron in combination with folic acid |
| (B03AD01) Ferrous amino acid complex |
| (B03AD02) Ferrous fumarate |
| (B03AD03) Ferrous sulfate |
| (B03AD04) Dextriferron |
| (B03AE) Iron in other combinations |
| (B03AE01) Iron, vitamin B12 and folic acid |
| (B03AE02) Iron, multivitamins and folic acid |
| (B03AE03) Iron and multivitamins |
| (B03AE04) Iron, multivitamins and minerals |
| (B03AE10) Various combinations |
| (B03B) VITAMIN B12 AND FOLIC ACID |
| (B03BA) Vitamin B12 (cyanocobalamin and analogues) |
| (B03BA01) Cyanocobalamin |
| (B03BA02) Cyanocobalamin tannin complex |
| (B03BA03) Hydroxocobalamin |
| (B03BA04) Cobamamide |
| (B03BA05) Mecobalamin |
| (B03BA51) Cyanocobalamin, combinations |
| (B03BA53) Hydroxocobalamin, combinations |
| (B03BB) Folic acid and derivatives |
| (B03BB01) Folic acid |
| (B03BB51) Folic acid, combinations |
| (B03X) OTHER ANTIANEMIC PREPARATIONS |
| (B03XA) Other antianemic preparations |
| (B03XA01) Erythropoietin |
| (B03XA02) Darbepoetin alfa |
| (B05) BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS |
| (B05A) BLOOD AND RELATED PRODUCTS |
| (B05AA) Blood substitutes and plasma protein fractions |
| (B05AA01) Albumin |
| (B05AA02) Other plasma protein fractions |
| (B05AA03) Fluorocarbon blood substitutes |
| (B05AA05) Dextran |
| (B05AA06) Gelatin agents |
| (B05AA07) Hydroxyethylstarch |
| (B05AA08) Hemoglobin crosfumaril |
| (B05AA09) Hemoglobin raffimer |
| (B05B) I.V. SOLUTIONS |
| (B05BA) Solutions for parenteral nutrition |
| (B05BA01) Amino acids |
| (B05BA02) Fat emulsions |
| (B05BA03) Carbohydrates |
| (B05BA04) Protein hydrolysates |
| (B05BA10) Combinations |
| (B05BB) Solutions affecting the electrolyte balance |
| (B05BB01) Electrolytes |
| (B05BB02) Electrolytes with carbohydrates |
| (B05BB03) Trometamol |
| (B05BC) Solutions producing osmotic diuresis |
| (B05BC01) Mannitol |
| (B05BC02) Carbamide |
| (B05C) IRRIGATING SOLUTIONS |
| (B05CA) Antiinfectives |
| (B05CA01) Cetylpyridinium |
| (B05CA02) Chlorhexidine |
| (B05CA03) Nitrofural |
| (B05CA04) Sulfamethizole |
| (B05CA05) Taurolidine |
| (B05CA06) Mandelic acid |
| (B05CA07) Noxytiolin |
| (B05CA08) Ethacridine lactate |
| (B05CA09) Neomycin |
| (B05CA10) Combinations |
| (B05CB) Salt solutions |
| (B05CB01) Sodium chloride |
| (B05CB02) Sodium citrate |
| (B05CB03) Magnesium citrate |
| (B05CB04) Sodium bicarbonate |
| (B05CB10) Combinations |
| (B05CX) Other irrigating solutions |
| (B05CX01) Glucose |
| (B05CX02) Sorbitol |
| (B05CX03) Glycine |
| (B05CX04) Mannitol |
| (B05CX10) Combinations |
| (B05D) PERITONEAL DIALYTICS |
| (B05DA) Isotonic solutions |
| (B05DB) Hypertonic solutions |
| (B05X) I.V. SOLUTION ADDITIVES |
| (B05XA) Electrolyte solutions |
| (B05XA01) Potassium chloride |
| (B05XA02) Sodium bicarbonate |
| (B05XA03) Sodium chloride |
| (B05XA04) Ammonium chloride |
| (B05XA05) Magnesium sulfate |
| (B05XA06) Potassium phosphate, incl. comb. with other potassium salts |
| (B05XA07) Calcium chloride |
| (B05XA08) Sodium acetate |
| (B05XA09) Sodium phosphate |
| (B05XA10) Magnesium phosphate |
| (B05XA11) Magnesium chloride |
| (B05XA12) Zinc chloride |
| (B05XA13) Hydrochloric acid |
| (B05XA14) Sodium glycerophosphate |
| (B05XA15) Potassium lactate |
| (B05XA16) Cardioplegia solutions |
| (B05XA30) Combinations of electrolytes |
| (B05XA31) Electrolytes in combination with other drugs |
| (B05XB) Amino acids |
| (B05XB01) Arginine hydrochloride |
| (B05XB02) Alanyl glutamine |
| (B05XB03) Lysine |
| (B05XC) Vitamins |
| (B05XX) Other i.v. solution additives |
| (B05XX02) Trometamol |
| (B05Z) HEMODIALYTICS AND HEMOFILTRATES |
| (B05ZA) Hemodialytics, concentrates |
| (B05ZB) Hemofiltrates |
| (B06) OTHER HEMATOLOGICAL AGENTS |
| (B06A) OTHER HEMATOLOGICAL AGENTS |
| (B06AA) Enzymes |
| (B06AA02) Fibrinolysin and desoxyribonuclease |
| (B06AA03) Hyaluronidase |
| (B06AA04) Chymotrypsin |
| (B06AA07) Trypsin |
| (B06AA10) Desoxyribonuclease |
| (B06AA11) Bromelains |
| (B06AA55) Streptokinase, combinations |
| (B06AB) Other hem products |
| (B06AB01) Hematin |
| (C) CARDIOVASCULAR SYSTEM |
| (C01) CARDIAC THERAPY |
| (C01A) CARDIAC GLYCOSIDES |
| (C01AA) Digitalis glycosides |
| (C01AA01) Acetyldigitoxin |
| (C01AA02) Acetyldigoxin |
| (C01AA03) Digitalis leaves |
| (C01AA04) Digitoxin |
| (C01AA05) Digoxin |
| (C01AA06) Lanatoside C |
| (C01AA07) Deslanoside |
| (C01AA08) Metildigoxin |
| (C01AA09) Gitoformate |
| (C01AA52) Acetyldigoxin, combinations |
| (C01AB) Scilla glycosides |
| (C01AB01) Proscillaridin |
| (C01AB51) Proscillaridin, combinations |
| (C01AC) Strophantus glycosides |
| (C01AC01) G-strophanthin |
| (C01AC03) Cymarin |
| (C01AX) Other cardiac glycosides |
| (C01AX02) Peruvoside |
| (C01B) ANTIARRHYTHMICS, CLASS I AND III |
| (C01BA) Antiarrhythmics, class Ia |
| (C01BA01) Quinidine |
| (C01BA02) Procainamide |
| (C01BA03) Disopyramide |
| (C01BA04) Sparteine |
| (C01BA05) Ajmaline |
| (C01BA08) Prajmaline |
| (C01BA12) Lorajmine |
| (C01BA51) Quinidine, combinations excl. psycholeptics |
| (C01BA71) Quinidine, combinations with psycholeptics |
| (C01BB) Antiarrhythmics, class Ib |
| (C01BB01) Lidocaine |
| (C01BB02) Mexiletine |
| (C01BB03) Tocainide |
| (C01BB04) Aprindine |
| (C01BC) Antiarrhythmics, class Ic |
| (C01BC03) Propafenone |
| (C01BC04) Flecainide |
| (C01BC07) Lorcainide |
| (C01BC08) Encainide |
| (C01BD) Antiarrhythmics, class III |
| (C01BD01) Amiodarone |
| (C01BD02) Bretylium tosilate |
| (C01BD03) Bunaftine |
| (C01BD04) Dofetilide |
| (C01BD05) Ibutilide |
| (C01BG) Other class I antiarrhythmics |
| (C01BG01) Moracizine |
| (C01BG07) Cibenzoline |
| (C01C) CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| (C01CA) Adrenergic and dopaminergic agents |
| (C01CA01) Etilefrine |
| (C01CA02) Isoprenaline |
| (C01CA03) Norepinephrine |
| (C01CA04) Dopamine |
| (C01CA05) Norfenefrine |
| (C01CA06) Phenylephrine |
| (C01CA07) Dobutamine |
| (C01CA08) Oxedrine |
| (C01CA09) Metaraminol |
| (C01CA10) Methoxamine |
| (C01CA11) Mephentermine |
| (C01CA12) Dimetofrine |
| (C01CA13) Prenalterol |
| (C01CA14) Dopexamine |
| (C01CA15) Gepefrine |
| (C01CA16) Ibopamine |
| (C01CA17) Midodrine |
| (C01CA18) Octopamine |
| (C01CA19) Fenoldopam |
| (C01CA21) Cafedrine |
| (C01CA22) Arbutamine |
| (C01CA23) Theodrenaline |
| (C01CA24) Epinephrine |
| (C01CA30) Combinations |
| (C01CA51) Etilefrine, combinations |
| (C01CE) Phosphodiesterase inhibitors |
| (C01CE01) Amrinone |
| (C01CE02) Milrinone |
| (C01CE03) Enoximone |
| (C01CE04) Bucladesine |
| (C01CX) Other cardiac stimulants |
| (C01CX06) Angiotensinamide |
| (C01CX07) Xamoterol |
| (C01CX08) Levosimendan |
| (C01D) VASODILATORS USED IN CARDIAC DISEASES |
| (C01DA) Organic nitrates |
| (C01DA02) Glyceryl trinitrate |
| (C01DA04) Methylpropylpropanediol dinitrate |
| (C01DA05) Pentaerithrityl tetranitrate |
| (C01DA07) Propatylnitrate |
| (C01DA08) Isosorbide dinitrate |
| (C01DA09) Trolnitrate |
| (C01DA13) Eritrityl tetranitrate |
| (C01DA14) Isosorbide mononitrate |
| (C01DA20) Organic nitrates in combination |
| (C01DA38) Tenitramine |
| (C01DA52) Glyceryl trinitrate, combinations |
| (C01DA54) Methylpropylpropanediol dinitrate, combinations |
| (C01DA55) Pentaerithrityl tetranitrate, combinations |
| (C01DA57) Propatylnitrate, combinations |
| (C01DA58) Isosorbide dinitrate, combinations |
| (C01DA59) Trolnitrate, combinations |
| (C01DA63) Eritrityl tetranitrate, combinations |
| (C01DA70) Organic nitrates in combination with psycholeptics |
| (C01DB) Quinolone vasodilators |
| (C01DB01) Flosequinan |
| (C01DX) Other vasodilators used in cardiac diseases |
| (C01DX01) Itramin tosilate |
| (C01DX02) Prenylamine |
| (C01DX03) Oxyfedrine |
| (C01DX04) Benziodarone |
| (C01DX05) Carbocromen |
| (C01DX06) Hexobendine |
| (C01DX07) Etafenone |
| (C01DX08) Heptaminol |
| (C01DX09) Imolamine |
| (C01DX10) Dilazep |
| (C01DX11) Trapidil |
| (C01DX12) Molsidomine |
| (C01DX13) Efloxate |
| (C01DX14) Cinepazet |
| (C01DX15) Cloridarol |
| (C01DX16) Nicorandil |
| (C01DX18) Linsidomine |
| (C01DX19) Nesiritide |
| (C01DX51) Itramin tosilate, combinations |
| (C01DX52) Prenylamine, combinations |
| (C01DX53) Oxyfedrine, combinations |
| (C01DX54) Benziodarone, combinations |
| (C01E) OTHER CARDIAC PREPARATIONS |
| (C01EA) Prostaglandins |
| (C01EA01) Alprostadil |
| (C01EB) Other cardiac preparations |
| (C01EB02) Camphora |
| (C01EB03) Indometacin |
| (C01EB04) Crataegus glycosides |
| (C01EB05) Creatinolfosfate |
| (C01EB06) Fosfocreatine |
| (C01EB07) Fructose 1,6-diphosphate |
| (C01EB09) Ubidecarenone |
| (C01EB10) Adenosine |
| (C01EB11) Tiracizine |
| (C01EB12) Tedisamil |
| (C01EB13) Acadesine |
| (C01EB15) Trimetazidine |
| (C01EX) Other cardiac combination products |
| (C02) ANTIHYPERTENSIVES |
| (C02A) ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| (C02AA) Rauwolfia alkaloids |
| (C02AA01) Rescinnamine |
| (C02AA02) Reserpine |
| (C02AA03) Combinations of rauwolfia alkaloids |
| (C02AA04) Rauwolfia alkaloids, whole root |
| (C02AA05) Deserpidine |
| (C02AA06) Methoserpidine |
| (C02AA07) Bietaserpine |
| (C02AA52) Reserpine, combinations |
| (C02AA53) Combinations of rauwolfia alkoloids, combinations |
| (C02AA57) Bietaserpine, combinations |
| (C02AB) Methyldopa |
| (C02AB01) Methyldopa (levorotatory) |
| (C02AB02) Methyldopa (racemic) |
| (C02AC) Imidazoline receptor agonists |
| (C02AC01) Clonidine |
| (C02AC02) Guanfacine |
| (C02AC04) Tolonidine |
| (C02AC05) Moxonidine |
| (C02AC06) Rilmenidine |
| (C02B) ANTIADRENERGIC AGENTS, GANGLION-BLOCKING |
| (C02BA) Sulfonium derivatives |
| (C02BA01) Trimetaphan |
| (C02BB) Secondary and tertiary amines |
| (C02BB01) Mecamylamine |
| (C02BC) Bisquaternary ammonium compounds |
| (C02C) ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING |
| (C02CA) Alpha-adrenoreceptor antagonists |
| (C02CA01) Prazosin |
| (C02CA02) Indoramin |
| (C02CA03) Trimazosin |
| (C02CA04) Doxazosin |
| (C02CA06) Urapidil |
| (C02CC) Guanidine derivatives |
| (C02CC01) Betanidine |
| (C02CC02) Guanethidine |
| (C02CC03) Guanoxan |
| (C02CC04) Debrisoquine |
| (C02CC05) Guanoclor |
| (C02CC06) Guanazodine |
| (C02CC07) Guanoxabenz |
| (C02D) ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON |
| (C02DA) Thiazide derivatives |
| (C02DA01) Diazoxide |
| (C02DB) Hydrazinophthalazine derivatives |
| (C02DB01) Dihydralazine |
| (C02DB02) Hydralazine |
| (C02DB03) Endralazine |
| (C02DB04) Cadralazine |
| (C02DC) Pyrimidine derivatives |
| (C02DC01) Minoxidil |
| (C02DD) Nitroferricyanide derivatives |
| (C02DD01) Nitroprusside |
| (C02DG) Guanidine derivatives |
| (C02DG01) Pinacidil |
| (C02K) OTHER ANTIHYPERTENSIVES |
| (C02KA) Alkaloids, excl. rauwolfia |
| (C02KA01) Veratrum |
| (C02KB) Tyrosine hydroxylase inhibitors |
| (C02KB01) Metirosine |
| (C02KC) MAO inhibitors |
| (C02KC01) Pargyline |
| (C02KD) Serotonin antagonists |
| (C02KD01) Ketanserin |
| (C02KX) Other antihypertensives |
| (C02KX01) Bosentan |
| (C02L) ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION |
| (C02LA) Rauwolfia alkaloids and diuretics in combination |
| (C02LA01) Reserpine and diuretics |
| (C02LA02) Rescinnamine and diuretics |
| (C02LA03) Deserpidine and diuretics |
| (C02LA04) Methoserpidine and diuretics |
| (C02LA07) Bietaserpine and diuretics |
| (C02LA08) Rauwolfia alkaloids, whole root and diuretics |
| (C02LA09) Syrosingopine and diuretics |
| (C02LA50) Comb. of rauwolfia alkaloids and diuretics incl. other combinations |
| (C02LA51) Reserpine and diuretics, combinations with other drugs |
| (C02LA52) Rescinnamine and diuretics, combinations with other drugs |
| (C02LA71) Reserpine and diuretics, combinations with psycholeptics |
| (C02LB) Methyldopa and diuretics in combination |
| (C02LB01) Methyldopa (levorotatory) and diuretics |
| (C02LC) Imidazoline receptor agonists in combination with diuretics |
| (C02LC01) Clonidine and diuretics |
| (C02LC05) Moxonidine and diuretics |
| (C02LC51) Clonidine and diuretics, combinations with other drugs |
| (C02LE) Alpha-adrenoreceptor antagonists and diuretics |
| (C02LE01) Prazosin and diuretics |
| (C02LF) Guanidine derivatives and diuretics |
| (C02LF01) Guanethidine and diuretics |
| (C02LG) Hydrazinophthalazine derivatives and diuretics |
| (C02LG01) Dihydralazine and diuretics |
| (C02LG02) Hydralazine and diuretics |
| (C02LG03) Picodralazine and diuretics |
| (C02LG51) Dihydralazine and diuretics, combinations with other drugs |
| (C02LG73) Picodralazine and diuretics, combinations with psycholeptics |
| (C02LK) Alkaloids, excl. rauwolfia, in combination with diuretics |
| (C02LK01) Veratrum and diuretics |
| (C02LL) MAO inhibitors and diuretics |
| (C02LL01) Pargyline and diuretics |
| (C02LN) Serotonin antagonists and diuretics |
| (C02LX) Other antihypertensives and diuretics |
| (C02LX01) Pinacidil and diuretics |
| (C02N) COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02 |
| (C03) DIURETICS |
| (C03A) LOW-CEILING DIURETICS, THIAZIDES |
| (C03AA) Thiazides, plain |
| (C03AA01) Bendroflumethiazide |
| (C03AA02) Hydroflumethiazide |
| (C03AA03) Hydrochlorothiazide |
| (C03AA04) Chlorothiazide |
| (C03AA05) Polythiazide |
| (C03AA06) Trichlormethiazide |
| (C03AA07) Cyclopenthiazide |
| (C03AA08) Methyclothiazide |
| (C03AA09) Cyclothiazide |
| (C03AA13) Mebutizide |
| (C03AB) Thiazides and potassium in combination |
| (C03AB01) Bendroflumethiazide and potassium |
| (C03AB02) Hydroflumethiazide and potassium |
| (C03AB03) Hydrochlorothiazide and potassium |
| (C03AB04) Chlorothiazide and potassium |
| (C03AB05) Polythiazide and potassium |
| (C03AB06) Trichlormethiazide and potassium |
| (C03AB07) Cyclopenthiazide and potassium |
| (C03AB08) Methyclothiazide and potassium |
| (C03AB09) Cyclothiazide and potassium |
| (C03AH) Thiazides, combinations with psycholeptics and/or analgesics |
| (C03AH01) Chlorothiazide, combinations |
| (C03AH02) Hydroflumethiazide, combinations |
| (C03AX) Thiazides, combinations with other drugs |
| (C03AX01) Hydrochlorothiazide, combinations |
| (C03B) LOW-CEILING DIURETICS, EXCL. THIAZIDES |
| (C03BA) Sulfonamides, plain |
| (C03BA02) Quinethazone |
| (C03BA03) Clopamide |
| (C03BA04) Chlortalidone |
| (C03BA05) Mefruside |
| (C03BA07) Clofenamide |
| (C03BA08) Metolazone |
| (C03BA09) Meticrane |
| (C03BA10) Xipamide |
| (C03BA11) Indapamide |
| (C03BA12) Clorexolone |
| (C03BA13) Fenquizone |
| (C03BA82) Clorexolone, comb. with psycholeptics |
| (C03BB) Sulfonamides and potassium in combination |
| (C03BB02) Quinethazone and potassium |
| (C03BB03) Clopamide and potassium |
| (C03BB04) Chlortalidone and potassium |
| (C03BB05) Mefruside and potassium |
| (C03BB07) Clofenamide and potassium |
| (C03BC) Mercurial diuretics |
| (C03BC01) Mersalyl |
| (C03BD) Xanthine derivatives |
| (C03BD01) Theobromine |
| (C03BK) Sulfonamides, combinations with other drugs |
| (C03BX) Other low-ceiling diuretics |
| (C03BX03) Cicletanine |
| (C03C) HIGH-CEILING DIURETICS |
| (C03CA) Sulfonamides, plain |
| (C03CA01) Furosemide |
| (C03CA02) Bumetanide |
| (C03CA03) Piretanide |
| (C03CA04) Torasemide |
| (C03CB) Sulfonamides and potassium in combination |
| (C03CB01) Furosemide and potassium |
| (C03CB02) Bumetanide and potassium |
| (C03CC) Aryloxyacetic acid derivatives |
| (C03CC01) Etacrynic acid |
| (C03CC02) Tienilic acid |
| (C03CD) Pyrazolone derivatives |
| (C03CD01) Muzolimine |
| (C03CX) Other high-ceiling diuretics |
| (C03CX01) Etozolin |
| (C03D) POTASSIUM-SPARING AGENTS |
| (C03DA) Aldosterone antagonists |
| (C03DA01) Spironolactone |
| (C03DA02) Potassium canrenoate |
| (C03DA03) Canrenone |
| (C03DB) Other potassium-sparing agents |
| (C03DB01) Amiloride |
| (C03DB02) Triamterene |
| (C03E) DIURETICS AND POTASSIUM-SPARING AGENTS IN COMBINATION |
| (C03EA) Low-ceiling diuretics and potassium-sparing agents |
| (C03EA01) Hydrochlorothiazide and potassium-sparing agents |
| (C03EA02) Trichlormethiazide and potassium-sparing agents |
| (C03EA03) Epitizide and potassium-sparing agents |
| (C03EA04) Altizide and potassium-sparing agents |
| (C03EA05) Mebutizide and potassium-sparing agents |
| (C03EA06) Chlortalidone and potassium-sparing agents |
| (C03EA07) Cyclopenthiazide and potassium-sparing agents |
| (C03EA12) Metolazone and potassium-sparing agents |
| (C03EA13) Bendroflumethiazide and potassium-sparing agents |
| (C03EA14) Butizide and potassium-sparing agents |
| (C03EB) High-ceiling diuretics and potassium-sparing agents |
| (C03EB01) Furosemide and potassium-sparing agents |
| (C03EB02) Bumetanide and potassium-sparing agents |
| (C04) PERIPHERAL VASODILATORS |
| (C04A) PERIPHERAL VASODILATORS |
| (C04AA) 2-amino-1-phenylethanol derivatives |
| (C04AA01) Isoxsuprine |
| (C04AA02) Buphenine |
| (C04AA31) Bamethan |
| (C04AB) Imidazoline derivatives |
| (C04AB01) Phentolamine |
| (C04AB02) Tolazoline |
| (C04AC) Nicotinic acid and derivatives |
| (C04AC01) Nicotinic acid |
| (C04AC02) Nicotinyl alcohol (pyridylcarbinol) |
| (C04AC03) Inositol nicotinate |
| (C04AC07) Ciclonicate |
| (C04AD) Purine derivatives |
| (C04AD01) Pentifylline |
| (C04AD02) Xantinol nicotinate |
| (C04AD03) Pentoxifylline |
| (C04AD04) Etofylline nicotinate |
| (C04AE) Ergot alkaloids |
| (C04AE01) Ergoloid mesylates |
| (C04AE02) Nicergoline |
| (C04AE04) Dihydroergocristine |
| (C04AE51) Ergoloid mesylates, combinations |
| (C04AE54) Dihydroergocristine, combinations |
| (C04AF) Enzymes |
| (C04AF01) Kallidinogenase |
| (C04AX) Other peripheral vasodilators |
| (C04AX01) Cyclandelate |
| (C04AX02) Phenoxybenzamine |
| (C04AX07) Vincamine |
| (C04AX10) Moxisylyte |
| (C04AX11) Bencyclane |
| (C04AX13) Piribedil |
| (C04AX17) Vinburnine |
| (C04AX19) Sulcotidil |
| (C04AX20) Buflomedil |
| (C04AX21) Naftidrofuryl |
| (C04AX23) Butalamine |
| (C04AX24) Visnadine |
| (C04AX26) Cetiedil |
| (C04AX27) Cinepazide |
| (C04AX28) Ifenprodil |
| (C04AX30) Azapetine |
| (C04AX32) Fasudil |
| (C05) VASOPROTECTIVES |
| (C05A) ANTIHEMORRHOIDALS FOR TOPICAL USE |
| (C05AA) Products containing corticosteroids |
| (C05AA01) Hydrocortisone |
| (C05AA04) Prednisolone |
| (C05AA05) Betamethasone |
| (C05AA06) Fluorometholone |
| (C05AA08) Fluocortolone |
| (C05AA09) Dexamethasone |
| (C05AA10) Fluocinolone acetonide |
| (C05AA11) Fluocinonide |
| (C05AB) Products containing antibiotics |
| (C05AD) Products containing local anesthetics |
| (C05AD01) Lidocaine |
| (C05AD02) Tetracaine |
| (C05AD03) Benzocaine |
| (C05AD04) Cinchocaine |
| (C05AD05) Procaine |
| (C05AD06) Oxetacaine |
| (C05AD07) Pramocaine |
| (C05AX) Other antihemorrhoidals for topical use |
| (C05AX01) Aluminium preparations |
| (C05AX02) Bismuth preparations, combinations |
| (C05AX03) Other preparations, combinations |
| (C05AX04) Zinc preparations |
| (C05AX05) Tribenoside |
| (C05B) ANTIVARICOSE THERAPY |
| (C05BA) Heparins or heparinoids for topical use |
| (C05BA01) Organo-heparinoid |
| (C05BA02) Sodium apolate |
| (C05BA03) Heparin |
| (C05BA04) Pentosan polysulfate sodium |
| (C05BA51) Heparinoid, combinations |
| (C05BA53) Heparin, combinations |
| (C05BB) Sclerosing agents for local injection |
| (C05BB01) Monoethanolamine oleate |
| (C05BB02) Polidocanol |
| (C05BB03) Invert sugar |
| (C05BB04) Sodium tetradecyl sulfate |
| (C05BB05) Phenol |
| (C05BB56) Glucose, combinations |
| (C05BX) Other sclerosing agents |
| (C05BX01) Calcium dobesilate |
| (C05BX51) Calcium dobesilate, combinations |
| (C05C) CAPILLARY STABILIZING AGENTS |
| (C05CA) Bioflavonoids |
| (C05CA01) Rutoside |
| (C05CA02) Monoxerutin |
| (C05CA03) Diosmin |
| (C05CA04) Troxerutin |
| (C05CA05) Hidrosmin |
| (C05CA51) Rutoside, combinations |
| (C05CA53) Diosmin, combinations |
| (C05CA54) Troxerutin, combinations |
| (C05CX) Other capillary stabilizing agents |
| (C05CX01) Tribenoside |
| (C07) BETA BLOCKING AGENTS |
| (C07A) BETA BLOCKING AGENTS |
| (C07AA) Beta blocking agents, non-selective |
| (C07AA01) Alprenolol |
| (C07AA02) Oxprenolol |
| (C07AA03) Pindolol |
| (C07AA05) Propranolol |
| (C07AA06) Timolol |
| (C07AA07) Sotalol |
| (C07AA12) Nadolol |
| (C07AA14) Mepindolol |
| (C07AA15) Carteolol |
| (C07AA16) Tertatolol |
| (C07AA17) Bopindolol |
| (C07AA19) Bupranolol |
| (C07AA23) Penbutolol |
| (C07AA27) Cloranolol |
| (C07AA57) Sotalol, combination packages |
| (C07AB) Beta blocking agents, selective |
| (C07AB01) Practolol |
| (C07AB02) Metoprolol |
| (C07AB03) Atenolol |
| (C07AB04) Acebutolol |
| (C07AB05) Betaxolol |
| (C07AB06) Bevantolol |
| (C07AB07) Bisoprolol |
| (C07AB08) Celiprolol |
| (C07AB09) Esmolol |
| (C07AB10) Epanolol |
| (C07AB11) S-atenolol |
| (C07AB12) Nebivolol |
| (C07AB13) Talinolol |
| (C07AB52) Metoprolol, combination packages |
| (C07AG) Alpha and beta blocking agents |
| (C07AG01) Labetalol |
| (C07AG02) Carvedilol |
| (C07B) BETA BLOCKING AGENTS AND THIAZIDES |
| (C07BA) Beta blocking agents, non-selective, and thiazides |
| (C07BA02) Oxprenolol and thiazides |
| (C07BA05) Propranolol and thiazides |
| (C07BA06) Timolol and thiazides |
| (C07BA07) Sotalol and thiazides |
| (C07BA12) Nadolol and thiazides |
| (C07BA68) Metipranolol and thiazides, combinations |
| (C07BB) Beta blocking agents, selective, and thiazides |
| (C07BB02) Metoprolol and thiazides |
| (C07BB03) Atenolol and thiazides |
| (C07BB04) Acebutolol and thiazides |
| (C07BB06) Bevantolol and thiazides |
| (C07BB07) Bisoprolol and thiazides |
| (C07BB52) Metoprolol and thiazides, combinations |
| (C07BG) Alpha and beta blocking agents and thiazides |
| (C07BG01) Labetalol and thiazides |
| (C07C) BETA BLOCKING AGENTS AND OTHER DIURETICS |
| (C07CA) Beta blocking agents, non-selective, and other diuretics |
| (C07CA02) Oxprenolol and other diuretics |
| (C07CA03) Pindolol and other diuretics |
| (C07CA17) Bopindolol and other diuretics |
| (C07CA23) Penbutolol and other diuretics |
| (C07CB) Beta blocking agents, selective, and other diuretics |
| (C07CB02) Metoprolol and other diuretics |
| (C07CB03) Atenolol and other diuretics |
| (C07CB53) Atenolol and other diuretics, combinations |
| (C07CG) Alpha and beta blocking agents and other diuretics |
| (C07CG01) Labetalol and other diuretics |
| (C07D) BETA BLOCKING AGENTS, THIAZIDES AND OTHER DIURETICS |
| (C07DA) Beta blocking agents, non-selective, thiazides and other diuretics |
| (C07DA06) Timolol, thiazides and other diuretics |
| (C07DB) Beta blocking agents, selective, thiazides and other diuretics |
| (C07DB01) Atenolol, thiazides and other diuretics |
| (C07E) BETA BLOCKING AGENTS AND VASODILATORS |
| (C07EA) Beta blocking agents, non-selective, and vasodilators |
| (C07EB) Beta blocking agents, selective, and vasodilators |
| (C07F) BETA BLOCKING AGENTS AND OTHER ANTIHYPERTENSIVES |
| (C07FA) Beta blocking agents, non-selective, and other antihypertensives |
| (C07FA05) Propranolol and other antihypertensives |
| (C07FB) Beta blocking agents, selective, and other antihypertensives |
| (C07FB02) Metoprolol and other antihypertensives |
| (C07FB03) Atenolol and other antihypertensives |
| (C08) CALCIUM CHANNEL BLOCKERS |
| (C08C) SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR EFFECTS |
| (C08CA) Dihydropyridine derivatives |
| (C08CA01) Amlodipine |
| (C08CA02) Felodipine |
| (C08CA03) Isradipine |
| (C08CA04) Nicardipine |
| (C08CA05) Nifedipine |
| (C08CA06) Nimodipine |
| (C08CA07) Nisoldipine |
| (C08CA08) Nitrendipine |
| (C08CA09) Lacidipine |
| (C08CA10) Nilvadipine |
| (C08CA11) Manidipine |
| (C08CA12) Barnidipine |
| (C08CA13) Lercanidipine |
| (C08CA14) Cilnidipine |
| (C08CA15) Benidipine |
| (C08CA55) Nifedipine, combinations |
| (C08CX) Other selective calcium channel blockers with mainly vascular effects |
| (C08CX01) Mibefradil |
| (C08D) SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS |
| (C08DA) Phenylalkylamine derivatives |
| (C08DA01) Verapamil |
| (C08DA02) Gallopamil |
| (C08DA51) Verapamil, combinations |
| (C08DB) Benzothiazepine derivatives |
| (C08DB01) Diltiazem |
| (C08E) NON-SELECTIVE CALCIUM CHANNEL BLOCKERS |
| (C08EA) Phenylalkylamine derivatives |
| (C08EA01) Fendiline |
| (C08EA02) Bepridil |
| (C08EX) Other non-selective calcium channel blockers |
| (C08EX01) Lidoflazine |
| (C08EX02) Perhexiline |
| (C08G) CALCIUM CHANNEL BLOCKERS AND DIURETICS |
| (C08GA) Calcium channel blockers and diuretics |
| (C08GA01) Nifedipine and diuretics |
| (C09) AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| (C09A) ACE INHIBITORS, PLAIN |
| (C09AA) ACE inhibitors, plain |
| (C09AA01) Captopril |
| (C09AA02) Enalapril |
| (C09AA03) Lisinopril |
| (C09AA04) Perindopril |
| (C09AA05) Ramipril |
| (C09AA06) Quinapril |
| (C09AA07) Benazepril |
| (C09AA08) Cilazapril |
| (C09AA09) Fosinopril |
| (C09AA10) Trandolapril |
| (C09AA11) Spirapril |
| (C09AA12) Delapril |
| (C09AA13) Moexipril |
| (C09AA14) Temocapril |
| (C09AA15) Zofenopril |
| (C09AA16) Imidapril |
| (C09B) ACE INHIBITORS, COMBINATIONS |
| (C09BA) ACE inhibitors and diuretics |
| (C09BA01) Captopril and diuretics |
| (C09BA02) Enalapril and diuretics |
| (C09BA03) Lisinopril and diuretics |
| (C09BA04) Perindopril and diuretics |
| (C09BA05) Ramipril and diuretics |
| (C09BA06) Quinapril and diuretics |
| (C09BA07) Benazepril and diuretics |
| (C09BA08) Cilazapril and diuretics |
| (C09BA09) Fosinopril and diuretics |
| (C09BA12) Delapril and diuretics |
| (C09BA13) Moexipril and diuretics |
| (C09BB) ACE inhibitors and calcium channel blockers |
| (C09BB05) Ramipril and calcium channel blockers |
| (C09BB10) Trandolapril and calcium channel blockers |
| (C09BB12) Delapril and calcium channel blockers |
| (C09C) ANGIOTENSIN II ANTAGONISTS, PLAIN |
| (C09CA) Angiotensin II antagonists, plain |
| (C09CA01) Losartan |
| (C09CA02) Eprosartan |
| (C09CA03) Valsartan |
| (C09CA04) Irbesartan |
| (C09CA05) Tasosartan |
| (C09CA06) Candesartan |
| (C09CA07) Telmisartan |
| (C09D) ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| (C09DA) Angiotensin II antagonists and diuretics |
| (C09DA01) Losartan and diuretics |
| (C09DA02) Eprosartan and diuretics |
| (C09DA03) Valsartan and diuretics |
| (C09DA04) Irbesartan and diuretics |
| (C09DA06) Candesartan and diuretics |
| (C09DA07) Telmisartan and diuretics |
| (C09DB) Angiotensin II antagonists and calcium channel blockers |
| (C09DB01) Valsartan and amlodipine |
| (C09DB02) Olmesartan medoxomil and amlodipine |
| (C09DB03) Telmisartan and amlodipine |
| (C09DX) Angiotensin II antagonists, other combinations |
| (C09DX01) Valsartan, amlodipine and hydrochlorothiazide |
| (C09DX02) Valsartan and aliskiren |
| (C09X) OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM |
| (C09XA) Renin-inhibitors |
| (C09XA01) Remikiren |
| (C09XA02) Aliskiren |
| (C09XA52) Aliskiren and hydrochlorothiazide |
| (C10) SERUM LIPID REDUCING AGENTS |
| (C10A) CHOLESTEROL AND TRIGLYCERIDE REDUCERS |
| (C10AA) HMG CoA reductase inhibitors |
| (C10AA01) Simvastatin |
| (C10AA02) Lovastatin |
| (C10AA03) Pravastatin |
| (C10AA04) Fluvastatin |
| (C10AA05) Atorvastatin |
| (C10AA06) Cerivastatin |
| (C10AA07) Rosuvastatin |
| (C10AA51) Simvastatin, combination packages |
| (C10AA52) Lovastatin, combinations |
| (C10AB) Fibrates |
| (C10AB01) Clofibrate |
| (C10AB02) Bezafibrate |
| (C10AB03) Aluminium clofibrate |
| (C10AB04) Gemfibrozil |
| (C10AB05) Fenofibrate |
| (C10AB06) Simfibrate |
| (C10AB07) Ronifibrate |
| (C10AB08) Ciprofibrate |
| (C10AB09) Etofibrate |
| (C10AB10) Clofibride |
| (C10AC) Bile acid sequestrants |
| (C10AC01) Colestyramine |
| (C10AC02) Colestipol |
| (C10AC03) Detaxtran |
| (C10AC04) Colesevelam |
| (C10AD) Nicotinic acid and derivatives |
| (C10AD01) Niceritrol |
| (C10AD02) Nicotinic acid |
| (C10AD03) Nicofuranose |
| (C10AD04) Aluminium nicotinate |
| (C10AD05) Nicotinyl alcohol (pyridylcarbinol) |
| (C10AD06) Acipimox |
| (C10AX) Other cholesterol and triglyceride reducers |
| (C10AX01) Dextrothyroxine |
| (C10AX02) Probucol |
| (C10AX03) Tiadenol |
| (C10AX04) Benfluorex |
| (C10AX05) Meglutol |
| (C10AX06) Omega-3-triglycerides |
| (C10AX07) Magnesium pyridoxal 5-phosphate glutamate |
| (C10AX08) Policosanol |
| (C10AX09) Ezetimibe |
| (C10B) LIPID MODIFYING AGENTS, COMBINATIONS |
| (C10BA) HMG CoA reductase inhibitors in combination with other lipid modifying agents |
| (C10BA01) Lovastatin and nicotinic acid |
| (C10BA02) Simvastatin and ezetimibe |
| (C10BA03) Pravastatin and fenofibrate |
| (C10BX) HMG CoA reductase inhibitors, other combinations |
| (C10BX01) Simvastatin and acetylsalicylic acid? |
| (C10BX02) Pravastatin and acetylsalicylic acid? |
| (C10BX03) Atorvastatin and amlodipine |
| (D) DERMATOLOGICALS |
| (D01) ANTIFUNGALS FOR DERMATOLOGICAL USE |
| (D01A) ANTIFUNGALS FOR TOPICAL USE |
| (D01AA) Antibiotics |
| (D01AA01) Nystatin |
| (D01AA02) Natamycin |
| (D01AA03) Hachimycin |
| (D01AA04) Pecilocin |
| (D01AA06) Mepartricin |
| (D01AA07) Pyrrolnitrin |
| (D01AA08) Griseofulvin |
| (D01AA20) Combinations |
| (D01AC) Imidazole and triazole derivatives |
| (D01AC01) Clotrimazole |
| (D01AC02) Miconazole |
| (D01AC03) Econazole |
| (D01AC04) Clomidazole |
| (D01AC05) Isoconazole |
| (D01AC06) Tiabendazole |
| (D01AC07) Tioconazole |
| (D01AC08) Ketoconazole |
| (D01AC09) Sulconazole |
| (D01AC10) Bifonazole |
| (D01AC11) Oxiconazole |
| (D01AC12) Fenticonazole |
| (D01AC13) Omoconazole |
| (D01AC14) Sertaconazole |
| (D01AC15) Fluconazole |
| (D01AC16) Flutrimazole |
| (D01AC20) Combinations |
| (D01AC52) Miconazole, combinations |
| (D01AC60) Bifonazole, combinations |
| (D01AE) Other antifungals for topical use |
| (D01AE01) Bromochlorosalicylanilide |
| (D01AE02) Methylrosaniline |
| (D01AE03) Tribromometacresol |
| (D01AE04) Undecylenic acid |
| (D01AE05) Polynoxylin |
| (D01AE06) 2-(4-chlorphenoxy)-ethanol |
| (D01AE07) Chlorphenesin |
| (D01AE08) Ticlatone |
| (D01AE09) Sulbentine |
| (D01AE10) Ethyl hydroxybenzoate |
| (D01AE11) Haloprogin |
| (D01AE12) Salicylic acid |
| (D01AE13) Selenium sulfide |
| (D01AE14) Ciclopirox |
| (D01AE15) Terbinafine |
| (D01AE16) Amorolfine |
| (D01AE17) Dimazole |
| (D01AE18) Tolnaftate |
| (D01AE19) Tolciclate |
| (D01AE20) Combinations |
| (D01AE21) Flucytosine |
| (D01AE22) Naftifine |
| (D01AE23) Butenafine |
| (D01B) ANTIFUNGALS FOR SYSTEMIC USE |
| (D01BA) Antifungals for systemic use |
| (D01BA01) Griseofulvin |
| (D01BA02) Terbinafine |
| (D02) EMOLLIENTS AND PROTECTIVES |
| (D02A) EMOLLIENTS AND PROTECTIVES |
| (D02AA) Silicone products |
| (D02AB) Zinc products |
| (D02AC) Soft paraffin and fat products |
| (D02AD) Liquid plasters |
| (D02AE) Carbamide products |
| (D02AE01) Carbamide |
| (D02AE51) Carbamide, combinations |
| (D02AF) Salicylic acid preparations |
| (D02AX) Other emollients and protectives |
| (D02B) PROTECTIVES AGAINST UV-RADIATION |
| (D02BA) Protectives against UV-radiation for topical use |
| (D02BA01) Aminobenzoic acid |
| (D02BA02) Octinoxate |
| (D02BB) Protectives against UV-radiation for systemic use |
| (D02BB01) Betacarotene |
| (D03) PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS |
| (D03A) CICATRIZANTS |
| (D03AA) Cod-liver oil ointments |
| (D03AX) Other cicatrizants |
| (D03AX01) Cadexomer iodine |
| (D03AX02) Dextranomer |
| (D03AX03) Dexpanthenol |
| (D03AX04) Calcium pantothenate |
| (D03AX05) Hyaluronic acid |
| (D03AX06) Becaplermin |
| (D03AX07) Glyceryl trinitrate |
| (D03AX08) Isosorbide dinitrate |
| (D03AX09) Crilanomer |
| (D03B) ENZYMES |
| (D03BA) Proteolytic enzymes |
| (D03BA01) Trypsin |
| (D03BA02) Clostridiopeptidase |
| (D03BA52) Clostridiopeptidase, combinations |
| (D04) ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| (D04A) ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. |
| (D04AA) Antihistamines for topical use |
| (D04AA01) Thonzylamine |
| (D04AA02) Mepyramine |
| (D04AA03) Thenalidine |
| (D04AA04) Tripelennamine |
| (D04AA09) Chloropyramine |
| (D04AA10) Promethazine |
| (D04AA12) Tolpropamine |
| (D04AA13) Dimetindene |
| (D04AA14) Clemastine |
| (D04AA15) Bamipine |
| (D04AA22) Isothipendyl |
| (D04AA32) Diphenhydramine |
| (D04AA33) Diphenhydramine methylbromide |
| (D04AA34) Chlorphenoxamine |
| (D04AB) Anesthetics for topical use |
| (D04AB01) Lidocaine |
| (D04AB02) Cinchocaine |
| (D04AB03) Oxybuprocaine |
| (D04AB04) Benzocaine |
| (D04AB05) Quinisocaine |
| (D04AB06) Tetracaine |
| (D04AB07) Pramocaine |
| (D04AX) Other antipruritics |
| (D05) ANTIPSORIATICS |
| (D05A) ANTIPSORIATICS FOR TOPICAL USE |
| (D05AA) Tars |
| (D05AC) Antracen derivatives |
| (D05AC01) Dithranol |
| (D05AC51) Dithranol, combinations |
| (D05AD) Psoralens for topical use |
| (D05AD01) Trioxysalen |
| (D05AD02) Methoxsalen |
| (D05AX) Other antipsoriatics for topical use |
| (D05AX01) Fumaric acid |
| (D05AX02) Calcipotriol |
| (D05AX03) Calcitriol |
| (D05AX04) Tacalcitol |
| (D05AX05) Tazarotene |
| (D05AX52) Calcipotriol, combinations |
| (D05B) ANTIPSORIATICS FOR SYSTEMIC USE |
| (D05BA) Psoralens for systemic use |
| (D05BA01) Trioxysalen |
| (D05BA02) Methoxsalen |
| (D05BA03) Bergapten |
| (D05BB) Retinoids for treatment of psoriasis |
| (D05BB01) Etretinate |
| (D05BB02) Acitretin |
| (D05BX) Other antipsoriatics for systemic use |
| (D05BX51) Fumaric acid derivatives, combinations |
| (D06) ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE |
| (D06A) ANTIBIOTICS FOR TOPICAL USE |
| (D06AA) Tetracycline and derivatives |
| (D06AA01) Demeclocycline |
| (D06AA02) Chlortetracycline |
| (D06AA03) Oxytetracycline |
| (D06AA04) Tetracycline |
| (D06AX) Other antibiotics for topical use |
| (D06AX01) Fusidic acid |
| (D06AX02) Chloramphenicol |
| (D06AX04) Neomycin |
| (D06AX05) Bacitracin |
| (D06AX07) Gentamicin |
| (D06AX08) Tyrothricin |
| (D06AX09) Mupirocin |
| (D06AX10) Virginiamycin |
| (D06AX11) Rifaximin |
| (D06AX12) Amikacin |
| (D06B) CHEMOTHERAPEUTICS FOR TOPICAL USE |
| (D06BA) Sulfonamides |
| (D06BA01) Silver sulfadiazine |
| (D06BA02) Sulfathiazole |
| (D06BA03) Mafenide |
| (D06BA04) Sulfamethizole |
| (D06BA51) Silver sulfadiazine, combinations |
| (D06BB) Antivirals |
| (D06BB01) Idoxuridine |
| (D06BB02) Tromantadine |
| (D06BB03) Aciclovir |
| (D06BB04) Podophyllotoxin |
| (D06BB05) Inosine |
| (D06BB06) Penciclovir |
| (D06BB07) Lysozyme |
| (D06BB08) Ibacitabine |
| (D06BB09) Edoxudine |
| (D06BB10) Imiquimod |
| (D06BB11) Docosanol |
| (D06BX) Other chemotherapeutics |
| (D06BX01) Metronidazole |
| (D06C) ANTIBIOTICS AND CHEMOTHERAPEUTICS, COMBINATIONS |
| (D07) CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS |
| (D07A) CORTICOSTEROIDS, PLAIN |
| (D07AA) Corticosteroids, weak (group I) |
| (D07AA01) Methylprednisolone |
| (D07AA02) Hydrocortisone |
| (D07AA03) Prednisolone |
| (D07AB) Corticosteroids, moderately potent (group II) |
| (D07AB01) Clobetasone |
| (D07AB02) Hydrocortisone butyrate |
| (D07AB03) Flumetasone |
| (D07AB04) Fluocortin |
| (D07AB05) Fluperolone |
| (D07AB06) Fluorometholone |
| (D07AB07) Fluprednidene |
| (D07AB08) Desonide |
| (D07AB09) Triamcinolone |
| (D07AB10) Alclometasone |
| (D07AB11) Hydrocortisone buteprate |
| (D07AB19) Dexamethasone |
| (D07AB21) Clocortolone |
| (D07AB30) Combinations of corticosteroids |
| (D07AC) Corticosteroids, potent (group III) |
| (D07AC01) Betamethasone |
| (D07AC02) Fluclorolone |
| (D07AC03) Desoximetasone |
| (D07AC04) Fluocinolone acetonide |
| (D07AC05) Fluocortolone |
| (D07AC06) Diflucortolone |
| (D07AC07) Fludroxycortide |
| (D07AC08) Fluocinonide |
| (D07AC09) Budesonide |
| (D07AC10) Diflorasone |
| (D07AC11) Amcinonide |
| (D07AC12) Halometasone |
| (D07AC13) Mometasone |
| (D07AC14) Methylprednisolone aceponate |
| (D07AC15) Beclometasone |
| (D07AC16) Hydrocortisone aceponate |
| (D07AC17) Fluticasone |
| (D07AC18) Prednicarbate |
| (D07AC19) Difluprednate |
| (D07AC21) Ulobetasol |
| (D07AD) Corticosteroids, very potent (group IV) |
| (D07AD01) Clobetasol |
| (D07AD02) Halcinonide |
| (D07B) CORTICOSTEROIDS, COMBINATIONS WITH ANTISEPTICS |
| (D07BA) Corticosteroids, weak, combinations with antiseptics |
| (D07BA01) Prednisolone and antiseptics |
| (D07BA04) Hydrocortisone and antiseptics |
| (D07BB) Corticosteroids, moderately potent, combinations with antiseptics |
| (D07BB01) Flumetasone and antiseptics |
| (D07BB02) Desonide and antiseptics |
| (D07BB03) Triamcinolone and antiseptics |
| (D07BB04) Hydrocortisone butyrate and antiseptics |
| (D07BC) Corticosteroids, potent, combinations with antiseptics |
| (D07BC01) Betamethasone and antiseptics |
| (D07BC02) Fluocinolone acetonide and antiseptics |
| (D07BC03) Fluocortolone and antiseptics |
| (D07BC04) Diflucortolone and antiseptics |
| (D07BD) Corticosteroids, very potent, combinations with antiseptics |
| (D07C) CORTICOSTEROIDS, COMBINATIONS WITH ANTIBIOTICS |
| (D07CA) Corticosteroids, weak, combinations with antibiotics |
| (D07CA01) Hydrocortisone and antibiotics |
| (D07CA02) Methylprednisolone and antibiotics |
| (D07CA03) Prednisolone and antibiotics |
| (D07CB) Corticosteroids, moderately potent, combinations with antibiotics |
| (D07CB01) Triamcinolone and antibiotics |
| (D07CB02) Fluprednidene and antibiotics |
| (D07CB03) Fluorometholone and antibiotics |
| (D07CB04) Dexamethasone and antibiotics |
| (D07CB05) Flumetasone and antibiotics |
| (D07CC) Corticosteroids, potent, combinations with antibiotics |
| (D07CC01) Betamethasone and antibiotics |
| (D07CC02) Fluocinolone acetonide and antibiotics |
| (D07CC03) Fludroxycortide and antibiotics |
| (D07CC04) Beclometasone and antibiotics |
| (D07CC05) Fluocinonide and antibiotics |
| (D07CC06) Fluocortolone and antibiotics |
| (D07CD) Corticosteroids, very potent, combinations with antibiotics |
| (D07CD01) Clobetasol and antibiotics |
| (D07X) CORTICOSTEROIDS, OTHER COMBINATIONS |
| (D07XA) Corticosteroids, weak, other combinations |
| (D07XA01) Hydrocortisone |
| (D07XA02) Prednisolone |
| (D07XB) Corticosteroids, moderately potent, other combinations |
| (D07XB01) Flumetasone |
| (D07XB02) Triamcinolone |
| (D07XB03) Fluprednidene |
| (D07XB04) Fluorometholone |
| (D07XB05) Dexamethasone |
| (D07XB30) Combinations of corticosteroids |
| (D07XC) Corticosteroids, potent, other combinations |
| (D07XC01) Betamethasone |
| (D07XC02) Desoximetasone |
| (D07XC03) Mometasone |
| (D07XC04) Diflucortolone |
| (D07XD) Corticosteroids, very potent, other combinations |
| (D08) ANTISEPTICS AND DISINFECTANTS |
| (D08A) ANTISEPTICS AND DISINFECTANTS |
| (D08AA) Acridine derivatives |
| (D08AA01) Ethacridine lactate |
| (D08AA02) Aminoacridine |
| (D08AA03) Euflavine |
| (D08AB) Aluminium agents |
| (D08AC) Biguanides and amidines |
| (D08AC01) Dibrompropamidine |
| (D08AC02) Chlorhexidine |
| (D08AC03) Propamidine |
| (D08AC04) Hexamidine |
| (D08AC05) Polihexanide |
| (D08AC52) Chlorhexidine, combinations |
| (D08AD) Boric acid products |
| (D08AE) Phenol and derivatives |
| (D08AE01) Hexachlorophene |
| (D08AE02) Policresulen |
| (D08AE03) Phenol |
| (D08AE04) Triclosan |
| (D08AE05) Chloroxylenol |
| (D08AE06) Biphenylol |
| (D08AF) Nitrofuran derivatives |
| (D08AF01) Nitrofural |
| (D08AG) Iodine products |
| (D08AG01) Iodine/octylphenoxypolyglycolether |
| (D08AG02) Povidone-iodine |
| (D08AG03) Iodine |
| (D08AG04) Diiodohydroxypropane |
| (D08AH) Quinoline derivatives |
| (D08AH01) Dequalinium |
| (D08AH02) Chlorquinaldol |
| (D08AH03) Oxyquinoline |
| (D08AH30) Clioquinol |
| (D08AJ) Quaternary ammonium compounds |
| (D08AJ01) Benzalkonium |
| (D08AJ02) Cetrimonium |
| (D08AJ03) Cetylpyridinium |
| (D08AJ04) Cetrimide |
| (D08AJ05) Benzoxonium chloride |
| (D08AJ06) Didecyldimethylammonium chloride |
| (D08AJ57) Octenidine, combinations |
| (D08AJ58) Benzethonium chloride, combinations |
| (D08AJ59) Dodeclonium bromide, combinations |
| (D08AK) Mercurial products |
| (D08AK01) Mercuric amidochloride |
| (D08AK02) Phenylmercuric borate |
| (D08AK03) Mercuric chloride |
| (D08AK04) Mercurochrome |
| (D08AK05) Mercury, metallic |
| (D08AK06) Thiomersal |
| (D08AK30) Mercuric iodide |
| (D08AL) Silver compounds |
| (D08AL01) Silver nitrate |
| (D08AL30) Silver |
| (D08AX) Other antiseptics and disinfectants |
| (D08AX01) Hydrogen peroxide |
| (D08AX02) Eosin |
| (D08AX03) Propanol |
| (D08AX04) Tosylchloramide sodium |
| (D08AX05) Isopropanol |
| (D08AX06) Potassium permanganate |
| (D08AX07) Sodium hypochlorite |
| (D08AX08) Ethanol |
| (D08AX53) Propanol, combinations |
| (D09) MEDICATED DRESSINGS |
| (D09A) MEDICATED DRESSINGS |
| (D09AA) Ointment dressings with antiinfectives |
| (D09AA01) Framycetin |
| (D09AA02) Fusidic acid |
| (D09AA03) Nitrofural |
| (D09AA04) Phenylmercuric nitrate |
| (D09AA05) Benzododecinium |
| (D09AA06) Triclosan |
| (D09AA07) Cetylpyridinium |
| (D09AA08) Aluminium chlorohydrate |
| (D09AA09) Povidone-iodine |
| (D09AA10) Clioquinol |
| (D09AA11) Benzalkonium |
| (D09AA12) Chlorhexidine |
| (D09AB) Zinc bandages |
| (D09AB01) Zinc bandage without supplements |
| (D09AB02) Zinc bandage with supplements |
| (D09AX) Soft paraffin dressings |
| (D10) ANTI-ACNE PREPARATIONS |
| (D10A) ANTI-ACNE PREPARATIONS FOR TOPICAL USE |
| (D10AA) Corticosteroids, combinations for treatment of acne |
| (D10AA01) Fluorometholone |
| (D10AA02) Methylprednisolone |
| (D10AA03) Dexamethasone |
| (D10AB) Preparations containing sulfur |
| (D10AB01) Bithionol |
| (D10AB02) Sulfur |
| (D10AB03) Tioxolone |
| (D10AB05) Mesulfen |
| (D10AD) Retinoids for topical use in acne |
| (D10AD01) Tretinoin |
| (D10AD02) Retinol |
| (D10AD03) Adapalene |
| (D10AD04) Isotretinoin |
| (D10AD05) Motretinide |
| (D10AD51) Tretinoin, combinations |
| (D10AD54) Isotretinoin, combinations |
| (D10AE) Peroxides |
| (D10AE01) Benzoyl peroxide |
| (D10AE51) Benzoyl peroxide, combinations |
| (D10AF) Antiinfectives for treatment of acne |
| (D10AF01) Clindamycin |
| (D10AF02) Erythromycin |
| (D10AF03) Chloramphenicol |
| (D10AF04) Meclocycline |
| (D10AF52) Erythromycin, combinations |
| (D10AX) Other anti-acne preparations for topical use |
| (D10AX01) Aluminium chloride |
| (D10AX02) Resorcinol |
| (D10AX03) Azelaic acid |
| (D10AX04) Aluminium oxide |
| (D10AX30) Various combinations |
| (D10B) ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE |
| (D10BA) Retinoids for treatment of acne |
| (D10BA01) Isotretinoin |
| (D10BX) Other anti-acne preparations for systemic use |
| (D10BX01) Ichtasol |
| (D11) OTHER DERMATOLOGICAL PREPARATIONS |
| (D11A) OTHER DERMATOLOGICAL PREPARATIONS |
| (D11AA) Antihidrotics |
| (D11AC) Medicated shampoos |
| (D11AC01) Cetrimide |
| (D11AC02) Cadmium compounds |
| (D11AC03) Selenium compounds |
| (D11AC06) Povidone-iodine |
| (D11AC08) Sulfur compounds |
| (D11AC09) Xenysalate |
| (D11AC30) Others |
| (D11AE) Androgens for topical use |
| (D11AE01) Metandienone |
| (D11AF) Wart and anti-corn preparations |
| (D11AX) Other dermatologicals |
| (D11AX01) Minoxidil |
| (D11AX02) Gamolenic acid |
| (D11AX03) Calcium gluconate |
| (D11AX04) Lithium succinate |
| (D11AX05) Magnesium sulfate |
| (D11AX06) Mequinol |
| (D11AX08) Tiratricol |
| (D11AX09) Oxaceprol |
| (D11AX10) Finasteride |
| (D11AX11) Hydroquinone |
| (D11AX12) Pyrithione zinc |
| (D11AX13) Monobenzone |
| (D11AX14) Tacrolimus |
| (D11AX15) Pimecrolimus |
| (D11AX16) Eflornithine |
| (D11AX52) Gamolenic acid, combinations |
| (D11AX57) Collagen, combinations |
| (G) GENITO URINARY SYSTEM AND SEX HORMONES |
| (G01) GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS |
| (G01A) ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS |
| (G01AA) Antibiotics |
| (G01AA01) Nystatin |
| (G01AA02) Natamycin |
| (G01AA03) Amphotericin B |
| (G01AA04) Candicidin |
| (G01AA05) Chloramphenicol |
| (G01AA06) Hachimycin |
| (G01AA07) Oxytetracycline |
| (G01AA08) Carfecillin |
| (G01AA09) Mepartricin |
| (G01AA10) Clindamycin |
| (G01AA11) Pentamycin |
| (G01AA51) Nystatin, combinations |
| (G01AB) Arsenic compounds |
| (G01AB01) Acetarsol |
| (G01AC) Quinoline derivatives |
| (G01AC01) Diiodohydroxyquinoline |
| (G01AC02) Clioquinol |
| (G01AC03) Chlorquinaldol |
| (G01AC05) Dequalinium |
| (G01AC06) Broxyquinoline |
| (G01AC30) Oxyquinoline |
| (G01AD) Organic acids |
| (G01AD01) Lactic acid |
| (G01AD02) Acetic acid |
| (G01AD03) Ascorbic acid |
| (G01AE) Sulfonamides |
| (G01AE01) Sulfatolamide |
| (G01AE10) Combinations of sulfonamides |
| (G01AF) Imidazole derivatives |
| (G01AF01) Metronidazole |
| (G01AF02) Clotrimazole |
| (G01AF04) Miconazole |
| (G01AF05) Econazole |
| (G01AF06) Ornidazole |
| (G01AF07) Isoconazole |
| (G01AF08) Tioconazole |
| (G01AF11) Ketoconazole |
| (G01AF12) Fenticonazole |
| (G01AF13) Azanidazole |
| (G01AF14) Propenidazole |
| (G01AF15) Butoconazole |
| (G01AF16) Omoconazole |
| (G01AF17) Oxiconazole |
| (G01AF20) Combinations of imidazole derivatives |
| (G01AG) Triazole derivatives |
| (G01AG02) Terconazole |
| (G01AX) Other antiinfectives and antiseptics |
| (G01AX01) Clodantoin |
| (G01AX02) Inosine |
| (G01AX03) Policresulen |
| (G01AX05) Nifuratel |
| (G01AX06) Furazolidone |
| (G01AX09) Methylrosaniline |
| (G01AX11) Povidone-iodine |
| (G01AX12) Ciclopirox |
| (G01AX13) Protiofate |
| (G01AX14) Lactobacillus fermentum |
| (G01AX15) Copper usnate |
| (G01AX66) Octenidine, combinations |
| (G01B) ANTIINFECTIVES/ANTISEPTICS IN COMBINATION WITH CORTICOSTEROIDS |
| (G01BA) Antibiotics and corticosteroids |
| (G01BC) Quinoline derivatives and corticosteroids |
| (G01BD) Antiseptics and corticosteroids |
| (G01BE) Sulfonamides and corticosteroids |
| (G01BF) Imidazole derivatives and corticosteroids |
| (G02) OTHER GYNECOLOGICALS |
| (G02A) OXYTOCICS |
| (G02AB) Ergot alkaloids |
| (G02AB01) Methylergometrine |
| (G02AB02) Ergot alkaloids |
| (G02AB03) Ergometrine |
| (G02AC) Ergot alkaloids and oxytocin incl. analogues, in combination |
| (G02AC01) Methylergometrine and oxytocin |
| (G02AD) Prostaglandins |
| (G02AD01) Dinoprost |
| (G02AD02) Dinoprostone |
| (G02AD03) Gemeprost |
| (G02AD04) Carboprost |
| (G02AD05) Sulprostone |
| (G02AX) Other oxytocics |
| (G02B) CONTRACEPTIVES FOR TOPICAL USE |
| (G02BA) Intrauterine contraceptives |
| (G02BA01) Plastic IUD |
| (G02BA02) Plastic IUD with copper |
| (G02BA03) Plastic IUD with progestogen |
| (G02BB) Intravaginal contraceptives |
| (G02BB01) Vaginal ring with progestogen and estrogen |
| (G02C) OTHER GYNECOLOGICALS |
| (G02CA) Sympathomimetics, labour repressants |
| (G02CA01) Ritodrine |
| (G02CA02) Buphenine |
| (G02CA03) Fenoterol |
| (G02CB) Prolactine inhibitors |
| (G02CB01) Bromocriptine |
| (G02CB02) Lisuride |
| (G02CB03) Cabergoline |
| (G02CB04) Quinagolide |
| (G02CB05) Metergoline |
| (G02CC) Antiinflammatory products for vaginal administration |
| (G02CC01) Ibuprofen |
| (G02CC02) Naproxen |
| (G02CC03) Benzydamine |
| (G02CC04) Flunoxaprofen |
| (G02CX) Other gynecologicals |
| (G02CX01) Atosiban |
| (G03) SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| (G03A) HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE |
| (G03AA) Progestogens and estrogens, fixed combinations |
| (G03AA01) Etynodiol and estrogen |
| (G03AA02) Quingestanol and estrogen |
| (G03AA03) Lynestrenol and estrogen |
| (G03AA04) Megestrol and estrogen |
| (G03AA05) Norethisterone and estrogen |
| (G03AA06) Norgestrel and estrogen |
| (G03AA07) Levonorgestrel and estrogen |
| (G03AA08) Medroxyprogesterone and estrogen |
| (G03AA09) Desogestrel and estrogen |
| (G03AA10) Gestodene and estrogen |
| (G03AA11) Norgestimate and estrogen |
| (G03AA12) Drospirenone and estrogen |
| (G03AA13) Norelgestromin and estrogen |
| (G03AB) Progestogens and estrogens, sequential preparations |
| (G03AB01) Megestrol and estrogen |
| (G03AB02) Lynestrenol and estrogen |
| (G03AB03) Levonorgestrel and estrogen |
| (G03AB04) Norethisterone and estrogen |
| (G03AB05) Desogestrel and estrogen |
| (G03AB06) Gestodene and estrogen |
| (G03AB07) Chlormadinone and estrogen |
| (G03AC) Progestogens |
| (G03AC01) Norethisterone |
| (G03AC02) Lynestrenol |
| (G03AC03) Levonorgestrel |
| (G03AC04) Quingestanol |
| (G03AC05) Megestrol |
| (G03AC06) Medroxyprogesterone |
| (G03AC07) Norgestrienone |
| (G03AC08) Etonogestrel |
| (G03AC09) Desogestrel |
| (G03B) ANDROGENS |
| (G03BA) 3-oxoandrosten (4) derivatives |
| (G03BA01) Fluoxymesterone |
| (G03BA02) Methyltestosterone |
| (G03BA03) Testosterone |
| (G03BB) 5-androstanon (3) derivatives |
| (G03BB01) Mesterolone |
| (G03BB02) Androstanolone |
| (G03C) ESTROGENS |
| (G03CA) Natural and semisynthetic estrogens, plain |
| (G03CA01) Ethinylestradiol |
| (G03CA03) Estradiol |
| (G03CA04) Estriol |
| (G03CA06) Chlorotrianisene |
| (G03CA07) Estrone |
| (G03CA09) Promestriene |
| (G03CA53) Estradiol, combinations |
| (G03CA57) Conjugated estrogens |
| (G03CB) Synthetic estrogens, plain |
| (G03CB01) Dienestrol |
| (G03CB02) Diethylstilbestrol |
| (G03CB03) Methallenestril |
| (G03CB04) Moxestrol |
| (G03CC) Estrogens, combinations with other drugs |
| (G03CC02) Dienestrol |
| (G03CC03) Methallenestril |
| (G03CC04) Estrone |
| (G03CC05) Diethylstilbestrol |
| (G03CC06) Estriol |
| (G03D) PROGESTOGENS |
| (G03DA) Pregnen (4) derivatives |
| (G03DA01) Gestonorone |
| (G03DA02) Medroxyprogesterone |
| (G03DA03) Hydroxyprogesterone |
| (G03DA04) Progesterone |
| (G03DB) Pregnadien derivatives |
| (G03DB01) Dydrogesterone |
| (G03DB02) Megestrol |
| (G03DB03) Medrogestone |
| (G03DB04) Nomegestrol |
| (G03DB05) Demegestone |
| (G03DB06) Chlormadinone |
| (G03DB07) Promegestone |
| (G03DC) Estren derivatives |
| (G03DC01) Allylestrenol |
| (G03DC02) Norethisterone |
| (G03DC03) Lynestrenol |
| (G03DC04) Ethisterone |
| (G03DC05) Tibolone |
| (G03DC06) Etynodiol |
| (G03DC31) Methylestrenolone |
| (G03E) ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION |
| (G03EA) Androgens and estrogens |
| (G03EA01) Methyltestosterone and estrogen |
| (G03EA02) Testosterone and estrogen |
| (G03EA03) Prasterone and estrogen |
| (G03EB) Androgen, progestogen and estrogen in combination |
| (G03EK) Androgens and female sex hormones in combination with other drugs |
| (G03EK01) Methyltestosterone |
| (G03F) PROGESTOGENS AND ESTROGENS IN COMBINATION |
| (G03FA) Progestogens and estrogens, fixed combinations |
| (G03FA01) Norethisterone and estrogen |
| (G03FA02) Hydroxyprogesterone and estrogen |
| (G03FA03) Ethisterone and estrogen |
| (G03FA04) Progesterone and estrogen |
| (G03FA05) Methylnortestosterone and estrogen |
| (G03FA06) Etynodiol and estrogen |
| (G03FA07) Lynestrenol and estrogen |
| (G03FA08) Megestrol and estrogen |
| (G03FA09) Noretynodrel and estrogen |
| (G03FA10) Norgestrel and estrogen |
| (G03FA11) Levonorgestrel and estrogen |
| (G03FA12) Medroxyprogesterone and estrogen |
| (G03FA13) Norgestimate and estrogen |
| (G03FA14) Dydrogesterone and estrogen |
| (G03FA15) Dienogest and estrogen |
| (G03FA16) Trimegestone and estrogen |
| (G03FA17) Drospirenone and estrogen |
| (G03FB) Progestogens and estrogens, sequential preparations |
| (G03FB01) Norgestrel and estrogen |
| (G03FB02) Lynestrenol and estrogen |
| (G03FB03) Chlormadinone and estrogen |
| (G03FB04) Megestrol and estrogen |
| (G03FB05) Norethisterone and estrogen |
| (G03FB06) Medroxyprogesterone and estrogen |
| (G03FB07) Medrogestone and estrogen |
| (G03FB08) Dydrogesterone and estrogen |
| (G03FB09) Levonorgestrel and estrogen |
| (G03FB10) Desogestrel and estrogen |
| (G03FB11) Trimegestone and estrogen |
| (G03G) GONADOTROPINS AND OTHER OVULATION STIMULANTS |
| (G03GA) Gonadotropins |
| (G03GA01) Chorionic gonadotrophin |
| (G03GA02) Human menopausal gonadotrophin |
| (G03GA03) Serum gonadotrophin |
| (G03GA04) Urofollitropin |
| (G03GA05) Follitropin alfa |
| (G03GA06) Follitropin beta |
| (G03GA07) Lutropin alfa |
| (G03GA08) Choriogonadotropin alfa |
| (G03GB) Ovulation stimulants, synthetic |
| (G03GB01) Cyclofenil |
| (G03GB02) Clomifene |
| (G03GB03) Epimestrol |
| (G03H) ANTIANDROGENS |
| (G03HA) Antiandrogens, plain |
| (G03HA01) Cyproterone |
| (G03HB) Antiandrogens and estrogens |
| (G03HB01) Cyproterone and estrogen |
| (G03X) OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM |
| (G03XA) Antigonadotropins and similar agents |
| (G03XA01) Danazol |
| (G03XA02) Gestrinone |
| (G03XB) Antiprogestogens |
| (G03XB01) Mifepristone |
| (G03XC) Selective estrogen receptor modulators |
| (G03XC01) Raloxifene |
| (G04) UROLOGICALS |
| (G04B) OTHER UROLOGICALS, INCL. ANTISPASMODICS |
| (G04BA) Acidifiers |
| (G04BA01) Ammonium chloride |
| (G04BA03) Calcium chloride |
| (G04BC) Urinary concrement solvents |
| (G04BD) Urinary antispasmodics |
| (G04BD01) Emepronium |
| (G04BD02) Flavoxate |
| (G04BD03) Meladrazine |
| (G04BD04) Oxybutynin |
| (G04BD05) Terodiline |
| (G04BD06) Propiverine |
| (G04BD07) Tolterodine |
| (G04BD08) Solifenacin |
| (G04BD09) Trospium |
| (G04BE) Drugs used in erectile dysfunction |
| (G04BE01) Alprostadil |
| (G04BE02) Papaverine |
| (G04BE03) Sildenafil |
| (G04BE04) Yohimbin |
| (G04BE05) Phentolamine |
| (G04BE06) Moxisylyte |
| (G04BE07) Apomorphine |
| (G04BE08) Tadalafil |
| (G04BE09) Vardenafil |
| (G04BE30) Combinations |
| (G04BE52) Papaverine, combinations |
| (G04BX) Other urologicals |
| (G04BX01) Magnesium hydroxide |
| (G04BX03) Acetohydroxamic acid |
| (G04BX06) Phenazopyridine |
| (G04BX10) Succinimide |
| (G04BX11) Collagen |
| (G04BX12) Phenyl salicylate |
| (G04BX13) Dimethyl sulfoxide |
| (G04C) DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY |
| (G04CA) Alpha-adrenoreceptor antagonists |
| (G04CA01) Alfuzosin |
| (G04CA02) Tamsulosin |
| (G04CA03) Terazosin |
| (G04CB) Testosterone-5-alpha reductase inhibitors |
| (G04CB01) Finasteride |
| (G04CB02) Dutasteride |
| (G04CX) Other drugs used in benign prostatic hypertrophy |
| (G04CX01) Pygeum africanum |
| (G04CX02) Serenoa repens |
| (G04CX03) Mepartricin |
| (H) SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS |
| (H01) PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES |
| (H01A) ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
| (H01AA) ACTH |
| (H01AA01) Corticotropin |
| (H01AA02) Tetracosactide |
| (H01AB) Thyrotropin |
| (H01AB01) Thyrotropin |
| (H01AC) Somatropin and somatropin agonists |
| (H01AC01) Somatropin |
| (H01AC02) Somatrem |
| (H01AC03) Mecasermin |
| (H01AC04) Sermorelin |
| (H01AX) Other anterior pituitary lobe hormones and analogues |
| (H01AX01) Pegvisomant |
| (H01B) POSTERIOR PITUITARY LOBE HORMONES |
| (H01BA) Vasopressin and analogues |
| (H01BA01) Vasopressin |
| (H01BA02) Desmopressin |
| (H01BA03) Lypressin |
| (H01BA04) Terlipressin |
| (H01BA05) Ornipressin |
| (H01BA06) Argipressin |
| (H01BB) Oxytocin and analogues |
| (H01BB01) Demoxytocin |
| (H01BB02) Oxytocin |
| (H01BB03) Carbetocin |
| (H01C) HYPOTHALAMIC HORMONES |
| (H01CA) Gonadotropin-releasing hormones |
| (H01CA01) Gonadorelin |
| (H01CA02) Nafarelin |
| (H01CA03) Histrelin |
| (H01CB) Antigrowth hormone |
| (H01CB01) Somatostatin |
| (H01CB02) Octreotide |
| (H01CB03) Lanreotide |
| (H01CC) Anti-gonadotropin-releasing hormones |
| (H01CC01) Ganirelix |
| (H01CC02) Cetrorelix |
| (H02) CORTICOSTEROIDS FOR SYSTEMIC USE |
| (H02A) CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
| (H02AA) Mineralocorticoids |
| (H02AA01) Aldosterone |
| (H02AA02) Fludrocortisone |
| (H02AA03) Desoxycortone |
| (H02AB) Glucocorticoids |
| (H02AB01) Betamethasone |
| (H02AB02) Dexamethasone |
| (H02AB03) Fluocortolone |
| (H02AB04) Methylprednisolone |
| (H02AB05) Paramethasone |
| (H02AB06) Prednisolone |
| (H02AB07) Prednisone |
| (H02AB08) Triamcinolone |
| (H02AB09) Hydrocortisone |
| (H02AB10) Cortisone |
| (H02AB11) Prednylidene |
| (H02AB12) Rimexolone |
| (H02AB13) Deflazacort |
| (H02AB14) Cloprednol |
| (H02AB15) Meprednisone |
| (H02AB17) Cortivazol |
| (H02B) CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS |
| (H02BX) Corticosteroids for systemic use, combinations |
| (H02BX01) Methylprednisolone, combinations |
| (H02C) ANTIADRENAL PREPARATIONS |
| (H02CA) Anticorticosteroids |
| (H02CA01) Trilostane |
| (H03) THYROID THERAPY |
| (H03A) THYROID PREPARATIONS |
| (H03AA) Thyroid hormones |
| (H03AA01) Levothyroxine sodium |
| (H03AA02) Liothyronine sodium |
| (H03AA03) Combinations of levothyroxine and liothyronine |
| (H03AA04) Tiratricol |
| (H03AA05) Thyroid gland preparations |
| (H03B) ANTITHYROID PREPARATIONS |
| (H03BA) Thiouracils |
| (H03BA01) Methylthiouracil |
| (H03BA02) Propylthiouracil |
| (H03BA03) Benzylthiouracil |
| (H03BB) Sulfur-containing imidazole derivatives |
| (H03BB01) Carbimazole |
| (H03BB02) Thiamazole |
| (H03BB52) Thiamazole, combinations |
| (H03BC) Perchlorates |
| (H03BC01) Potassium perchlorate |
| (H03BX) Other antithyroid preparations |
| (H03BX01) Diiodotyrosine |
| (H03BX02) Dibromotyrosine |
| (H03C) IODINE THERAPY |
| (H03CA) Iodine therapy |
| (H04) PANCREATIC HORMONES |
| (H04A) GLYCOGENOLYTIC HORMONES |
| (H04AA) Glycogenolytic hormones |
| (H04AA01) Glucagon |
| (H05) CALCIUM HOMEOSTASIS |
| (H05A) PARATHYROID HORMONES AND ANALOGUES |
| (H05AA) Parathyroid hormones and analogues |
| (H05AA01) Parathyroid gland extract |
| (H05AA02) Teriparatide |
| (H05B) ANTI-PARATHYROID HORMONES |
| (H05BA) Calcitonin preparations |
| (H05BA01) Calcitonin (salmon synthetic) |
| (H05BA02) Calcitonin (pork natural) |
| (H05BA03) Calcitonin (human synthetic) |
| (H05BA04) Elcatonin |
| (J) ANTIINFECTIVES FOR SYSTEMIC USE |
| (J01) ANTIBACTERIALS FOR SYSTEMIC USE |
| (J01A) TETRACYCLINES |
| (J01AA) Tetracyclines |
| (J01AA01) Demeclocycline |
| (J01AA02) Doxycycline |
| (J01AA03) Chlortetracycline |
| (J01AA04) Lymecycline |
| (J01AA05) Metacycline |
| (J01AA06) Oxytetracycline |
| (J01AA07) Tetracycline |
| (J01AA08) Minocycline |
| (J01AA09) Rolitetracycline |
| (J01AA10) Penimepicycline |
| (J01AA11) Clomocycline |
| (J01AA12) Tigecycline? |
| (J01AA20) Combinations of tetracyclines |
| (J01AA56) Oxytetracycline, combinations |
| (J01B) AMPHENICOLS |
| (J01BA) Amphenicols |
| (J01BA01) Chloramphenicol |
| (J01BA02) Thiamphenicol |
| (J01BA52) Thiamphenicol, combinations |
| (J01C) BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| (J01CA) Penicillins with extended spectrum |
| (J01CA01) Ampicillin |
| (J01CA02) Pivampicillin |
| (J01CA03) Carbenicillin |
| (J01CA04) Amoxicillin |
| (J01CA05) Carindacillin |
| (J01CA06) Bacampicillin |
| (J01CA07) Epicillin |
| (J01CA08) Pivmecillinam |
| (J01CA09) Azlocillin |
| (J01CA10) Mezlocillin |
| (J01CA11) Mecillinam |
| (J01CA12) Piperacillin |
| (J01CA13) Ticarcillin |
| (J01CA14) Metampicillin |
| (J01CA15) Talampicillin |
| (J01CA16) Sulbenicillin |
| (J01CA17) Temocillin |
| (J01CA18) Hetacillin |
| (J01CA20) Combinations |
| (J01CA51) Ampicillin, combinations |
| (J01CE) Beta-lactamase sensitive penicillins |
| (J01CE01) Benzylpenicillin |
| (J01CE02) Phenoxymethylpenicillin |
| (J01CE03) Propicillin |
| (J01CE04) Azidocillin |
| (J01CE05) Pheneticillin |
| (J01CE06) Penamecillin |
| (J01CE07) Clometocillin |
| (J01CE08) Benzathine benzylpenicillin |
| (J01CE09) Procaine benzylpenicillin |
| (J01CE10) Benzathine phenoxymethylpenicillin |
| (J01CE30) Combinations |
| (J01CF) Beta-lactamase resistant penicillins |
| (J01CF01) Dicloxacillin |
| (J01CF02) Cloxacillin |
| (J01CF03) Methicillin |
| (J01CF04) Oxacillin |
| (J01CF05) Flucloxacillin |
| (J01CG) Beta-lactamase inhibitors |
| (J01CG01) Sulbactam |
| (J01CG02) Tazobactam |
| (J01CR) Combinations of penicillins, incl. beta-lactamase inhibitors |
| (J01CR01) Ampicillin and enzyme inhibitor |
| (J01CR02) Amoxicillin and enzyme inhibitor |
| (J01CR03) Ticarcillin and enzyme inhibitor |
| (J01CR04) Sultamicillin |
| (J01CR05) Piperacillin and enzyme inhibitor |
| (J01CR50) Combinations of penicillins |
| (J01D) OTHER BETA-LACTAM ANTIBACTERIALS |
| (J01DA) Cephalosporins and related substances |
| (J01DA01) Cefalexin |
| (J01DA02) Cefaloridine |
| (J01DA03) Cefalotin |
| (J01DA04) Cefazolin |
| (J01DA05) Cefoxitin |
| (J01DA06) Cefuroxime |
| (J01DA07) Cefamandole |
| (J01DA08) Cefaclor |
| (J01DA09) Cefadroxil |
| (J01DA10) Cefotaxime |
| (J01DA11) Ceftazidime |
| (J01DA12) Cefsulodin |
| (J01DA13) Ceftriaxone |
| (J01DA14) Cefotetan |
| (J01DA15) Cefazedone |
| (J01DA16) Cefmenoxime |
| (J01DA17) Cefonicide |
| (J01DA18) Latamoxef |
| (J01DA19) Cefotiam |
| (J01DA21) Cefatrizine |
| (J01DA22) Ceftizoxime |
| (J01DA23) Cefixime |
| (J01DA24) Cefepime |
| (J01DA25) Cefodizime |
| (J01DA26) Cefetamet |
| (J01DA27) Cefpiramide |
| (J01DA30) Cefapirin |
| (J01DA31) Cefradine |
| (J01DA32) Cefoperazone |
| (J01DA33) Cefpodoxime |
| (J01DA34) Cefacetrile |
| (J01DA35) Cefroxadine |
| (J01DA36) Ceftezole |
| (J01DA37) Cefpirome |
| (J01DA38) Loracarbef |
| (J01DA39) Ceftibuten |
| (J01DA40) Cefmetazole |
| (J01DA41) Cefprozil |
| (J01DA42) Cefdinir |
| (J01DA63) Ceftriaxone, combinations |
| (J01DB) First-generation cephalosporins |
| (J01DB01) Cefalexin |
| (J01DB02) Cefaloridine |
| (J01DB03) Cefalotin |
| (J01DB04) Cefazolin |
| (J01DB05) Cefadroxil |
| (J01DB06) Cefazedone |
| (J01DB07) Cefatrizine |
| (J01DB08) Cefapirin |
| (J01DB09) Cefradine |
| (J01DB10) Cefacetrile |
| (J01DB11) Cefroxadine |
| (J01DB12) Ceftezole |
| (J01DC) Second-generation cephalosporins |
| (J01DC01) Cefoxitin |
| (J01DC02) Cefuroxime |
| (J01DC03) Cefamandole |
| (J01DC04) Cefaclor |
| (J01DC05) Cefotetan |
| (J01DC06) Cefonicid |
| (J01DC07) Cefotiam |
| (J01DC08) Loracarbef |
| (J01DC09) Cefmetazole |
| (J01DC10) Cefprozil |
| (J01DC11) Ceforanide |
| (J01DD) Third-generation cephalosporins |
| (J01DD01) Cefotaxime |
| (J01DD02) Ceftazidime |
| (J01DD03) Cefsulodin |
| (J01DD04) Ceftriaxone |
| (J01DD05) Cefmenoxime |
| (J01DD06) Latamoxef |
| (J01DD07) Ceftizoxime |
| (J01DD08) Cefixime |
| (J01DD09) Cefodizime |
| (J01DD10) Cefetamet |
| (J01DD11) Cefpiramide |
| (J01DD12) Cefoperazone |
| (J01DD13) Cefpodoxime |
| (J01DD14) Ceftibuten |
| (J01DD15) Cefdinir |
| (J01DD16) Cefditoren |
| (J01DD17) Cefcapene |
| (J01DD54) Ceftriaxone, combinations |
| (J01DD62) Cefoperazone, combinations |
| (J01DE) Fourth-generation cephalosporins |
| (J01DE01) Cefepime |
| (J01DE02) Cefpirome |
| (J01DE03) Cefozopran |
| (J01DF) Monobactams |
| (J01DF01) Aztreonam |
| (J01DH) Carbapenems |
| (J01DH02) Meropenem |
| (J01DH03) Ertapenem |
| (J01DH51) Imipenem and enzyme inhibitor |
| (J01E) SULFONAMIDES AND TRIMETHOPRIM |
| (J01EA) Trimethoprim and derivatives |
| (J01EA01) Trimethoprim |
| (J01EA02) Brodimoprim |
| (J01EB) Short-acting sulfonamides |
| (J01EB01) Sulfaisodimidine |
| (J01EB02) Sulfamethizole |
| (J01EB03) Sulfadimidine |
| (J01EB04) Sulfapyridine |
| (J01EB05) Sulfafurazole |
| (J01EB06) Sulfanilamide |
| (J01EB07) Sulfathiazole |
| (J01EB08) Sulfathiourea |
| (J01EB20) Combinations |
| (J01EC) Intermediate-acting sulfonamides |
| (J01EC01) Sulfamethoxazole |
| (J01EC02) Sulfadiazine |
| (J01EC03) Sulfamoxole |
| (J01EC20) Combinations |
| (J01ED) Long-acting sulfonamides |
| (J01ED01) Sulfadimethoxine |
| (J01ED02) Sulfalene |
| (J01ED03) Sulfametomidine |
| (J01ED04) Sulfametoxydiazine |
| (J01ED05) Sulfamethoxypyridazine |
| (J01ED06) Sulfaperin |
| (J01ED07) Sulfamerazine |
| (J01ED08) Sulfaphenazole |
| (J01ED09) Sulfamazon |
| (J01ED20) Combinations |
| (J01EE) Combinations of sulfonamides and trimethoprim, incl. derivatives |
| (J01EE01) Sulfamethoxazole and trimethoprim |
| (J01EE02) Sulfadiazine and trimethoprim |
| (J01EE03) Sulfametrole and trimethoprim |
| (J01EE04) Sulfamoxole and trimethoprim |
| (J01EE05) Sulfadimidine and trimethoprim |
| (J01EE06) Sulfadiazine and tetroxoprim |
| (J01F) MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| (J01FA) Macrolides |
| (J01FA01) Erythromycin |
| (J01FA02) Spiramycin |
| (J01FA03) Midecamycin |
| (J01FA05) Oleandomycin |
| (J01FA06) Roxithromycin |
| (J01FA07) Josamycin |
| (J01FA08) Troleandomycin |
| (J01FA09) Clarithromycin |
| (J01FA10) Azithromycin |
| (J01FA11) Miocamycin |
| (J01FA12) Rokitamycin |
| (J01FA13) Dirithromycin |
| (J01FA14) Flurithromycin |
| (J01FA15) Telithromycin |
| (J01FF) Lincosamides |
| (J01FF01) Clindamycin |
| (J01FF02) Lincomycin |
| (J01FG) Streptogramins |
| (J01FG01) Pristinamycin |
| (J01FG02) Quinupristin/dalfopristin |
| (J01G) AMINOGLYCOSIDE ANTIBACTERIALS |
| (J01GA) Streptomycins |
| (J01GA01) Streptomycin |
| (J01GA02) Streptoduocin |
| (J01GB) Other aminoglycosides |
| (J01GB01) Tobramycin |
| (J01GB03) Gentamicin |
| (J01GB04) Kanamycin |
| (J01GB05) Neomycin |
| (J01GB06) Amikacin |
| (J01GB07) Netilmicin |
| (J01GB08) Sisomicin |
| (J01GB09) Dibekacin |
| (J01GB10) Ribostamycin |
| (J01GB11) Isepamicin |
| (J01M) QUINOLONE ANTIBACTERIALS |
| (J01MA) Fluoroquinolones |
| (J01MA01) Ofloxacin |
| (J01MA02) Ciprofloxacin |
| (J01MA03) Pefloxacin |
| (J01MA04) Enoxacin |
| (J01MA05) Temafloxacin |
| (J01MA06) Norfloxacin |
| (J01MA07) Lomefloxacin |
| (J01MA08) Fleroxacin |
| (J01MA09) Sparfloxacin |
| (J01MA10) Rufloxacin |
| (J01MA11) Grepafloxacin |
| (J01MA12) Levofloxacin |
| (J01MA13) Trovafloxacin |
| (J01MA14) Moxifloxacin |
| (J01MA15) Gemifloxacin |
| (J01MA16) Gatifloxacin |
| (J01MB) Other quinolones |
| (J01MB01) Rosoxacin |
| (J01MB02) Nalidixic acid |
| (J01MB03) Piromidic acid |
| (J01MB04) Pipemidic acid |
| (J01MB05) Oxolinic acid |
| (J01MB06) Cinoxacin |
| (J01MB07) Flumequine |
| (J01R) COMBINATIONS OF ANTIBACTERIALS |
| (J01RA) Combinations of antibacterials |
| (J01RA01) Penicillins, combinations with other antibacterials |
| (J01RA02) Sulfonamides, combinations with other antibacterials (excl. trimethoprim) |
| (J01RA03) Cefuroxime, combinations with other antibacterials |
| (J01X) OTHER ANTIBACTERIALS |
| (J01XA) Glycopeptide antibacterials |
| (J01XA01) Vancomycin |
| (J01XA02) Teicoplanin |
| (J01XB) Polymyxins |
| (J01XB01) Colistin |
| (J01XB02) Polymyxin B |
| (J01XC) Steroid antibacterials |
| (J01XC01) Fusidic acid |
| (J01XD) Imidazole derivatives |
| (J01XD01) Metronidazole |
| (J01XD02) Tinidazole |
| (J01XD03) Ornidazole |
| (J01XE) Nitrofuran derivatives |
| (J01XE01) Nitrofurantoin |
| (J01XE02) Nifurtoinol |
| (J01XX) Other antibacterials |
| (J01XX01) Fosfomycin |
| (J01XX02) Xibornol |
| (J01XX03) Clofoctol |
| (J01XX04) Spectinomycin |
| (J01XX05) Methenamine |
| (J01XX06) Mandelic acid |
| (J01XX07) Nitroxoline |
| (J01XX08) Linezolid |
| (J02) ANTIMYCOTICS FOR SYSTEMIC USE |
| (J02A) ANTIMYCOTICS FOR SYSTEMIC USE |
| (J02AA) Antibiotics |
| (J02AA01) Amphotericin B |
| (J02AA02) Hachimycin |
| (J02AB) Imidazole derivatives |
| (J02AB01) Miconazole |
| (J02AB02) Ketoconazole |
| (J02AC) Triazole derivatives |
| (J02AC01) Fluconazole |
| (J02AC02) Itraconazole |
| (J02AC03) Voriconazole |
| (J02AX) Other antimycotics for systemic use |
| (J02AX01) Flucytosine |
| (J02AX04) Caspofungin |
| (J04) ANTIMYCOBACTERIALS |
| (J04A) DRUGS FOR TREATMENT OF TUBERCULOSIS |
| (J04AA) Aminosalicylic acid and derivatives |
| (J04AA01) Aminosalicylic acid |
| (J04AA02) Sodium aminosalicylate |
| (J04AA03) Calcium aminosalicylate |
| (J04AB) Antibiotics |
| (J04AB01) Cycloserine |
| (J04AB02) Rifampicin |
| (J04AB03) Rifamycin |
| (J04AB04) Rifabutin |
| (J04AB05) Rifapentin |
| (J04AB30) Capreomycin |
| (J04AC) Hydrazides |
| (J04AC01) Isoniazid |
| (J04AC51) Isoniazid, combinations |
| (J04AD) Thiocarbamide derivatives |
| (J04AD01) Protionamide |
| (J04AD02) Tiocarlide |
| (J04AD03) Ethionamide |
| (J04AK) Other drugs for treatment of tuberculosis |
| (J04AK01) Pyrazinamide |
| (J04AK02) Ethambutol |
| (J04AK03) Terizidone |
| (J04AK04) Morinamide |
| (J04AM) Combinations of drugs for treatment of tuberculosis |
| (J04AM01) Streptomycin and isoniazid |
| (J04AM02) Rifampicin and isoniazid |
| (J04AM03) Ethambutol and isoniazid |
| (J04AM04) Thioacetazone and isoniazid |
| (J04AM05) Rifampicin, pyrazinamide and isoniazid |
| (J04AM06) Rifampicin, pyrazinamide, ethambutol and isoniazid |
| (J04B) DRUGS FOR TREATMENT OF LEPRA |
| (J04BA) Drugs for treatment of lepra |
| (J04BA01) Clofazimine |
| (J04BA02) Dapsone |
| (J04BA03) Aldesulfone sodium |
| (J05) ANTIVIRALS FOR SYSTEMIC USE |
| (J05A) DIRECT ACTING ANTIVIRALS |
| (J05AA) Thiosemicarbazones |
| (J05AA01) Metisazone |
| (J05AB) Nucleosides and nucleotides excl. reverse transcriptase inhibitors |
| (J05AB01) Aciclovir |
| (J05AB02) Idoxuridine |
| (J05AB03) Vidarabine |
| (J05AB04) Ribavirin |
| (J05AB06) Ganciclovir |
| (J05AB09) Famciclovir |
| (J05AB11) Valaciclovir |
| (J05AB12) Cidofovir |
| (J05AB13) Penciclovir |
| (J05AB14) Valganciclovir |
| (J05AB54) Ribavirin, combinations |
| (J05AC) Cyclic amines |
| (J05AC02) Rimantadine |
| (J05AC03) Tromantadine |
| (J05AD) Phosphonic acid derivatives |
| (J05AD01) Foscarnet |
| (J05AD02) Fosfonet |
| (J05AE) Protease inhibitors |
| (J05AE01) Saquinavir |
| (J05AE02) Indinavir |
| (J05AE03) Ritonavir |
| (J05AE04) Nelfinavir |
| (J05AE05) Amprenavir |
| (J05AE06) Lopinavir |
| (J05AF) Nucleoside and nucleotide reverse transcriptase inhibitors |
| (J05AF01) Zidovudine |
| (J05AF02) Didanosine |
| (J05AF03) Zalcitabine |
| (J05AF04) Stavudine |
| (J05AF05) Lamivudine |
| (J05AF06) Abacavir |
| (J05AF07) Tenofovir disoproxil |
| (J05AF08) Adefovir dipivoxil |
| (J05AF09) Emtricitabine |
| (J05AF10) Entecavir |
| (J05AF11) Telbivudine |
| (J05AF12) Clevudine |
| (J05AF30) Combinations |
| (J05AG) Non-nucleoside reverse transcriptase inhibitors |
| (J05AG01) Nevirapine |
| (J05AG02) Delavirdine |
| (J05AG03) Efavirenz |
| (J05AH) Neuraminidase inhibitors |
| (J05AH01) Zanamivir |
| (J05AH02) Oseltamivir |
| (J05AX) Other antivirals |
| (J05AX01) Moroxydine |
| (J05AX02) Lysozyme |
| (J05AX05) Inosine pranobex |
| (J05AX06) Pleconaril |
| (J06) IMMUNE SERA AND IMMUNOGLOBULINS |
| (J06A) IMMUNE SERA |
| (J06AA) Immune sera |
| (J06AA01) Diphtheria antitoxin |
| (J06AA02) Tetanus antitoxin |
| (J06AA03) Snake venom antiserum |
| (J06AA04) Botulinum antitoxin |
| (J06AA05) Gas-gangrene sera |
| (J06AA06) Rabies serum |
| (J06B) IMMUNOGLOBULINS |
| (J06BA) Immunoglobulins, normal human |
| (J06BA01) Immunoglobulins, normal human, for extravascular adm. |
| (J06BA02) Immunoglobulins, normal human, for intravascular adm. |
| (J06BB) Specific immunoglobulins |
| (J06BB01) Anti-D (rh) immunoglobulin |
| (J06BB02) Tetanus immunoglobulin |
| (J06BB03) Varicella/zoster immunoglobulin |
| (J06BB04) Hepatitis B immunoglobulin |
| (J06BB05) Rabies immunoglobulin |
| (J06BB06) Rubella immunoglobulin |
| (J06BB07) Vaccinia immunoglobulin |
| (J06BB08) Staphylococcus immunoglobulin |
| (J06BB09) Cytomegalovirus immunoglobulin |
| (J06BB10) Diphtheria immunoglobulin |
| (J06BB11) Hepatitis A immunoglobulin |
| (J06BB12) Encephalitis, tick borne immunoglobulin |
| (J06BB13) Pertussis immunoglobulin |
| (J06BB14) Morbilli immunoglobulin |
| (J06BB15) Parotitis immunoglobulin |
| (J06BB16) Palivizumab |
| (J06BB30) Combinations |
| (J06BC) Other immunoglobulins |
| (J06BC01) Nebacumab |
| (J07) VACCINES |
| (J07A) BACTERIAL VACCINES |
| (J07AC) Anthrax vaccines |
| (J07AC01) Anthrax antigen |
| (J07AD) Brucellosis vaccines |
| (J07AD01) Brucella antigen |
| (J07AE) Cholera vaccines |
| (J07AE01) Cholera, inactivated, whole cell |
| (J07AE02) Cholera, live attenuated |
| (J07AE51) Cholera, combinations with typhoid vaccine, inactivated, whole cell |
| (J07AF) Diphtheria vaccines |
| (J07AF01) Diphtheria toxoid |
| (J07AG) Hemophilus influenzae B vaccines |
| (J07AG01) Hemophilus influenzae B, purified antigen conjugated |
| (J07AG51) Hemophilus influenzae B, combinations with toxoids |
| (J07AG52) Hemophilus influenzae B, combinations with pertussis and toxoids |
| (J07AH) Meningococcal vaccines |
| (J07AH01) Meningococcus A, purified polysaccharides antigen |
| (J07AH02) Other meningococcal monovalent purified polysaccharides antigen |
| (J07AH03) Meningococcus, bivalent purified polysaccharides antigen |
| (J07AH04) Meningococcus, tetravalent purified polysaccharides antigen |
| (J07AH05) Other meningococcal polyvalent purified polysaccharides antigen |
| (J07AH06) Meningococcus B, outer membrane vesicle vaccine |
| (J07AH07) Meningococcus C, purified polysaccharides antigen conjugated |
| (J07AJ) Pertussis vaccines |
| (J07AJ01) Pertussis, inactivated, whole cell |
| (J07AJ02) Pertussis, purified antigen |
| (J07AJ51) Pertussis, inactivated, whole cell, combinations with toxoids |
| (J07AJ52) Pertussis, purified antigen, combinations with toxoids |
| (J07AK) Plague vaccines |
| (J07AK01) Plague, inactivated, whole cell |
| (J07AL) Pneumococcal vaccines |
| (J07AL01) Pneumococcus, purified polysaccharides antigen |
| (J07AL02) Pneumococcus, purified polysaccharides antigen conjugated |
| (J07AM) Tetanus vaccines |
| (J07AM01) Tetanus toxoid |
| (J07AM51) Tetanus toxoid, combinations with diphtheria toxoid |
| (J07AM52) Tetanus toxoid, combinations with tetanus immunoglobulin |
| (J07AN) Tuberculosis vaccines |
| (J07AN01) Tuberculosis, live attenuated |
| (J07AP) Typhoid vaccines |
| (J07AP01) Typhoid, oral, live attenuated |
| (J07AP02) Typhoid, inactivated, whole cell |
| (J07AP03) Typhoid, purified polysaccharide antigen |
| (J07AP10) Typhoid, combinations with paratyphi types |
| (J07AR) Typhus (exanthematicus) vaccines |
| (J07AR01) Typhus exanthematicus, inactivated, whole cell |
| (J07AX) Other bacterial vaccines |
| (J07B) VIRAL VACCINES |
| (J07BA) Encephalitis vaccines |
| (J07BA01) Encephalitis, tick borne, inactivated, whole virus |
| (J07BA02) Encephalitis, Japanese, inactivated, whole virus |
| (J07BB) Influenza vaccines |
| (J07BB01) Influenza, inactivated, whole virus |
| (J07BB02) Influenza, purified antigen |
| (J07BC) Hepatitis vaccines |
| (J07BC01) Hepatitis B, purified antigen |
| (J07BC02) Hepatitis A, inactivated, whole virus |
| (J07BC20) Combinations |
| (J07BD) Morbilli vaccines |
| (J07BD01) Morbilli, live attenuated |
| (J07BD51) Morbilli, combinations with parotitis, live attenuated |
| (J07BD52) Morbilli, combinations with parotitis and rubella, live attenuated |
| (J07BD53) Morbilli, combinations with rubella, live attenuated |
| (J07BE) Parotitis vaccines |
| (J07BE01) Parotitis, live attenuated |
| (J07BF) Poliomyelitis vaccines |
| (J07BF01) Poliomyelitis oral, monovalent live attenuated |
| (J07BF02) Poliomyelitis oral, trivalent, live attenuated |
| (J07BF03) Poliomyelitis, trivalent, inactivated, whole virus |
| (J07BG) Rabies vaccines |
| (J07BG01) Rabies, inactivated, whole virus |
| (J07BH) Rota virus diarrhea vaccines |
| (J07BH01) Rota virus, live attenuated |
| (J07BJ) Rubella vaccines |
| (J07BJ01) Rubella, live attenuated |
| (J07BJ51) Rubella, combinations with parotitis, live attenuated |
| (J07BK) Varicella vaccines |
| (J07BK01) Varicella, live attenuated |
| (J07BL) Yellow fever vaccines |
| (J07BL01) Yellow fever, live attenuated |
| (J07BM) Papillomavirus vaccines |
| (J07BM01) Papillomavirus (human types 6, 11, 16, 18) |
| (J07BM02) Papillomavirus (human types 16, 18) |
| (J07BX) Other viral vaccines |
| (J07C) BACTERIAL AND VIRAL VACCINES, COMBINED |
| (J07CA) Bacterial and viral vaccines, combined |
| (J07CA01) Diphtheria-poliomyelitis-tetanus |
| (J07CA02) Diphtheria-pertussis-poliomyelitis-tetanus |
| (J07CA03) Diphtheria-rubella-tetanus |
| (J07CA04) Hemophilus influenzae B and poliomyelitis |
| (J07CA05) Diphtheria-hepatitis B-pertussis-tetanus |
| (J07CA06) Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus |
| (J07CA07) Diphtheria-hepatitis B-tetanus |
| (J07CA08) Hemophilus influenzae B and hepatitis B |
| (J07CA09) Diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
| (J07X) OTHER VACCINES |
| (L) ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS |
| (L01) ANTINEOPLASTIC AGENTS |
| (L01A) ALKYLATING AGENTS |
| (L01AA) Nitrogen mustard analogues |
| (L01AA01) Cyclophosphamide |
| (L01AA02) Chlorambucil |
| (L01AA03) Melphalan |
| (L01AA05) Chlormethine |
| (L01AA06) Ifosfamide |
| (L01AA07) Trofosfamide |
| (L01AA08) Prednimustine |
| (L01AB) Alkyl sulfonates |
| (L01AB01) Busulfan |
| (L01AB02) Treosulfan |
| (L01AB03) Mannosulfan |
| (L01AC) Ethylene imines |
| (L01AC01) Thiotepa |
| (L01AC02) Triaziquone |
| (L01AC03) Carboquone |
| (L01AD) Nitrosoureas |
| (L01AD01) Carmustine |
| (L01AD02) Lomustine |
| (L01AD03) Semustine |
| (L01AD04) Streptozocin |
| (L01AD05) Fotemustine |
| (L01AD06) Nimustine |
| (L01AD07) Ranimustine |
| (L01AG) Epoxides |
| (L01AG01) Etoglucid |
| (L01AX) Other alkylating agents |
| (L01AX01) Mitobronitol |
| (L01AX02) Pipobroman |
| (L01AX03) Temozolomide |
| (L01AX04) Dacarbazine |
| (L01B) ANTIMETABOLITES |
| (L01BA) Folic acid analogues |
| (L01BA01) methotrexate? |
| (L01BA03) raltitrexed? |
| (L01BA04) pemetrexed? |
| (L01BA05) pralatrexate? |
| (L01BB) Purine analogues |
| (L01BB02) Mercaptopurine |
| (L01BB03) Tioguanine |
| (L01BB04) Cladribine |
| (L01BB05) Fludarabine |
| (L01BC) Pyrimidine analogues |
| (L01BC01) Cytarabine |
| (L01BC02) Fluorouracil |
| (L01BC03) Tegafur |
| (L01BC04) Carmofur |
| (L01BC05) Gemcitabine |
| (L01BC06) Capecitabine |
| (L01BC52) Fluorouracil, combinations |
| (L01BC53) Tegafur, combinations |
| (L01C) PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| (L01CA) Vinca alkaloids and analogues |
| (L01CA01) Vinblastine |
| (L01CA02) Vincristine |
| (L01CA03) Vindesine |
| (L01CA04) Vinorelbine |
| (L01CB) Podophyllotoxin derivatives |
| (L01CB01) Etoposide |
| (L01CB02) Teniposide |
| (L01CC) Colchicine derivatives |
| (L01CC01) Demecolcine |
| (L01CD) Taxanes |
| (L01CD01) Paclitaxel |
| (L01CD02) Docetaxel |
| (L01CX) Other plant alkaloids and natural products |
| (L01CX01) Trabectedin |
| (L01D) CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| (L01DA) Actinomycines |
| (L01DA01) Dactinomycin |
| (L01DB) Anthracyclines and related substances |
| (L01DB01) Doxorubicin |
| (L01DB02) Daunorubicin |
| (L01DB03) Epirubicin |
| (L01DB04) Aclarubicin |
| (L01DB05) Zorubicin |
| (L01DB06) Idarubicin |
| (L01DB07) Mitoxantrone |
| (L01DB08) Pirarubicin |
| (L01DB09) Valrubicin |
| (L01DC) Other cytotoxic antibiotics |
| (L01DC01) Bleomycin |
| (L01DC02) Plicamycin |
| (L01DC03) Mitomycin |
| (L01DC04) Ixabepilone |
| (L01X) OTHER ANTINEOPLASTIC AGENTS |
| (L01XA) Platinum compounds |
| (L01XA01) Cisplatin |
| (L01XA02) Carboplatin |
| (L01XA03) Oxaliplatin |
| (L01XB) Methylhydrazines |
| (L01XB01) Procarbazine |
| (L01XC) Monoclonal antibodies |
| (L01XC01) Edrecolomab |
| (L01XC02) Rituximab |
| (L01XC03) Trastuzumab |
| (L01XC04) Alemtuzumab |
| (L01XC05) Gemtuzumab |
| (L01XC06) Cetuximab |
| (L01XC07) Bevacizumab |
| (L01XC08) Panitumumab |
| (L01XC09) Catumaxomab |
| (L01XC10) Ofatumumab |
| (L01XD) Agents used in photodynamic therapy |
| (L01XD01) Porfimer sodium |
| (L01XD02) Verteporfin |
| (L01XD03) Methyl aminolevulinate |
| (L01XD04) Aminolevulinic acid |
| (L01XE) Protein kinase inhibitors |
| (L01XE01) Imatinib |
| (L01XE02) Gefitinib |
| (L01XE03) Erlotinib |
| (L01XE04) Sunitinib |
| (L01XE05) Sorafenib |
| (L01XE06) Dasatinib |
| (L01XE07) Lapatinib |
| (L01XE08) Nilotinib |
| (L01XE09) Temsirolimus |
| (L01XE10) Everolimus |
| (L01XE11) Pazopanib |
| (L01XX) Other antineoplastic agents |
| (L01XX01) Amsacrine |
| (L01XX02) Asparaginase |
| (L01XX03) Altretamine |
| (L01XX05) Hydroxycarbamide |
| (L01XX07) Lonidamine |
| (L01XX08) Pentostatin |
| (L01XX09) Miltefosine |
| (L01XX10) Masoprocol |
| (L01XX11) Estramustine |
| (L01XX14) Tretinoin |
| (L01XX16) Mitoguazone |
| (L01XX17) Topotecan |
| (L01XX18) Tiazofurine |
| (L01XX19) Irinotecan |
| (L01XX22) Alitretinoin |
| (L01XX23) Mitotane |
| (L01XX24) Pegaspargase |
| (L01XX25) Bexarotene |
| (L01XX27) Arsenic trioxide |
| (L01XX28) Imatinib |
| (L01XX29) Denileukin diftitox |
| (L01XX31) Gefitinib |
| (L01XX32) Bortezomib |
| (L01XX33) Celecoxib |
| (L01XY) Combinations of antineoplastic agents |
| (L02) ENDOCRINE THERAPY |
| (L02A) HORMONES AND RELATED AGENTS |
| (L02AA) Estrogens |
| (L02AA01) Diethylstilbestrol |
| (L02AA02) Polyestradiol phosphate |
| (L02AA03) Ethinylestradiol |
| (L02AA04) Fosfestrol |
| (L02AB) Progestogens |
| (L02AB01) Megestrol |
| (L02AB02) Medroxyprogesterone |
| (L02AB03) Gestonorone |
| (L02AE) Gonadotropin releasing hormone analogues |
| (L02AE01) Buserelin |
| (L02AE02) Leuprorelin |
| (L02AE03) Goserelin |
| (L02AE04) Triptorelin |
| (L02AX) Other hormones |
| (L02B) HORMONE ANTAGONISTS AND RELATED AGENTS |
| (L02BA) Anti-estrogens |
| (L02BA01) Tamoxifen |
| (L02BA02) Toremifene |
| (L02BA03) Fulvestrant |
| (L02BB) Anti-androgens |
| (L02BB01) Flutamide |
| (L02BB02) Nilutamide |
| (L02BB03) Bicalutamide |
| (L02BG) Enzyme inhibitors |
| (L02BG01) Aminogluthetimide |
| (L02BG02) Formestane |
| (L02BG03) Anastrozole |
| (L02BG04) Letrozole |
| (L02BG05) Vorozole |
| (L02BG06) Exemestane |
| (L03) IMMUNOSTIMULANTS |
| (L03A) CYTOKINES AND IMMUNOMODULATORS |
| (L03AA) Colony stimulating factors |
| (L03AA02) Filgrastim |
| (L03AA03) Molgramostim |
| (L03AA09) Sargramostim |
| (L03AA10) Lenograstim |
| (L03AA12) Ancestim |
| (L03AA13) Pegfilgrastim |
| (L03AB) Interferons |
| (L03AB01) Interferon alfa natural |
| (L03AB02) Interferon beta natural |
| (L03AB03) Interferon gamma |
| (L03AB04) Interferon alfa-2a |
| (L03AB05) Interferon alfa-2b |
| (L03AB06) Interferon alfa-n1 |
| (L03AB07) Interferon beta-1a |
| (L03AB08) Interferon beta-1b |
| (L03AB09) Interferon alfacon-1 |
| (L03AB10) Peginterferon alfa-2b |
| (L03AB11) Peginterferon alfa-2a |
| (L03AC) Interleukins |
| (L03AC01) Aldesleukin |
| (L03AC02) Oprelvekin |
| (L03AX) Other cytokines and immunomodulators |
| (L03AX01) Lentinan |
| (L03AX02) Roquinimex |
| (L03AX03) BCG vaccine |
| (L03AX04) Pegademase |
| (L03AX05) Pidotimod |
| (L03AX07) Poly I:C |
| (L03AX08) Poly ICLC |
| (L03AX09) Thymopentin |
| (L03AX10) Immunocyanin |
| (L03AX11) Tasonermin |
| (L03AX12) Melanoma vaccine |
| (L03AX13) Glatiramer acetate |
| (L04) IMMUNOSUPPRESSIVE AGENTS |
| (L04A) IMMUNOSUPPRESSIVE AGENTS |
| (L04AA) Selective immunosuppressive agents |
| (L04AA02) muromonab-CD3? |
| (L04AA03) antilymphocyte immunoglobulin (horse)? |
| (L04AA04) antithymocyte immunoglobulin (rabbit)? |
| (L04AA06) mycophenolic acid? |
| (L04AA10) sirolimus? |
| (L04AA13) leflunomide? |
| (L04AA15) alefacept? |
| (L04AA18) everolimus? |
| (L04AA19) gusperimus? |
| (L04AA21) efalizumab? |
| (L04AA22) abetimus? |
| (L04AA23) natalizumab? |
| (L04AA24) abatacept? |
| (L04AA25) eculizumab? |
| (L04AB) Tumor necrosis factor alpha (TNF-α) inhibitors |
| (L04AB01) etanercept? |
| (L04AB01) etanercept? |
| (L04AB02) infliximab? |
| (L04AB02) infliximab? |
| (L04AB03) afelimomab? |
| (L04AB03) afelimomab? |
| (L04AB04) adalimumab? |
| (L04AB04) adalimumab? |
| (L04AB05) certolizumab pegol? |
| (L04AB05) certolizumab pegol? |
| (L04AB06) golimumab? |
| (L04AB06) golimumab? |
| (L04AC) Interleukin inhibitors |
| (L04AC01) daclizumab? |
| (L04AC02) basiliximab? |
| (L04AC03) anakinra? |
| (L04AC04) rilonacept? |
| (L04AC05) ustekinumab? |
| (L04AC06) mepolizumab? |
| (L04AC07) tocilizumab? |
| (L04AC08) canakinumab? |
| (L04AD) Calcineurin inhibitors |
| (L04AD01) ciclosporin? |
| (L04AD02) tacrolimus? |
| (L04AX) Other immunosuppressive agents |
| (L04AX01) Azathioprine |
| (L04AX02) Thalidomide |
| (L04AX03) Methotrexate |
| (L04AX04) lenalidomide? |
| (M) MUSCULO-SKELETAL SYSTEM |
| (M01) ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS |
| (M01A) ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS |
| (M01AA) Butylpyrazolidines |
| (M01AA01) Phenylbutazone |
| (M01AA02) Mofebutazone |
| (M01AA03) Oxyphenbutazone |
| (M01AA05) Clofezone |
| (M01AA06) Kebuzone |
| (M01AB) Acetic acid derivatives and related substances |
| (M01AB01) Indometacin |
| (M01AB02) Sulindac |
| (M01AB03) Tolmetin |
| (M01AB04) Zomepirac |
| (M01AB05) Diclofenac |
| (M01AB06) Alclofenac |
| (M01AB07) Bumadizone |
| (M01AB08) Etodolac |
| (M01AB09) Lonazolac |
| (M01AB10) Fentiazac |
| (M01AB11) Acemetacin |
| (M01AB12) Difenpiramide |
| (M01AB13) Oxametacin |
| (M01AB14) Proglumetacin |
| (M01AB15) Ketorolac |
| (M01AB16) Aceclofenac |
| (M01AB17) Bufexamac |
| (M01AB51) Indometacin, combinations |
| (M01AB55) Diclofenac, combinations |
| (M01AC) Oxicams |
| (M01AC01) Piroxicam |
| (M01AC02) Tenoxicam |
| (M01AC04) Droxicam |
| (M01AC05) Lornoxicam |
| (M01AC06) Meloxicam |
| (M01AE) Propionic acid derivatives |
| (M01AE01) Ibuprofen |
| (M01AE02) Naproxen |
| (M01AE03) Ketoprofen |
| (M01AE04) Fenoprofen |
| (M01AE05) Fenbufen |
| (M01AE06) Benoxaprofen |
| (M01AE07) Suprofen |
| (M01AE08) Pirprofen |
| (M01AE09) Flurbiprofen |
| (M01AE10) Indoprofen |
| (M01AE11) Tiaprofenic acid |
| (M01AE12) Oxaprozin |
| (M01AE13) Ibuproxam |
| (M01AE14) Dexibuprofen |
| (M01AE15) Flunoxaprofen |
| (M01AE16) Alminoprofen |
| (M01AE17) Dexketoprofen |
| (M01AE51) Ibuprofen, combinations |
| (M01AE53) Ketoprofen, combinations |
| (M01AG) Fenamates |
| (M01AG01) Mefenamic acid |
| (M01AG02) Tolfenamic acid |
| (M01AG03) Flufenamic acid |
| (M01AG04) Meclofenamic acid |
| (M01AH) Coxibs |
| (M01AH01) Celecoxib |
| (M01AH02) Rofecoxib |
| (M01AH03) Valdecoxib |
| (M01AH04) Parecoxib |
| (M01AH05) Etoricoxib |
| (M01AH06) Lumiracoxib |
| (M01AX) Other antiinflammatory and antirheumatic agents, non-steroids |
| (M01AX01) Nabumetone |
| (M01AX02) Niflumic acid |
| (M01AX04) Azapropazone |
| (M01AX05) Glucosamine |
| (M01AX07) Benzydamine |
| (M01AX12) Glucosaminoglycan polysulfate |
| (M01AX13) Proquazone |
| (M01AX14) Orgotein |
| (M01AX17) Nimesulide |
| (M01AX18) Feprazone |
| (M01AX21) Diacerein |
| (M01AX22) Morniflumate |
| (M01AX23) Tenidap |
| (M01AX24) Oxaceprol |
| (M01AX25) Chondroitin sulfate |
| (M01AX68) Feprazone, combinations |
| (M01B) ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION |
| (M01BA) Antiinflammatory/antirheumatic agents in combination with corticosteroids |
| (M01BA01) Phenylbutazone and corticosteroids |
| (M01BA02) Dipyrocetyl and corticosteroids |
| (M01BA03) Acetylsalicylic acid and corticosteroids |
| (M01BX) Other antiinflammatory/antirheumatic agents in combination with other drugs |
| (M01C) SPECIFIC ANTIRHEUMATIC AGENTS |
| (M01CA) Quinolines |
| (M01CA03) Oxycinchophen |
| (M01CB) Gold preparations |
| (M01CB01) Sodium aurothiomalate |
| (M01CB02) Sodium aurothiosulfate |
| (M01CB03) Auranofin |
| (M01CB04) Aurothioglucose |
| (M01CB05) Aurotioprol |
| (M01CC) Penicillamine and similar agents |
| (M01CC01) Penicillamine |
| (M01CC02) Bucillamine |
| (M01CX) Other specific antirheumatic agents |
| (M02) TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| (M02A) TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN |
| (M02AA) Antiinflammatory preparations, non-steroids for topical use |
| (M02AA01) Phenylbutazone |
| (M02AA02) Mofebutazone |
| (M02AA03) Clofezone |
| (M02AA04) Oxyphenbutazone |
| (M02AA05) Benzydamine |
| (M02AA06) Etofenamate |
| (M02AA07) Piroxicam |
| (M02AA08) Felbinac |
| (M02AA09) Bufexamac |
| (M02AA10) Ketoprofen |
| (M02AA11) Bendazac |
| (M02AA12) Naproxen |
| (M02AA13) Ibuprofen |
| (M02AA14) Fentiazac |
| (M02AA15) Diclofenac |
| (M02AA16) Feprazone |
| (M02AA17) Niflumic acid |
| (M02AA18) Meclofenamic acid |
| (M02AA19) Flurbiprofen |
| (M02AA21) Tolmetin |
| (M02AA22) Suxibuzone |
| (M02AA23) Indometacin |
| (M02AA24) Nifenazone |
| (M02AB) Capsicum preparations and similar agents |
| (M02AC) Preparations with salicylic acid derivatives |
| (M02AX) Other topical products for joint and muscular pain |
| (M02AX02) Tolazoline |
| (M02AX03) Dimethyl sulfoxide |
| (M02AX10) Various |
| (M03) MUSCLE RELAXANTS |
| (M03A) MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
| (M03AA) Curare alkaloids |
| (M03AA01) Alcuronium |
| (M03AA02) Tubocurarine |
| (M03AA04) Dimethyltubocurarine |
| (M03AB) Choline derivatives |
| (M03AB01) Suxamethonium |
| (M03AC) Other quaternary ammonium compounds |
| (M03AC01) Pancuronium |
| (M03AC02) Gallamine |
| (M03AC03) Vecuronium |
| (M03AC04) Atracurium |
| (M03AC05) Hexafluronium |
| (M03AC06) Pipecuronium bromide |
| (M03AC07) Doxacurium chloride |
| (M03AC08) Fazadinium bromide |
| (M03AC09) Rocuronium bromide |
| (M03AC10) Mivacurium chloride |
| (M03AC11) Cisatracurium |
| (M03AX) Other muscle relaxants, peripherally acting agents |
| (M03AX01) Botulinum toxin |
| (M03B) MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS |
| (M03BA) Carbamic acid esters |
| (M03BA01) Phenprobamate |
| (M03BA02) Carisoprodol |
| (M03BA03) Methocarbamol |
| (M03BA04) Styramate |
| (M03BA05) Febarbamate |
| (M03BA51) Phenprobamate, combinations excl. psycholeptics |
| (M03BA52) Carisoprodol, combinations excl. psycholeptics |
| (M03BA53) Methocarbamol, combinations excl. psycholeptics |
| (M03BA71) Phenprobamate, combinations with psycholeptics |
| (M03BA72) Carisoprodol, combinations with psycholeptics |
| (M03BA73) Methocarbamol, combinations with psycholeptics |
| (M03BB) Oxazol, thiazine, and triazine derivatives |
| (M03BB02) Chlormezanone |
| (M03BB03) Chlorzoxazone |
| (M03BB52) Chlormezanone, combinations excl. psycholeptics |
| (M03BB53) Chlorzoxazone, combinations excl. psycholeptics |
| (M03BB72) Chlormezanone, combinations with psycholeptics |
| (M03BB73) Chlorzoxazone, combinations with psycholeptics |
| (M03BC) Ethers, chemically close to antihistamines |
| (M03BC01) Orphenadrine (citrate) |
| (M03BC51) Orphenadrine, combinations |
| (M03BX) Other centrally acting agents |
| (M03BX01) Baclofen |
| (M03BX02) Tizanidine |
| (M03BX03) Pridinol |
| (M03BX04) Tolperisone |
| (M03BX05) Thiocolchicoside |
| (M03BX06) Mephenesin |
| (M03BX07) Tetrazepam |
| (M03BX08) Cyclobenzaprine |
| (M03BX30) Phenyramidol |
| (M03C) MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS |
| (M03CA) Dantrolene and derivatives |
| (M03CA01) Dantrolene |
| (M04) ANTIGOUT PREPARATIONS |
| (M04A) ANTIGOUT PREPARATIONS |
| (M04AA) Preparations inhibiting uric acid production |
| (M04AA01) Allopurinol |
| (M04AA02) Tisopurine |
| (M04AA51) Allopurinol, combinations |
| (M04AB) Preparations increasing uric acid excretion |
| (M04AB01) Probenecid |
| (M04AB02) Sulfinpyrazone |
| (M04AB03) Benzbromarone |
| (M04AB04) Isobromindione |
| (M04AC) Preparations with no effect on uric acid metabolism |
| (M04AC01) Colchicine |
| (M04AC02) Cinchophen |
| (M04AX) Other antigout preparations |
| (M04AX01) Urate oxidase |
| (M05) DRUGS FOR TREATMENT OF BONE DISEASES |
| (M05B) DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| (M05BA) Bisphosphonates |
| (M05BA01) Etidronic acid |
| (M05BA02) Clodronic acid |
| (M05BA03) Pamidronic acid |
| (M05BA04) Alendronic acid |
| (M05BA05) Tiludronic acid |
| (M05BA06) Ibandronic acid |
| (M05BA07) Risedronic acid |
| (M05BA08) Zoledronic acid |
| (M05BB) Bisphosphonates and calcium, sequential preparations |
| (M05BB01) Etidronic acid and calcium |
| (M05BC) Bone morphogenetic proteins |
| (M05BC01) Dibotermin alfa |
| (M05BC02) Eptotermin alfa |
| (M05BX) Other drugs affecting bone structure and mineralization |
| (M05BX01) Ipriflavone |
| (M05BX02) Aluminium chlorohydrate |
| (M09) OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| (M09A) OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM |
| (M09AA) Quinine and derivatives |
| (M09AA01) Hydroquinine |
| (M09AA72) Quinine, combinations with psycholeptics |
| (M09AB) Enzymes |
| (M09AB01) Chymopapain |
| (M09AB52) Trypsin, combinations |
| (M09AX) Other drugs for disorders of the musculo-skeletal system |
| (M09AX01) Hyaluronic acid |
| (N) NERVOUS SYSTEM |
| (N01) ANESTHETICS |
| (N01A) ANESTHETICS, GENERAL |
| (N01AA) Ethers |
| (N01AA01) Diethyl ether |
| (N01AA02) Vinyl ether |
| (N01AB) Halogenated hydrocarbons |
| (N01AB01) Halothane |
| (N01AB02) Chloroform |
| (N01AB03) Methoxyflurane |
| (N01AB04) Enflurane |
| (N01AB05) Trichloroethylene |
| (N01AB06) Isoflurane |
| (N01AB07) Desflurane |
| (N01AB08) Sevoflurane |
| (N01AF) Barbiturates, plain |
| (N01AF01) Methohexital |
| (N01AF02) Hexobarbital |
| (N01AF03) Thiopental |
| (N01AG) Barbiturates in combination with other drugs |
| (N01AG01) Narcobarbital |
| (N01AH) Opioid anesthetics |
| (N01AH01) Fentanyl |
| (N01AH02) Alfentanil |
| (N01AH03) Sufentanil |
| (N01AH04) Phenoperidine |
| (N01AH05) Anileridine |
| (N01AH06) Remifentanil |
| (N01AH51) Fentanyl, combinations |
| (N01AX) Other general anesthetics |
| (N01AX01) Droperidol |
| (N01AX03) Ketamine |
| (N01AX04) Propanidid |
| (N01AX05) Alfaxalone |
| (N01AX07) Etomidate |
| (N01AX10) Propofol |
| (N01AX11) Hydroxybutyric acid |
| (N01AX13) Nitrous oxide |
| (N01AX14) Esketamine |
| (N01B) ANESTHETICS, LOCAL |
| (N01BA) Esters of aminobenzoic acid |
| (N01BA01) Metabutethamine |
| (N01BA02) Procaine |
| (N01BA03) Tetracaine |
| (N01BA04) Chloroprocaine |
| (N01BA05) Benzocaine |
| (N01BA52) Procaine, combinations |
| (N01BB) Amides |
| (N01BB01) Bupivacaine |
| (N01BB02) Lidocaine |
| (N01BB03) Mepivacaine |
| (N01BB04) Prilocaine |
| (N01BB05) Butanilicaine |
| (N01BB06) Cinchocaine |
| (N01BB07) Etidocaine |
| (N01BB08) Articaine |
| (N01BB09) Ropivacaine |
| (N01BB10) Levobupivacaine |
| (N01BB20) Combinations |
| (N01BB51) Bupivacaine, combinations |
| (N01BB52) Lidocaine, combinations |
| (N01BB53) Mepivacaine, combinations |
| (N01BB54) Prilocaine, combinations |
| (N01BB57) Etidocaine, combinations |
| (N01BB58) Articaine, combinations |
| (N01BC) Esters of benzoic acid |
| (N01BC01) Cocaine |
| (N01BX) Other local anesthetics |
| (N01BX01) Ethyl chloride |
| (N01BX02) Dyclonine |
| (N01BX03) Phenol |
| (N01BX04) Capsaicin |
| (N02) ANALGESICS |
| (N02A) OPIOIDS |
| (N02AA) Natural opium alkaloids |
| (N02AA01) Morphine |
| (N02AA02) Opium |
| (N02AA03) Hydromorphone |
| (N02AA04) Nicomorphine |
| (N02AA05) Oxycodone |
| (N02AA08) Dihydrocodeine |
| (N02AA09) Diamorphine |
| (N02AA10) Papaveretum |
| (N02AA51) Morphine, combinations |
| (N02AA58) Dihydrocodeine, combinations |
| (N02AA59) Codeine, combinations excl. psycholeptics |
| (N02AA79) Codeine, combinations with psycholeptics |
| (N02AB) Phenylpiperidine derivatives |
| (N02AB01) Ketobemidone |
| (N02AB02) Pethidine |
| (N02AB03) Fentanyl |
| (N02AB52) Pethidine, combinations excl. psycholeptics |
| (N02AB72) Pethidine, combinations with psycholeptics |
| (N02AC) Diphenylpropylamine derivatives |
| (N02AC01) Dextromoramide |
| (N02AC03) Piritramide |
| (N02AC04) Dextropropoxyphene |
| (N02AC05) Bezitramide |
| (N02AC52) Methadone, comb. excl. psycholeptics |
| (N02AC54) Dextropropoxyphene, comb. excl. psycholeptics |
| (N02AC74) Dextropropoxyphene, comb. with psycholeptics |
| (N02AD) Benzomorphan derivatives |
| (N02AD01) Pentazocine |
| (N02AD02) Phenazocine |
| (N02AE) Oripavine derivatives |
| (N02AE01) Buprenorphine |
| (N02AF) Morphinan derivatives |
| (N02AF01) Butorphanol |
| (N02AF02) Nalbufine |
| (N02AG) Opioids in combination with antispasmodics |
| (N02AG01) Morphine and antispasmodics |
| (N02AG02) Ketobemidone and antispasmodics |
| (N02AG03) Pethidine and antispasmodics |
| (N02AG04) Hydromorphone and antispasmodics |
| (N02AX) Other opioids |
| (N02AX01) Tilidine |
| (N02AX02) Tramadol |
| (N02AX03) Dezocine |
| (N02AX52) Tramadol, combinations |
| (N02B) OTHER ANALGESICS AND ANTIPYRETICS |
| (N02BA) Salicylic acid and derivatives |
| (N02BA01) Acetylsalicylic acid |
| (N02BA02) Aloxiprin |
| (N02BA03) Choline salicylate |
| (N02BA04) Sodium salicylate |
| (N02BA05) Salicylamide |
| (N02BA06) Salsalate |
| (N02BA07) Ethenzamide |
| (N02BA08) Morpholine salicylate |
| (N02BA09) Dipyrocetyl |
| (N02BA10) Benorilate |
| (N02BA11) Diflunisal |
| (N02BA12) Potassium salicylate |
| (N02BA14) Guacetisal |
| (N02BA15) Carbasalate calcium |
| (N02BA16) Imidazole salicylate |
| (N02BA51) Acetylsalicylic acid, combinations excl. psycholeptics |
| (N02BA55) Salicylamide, combinations excl. psycholeptics |
| (N02BA57) Ethenzamide, combinations excl. psycholeptics |
| (N02BA59) Dipyrocetyl, combinations excl. psycholeptics |
| (N02BA65) Carbasalate calcium combinations excl. psycholeptics |
| (N02BA71) Acetylsalicylic acid, combinations with psycholeptics |
| (N02BA75) Salicylamide, combinations with psycholeptics |
| (N02BA77) Ethenzamide, combinations with psycholeptics |
| (N02BA79) Dipyrocetyl, combinations with psycholeptics |
| (N02BB) Pyrazolones |
| (N02BB01) Phenazone |
| (N02BB02) Metamizole sodium |
| (N02BB03) Aminophenazone |
| (N02BB04) Propyphenazone |
| (N02BB05) Nifenazone |
| (N02BB51) Phenazone, combinations excl. psycholeptics |
| (N02BB52) Metamizole sodium, combinations excl. psycholeptics |
| (N02BB53) Aminophenazone, combinations excl. psycholeptics |
| (N02BB54) Propyphenazone, combinations excl. psycholeptics |
| (N02BB71) Phenazone, combinations with psycholeptics |
| (N02BB72) Metamizole sodium, combinations with psycholeptics |
| (N02BB73) Aminophenazone, combinations with psycholeptics |
| (N02BB74) Propyphenazone, combinations with psycholeptics |
| (N02BE) Anilides |
| (N02BE01) Paracetamol |
| (N02BE03) Phenacetin |
| (N02BE04) Bucetin |
| (N02BE05) Propacetamol |
| (N02BE51) Paracetamol, combinations excl. psycholeptics |
| (N02BE53) Phenacetin, combinations excl. psycholeptics |
| (N02BE54) Bucetin, combinations excl. psycholeptics |
| (N02BE71) Paracetamol, combinations with psycholeptics |
| (N02BE73) Phenacetin, combinations with psycholeptics |
| (N02BE74) Bucetin, combinations with psycholeptics |
| (N02BG) Other analgesics and antipyretics |
| (N02BG02) Rimazolium |
| (N02BG03) Glafenine |
| (N02BG04) Floctafenine |
| (N02BG05) Viminol |
| (N02BG06) Nefopam |
| (N02BG07) Flupirtine |
| (N02C) ANTIMIGRAINE PREPARATIONS |
| (N02CA) Ergot alkaloids |
| (N02CA01) Dihydroergotamine |
| (N02CA02) Ergotamine |
| (N02CA04) Methysergide |
| (N02CA07) Lisuride |
| (N02CA51) Dihydroergotamine, combinations |
| (N02CA52) Ergotamine, combinations excl. psycholeptics |
| (N02CA72) Ergotamine, combinations with psycholeptics |
| (N02CB) Corticosteroid derivatives |
| (N02CB01) Flumedroxone |
| (N02CC) Selective serotonin (5HT1) agonists |
| (N02CC01) Sumatriptan |
| (N02CC02) Naratriptan |
| (N02CC03) Zolmitriptan |
| (N02CC04) Rizatriptan |
| (N02CC05) Almotriptan |
| (N02CC06) Eletriptan |
| (N02CC07) Frovatriptan |
| (N02CX) Other antimigraine preparations |
| (N02CX01) Pizotifen |
| (N02CX02) Clonidine |
| (N02CX03) Iprazochrome |
| (N02CX05) Dimetotiazine |
| (N02CX06) Oxetorone |
| (N03) ANTIEPILEPTICS |
| (N03A) ANTIEPILEPTICS |
| (N03AA) Barbiturates and derivatives |
| (N03AA01) Methylphenobarbital |
| (N03AA02) Phenobarbital |
| (N03AA03) Primidone |
| (N03AA04) Barbexaclone |
| (N03AA30) Metharbital |
| (N03AB) Hydantoin derivatives |
| (N03AB01) Ethotoin |
| (N03AB02) Phenytoin |
| (N03AB03) Amino(diphenylhydantoin) valeric acid |
| (N03AB04) Mephenytoin |
| (N03AB05) Fosphenytoin |
| (N03AB52) Phenytoin, combinations |
| (N03AB54) Mephenytoin, combinations |
| (N03AC) Oxazolidine derivatives |
| (N03AC01) Paramethadione |
| (N03AC02) Trimethadione |
| (N03AC03) Ethadione |
| (N03AD) Succinimide derivatives |
| (N03AD01) Ethosuximide |
| (N03AD02) Phensuximide |
| (N03AD03) Mesuximide |
| (N03AD51) Ethosuximide, combinations |
| (N03AE) Benzodiazepine derivatives |
| (N03AE01) Clonazepam |
| (N03AF) Carboxamide derivatives |
| (N03AF01) Carbamazepine |
| (N03AF02) Oxcarbazepine |
| (N03AG) Fatty acid derivatives |
| (N03AG01) Valproic acid |
| (N03AG02) Valpromide |
| (N03AG03) Aminobutyric acid |
| (N03AG04) Vigabatrin |
| (N03AG05) Progabide |
| (N03AG06) Tiagabine |
| (N03AX) Other antiepileptics |
| (N03AX03) Sultiame |
| (N03AX07) Phenacemide |
| (N03AX09) Lamotrigine |
| (N03AX10) Felbamate |
| (N03AX11) Topiramate |
| (N03AX12) Gabapentin |
| (N03AX13) Pheneturide |
| (N03AX14) Levetiracetam |
| (N03AX15) Zonisamide |
| (N03AX30) Beclamide |
| (N04) ANTI-PARKINSON DRUGS |
| (N04A) ANTICHOLINERGIC AGENTS |
| (N04AA) Tertiary amines |
| (N04AA01) Trihexyphenidyl |
| (N04AA02) Biperiden |
| (N04AA03) Metixene |
| (N04AA04) Procyclidine |
| (N04AA05) Profenamine |
| (N04AA08) Dexetimide |
| (N04AA09) Phenglutarimide |
| (N04AA10) Mazaticol |
| (N04AA11) Bornaprine |
| (N04AA12) Tropatepine |
| (N04AB) Ethers chemically close to antihistamines |
| (N04AB01) Etanautine |
| (N04AB02) Orphenadrine (chloride) |
| (N04AC) Ethers of tropine or tropine derivatives |
| (N04AC01) Benzatropine |
| (N04AC30) Etybenzatropine |
| (N04B) DOPAMINERGIC AGENTS |
| (N04BA) Dopa and dopa derivatives |
| (N04BA01) Levodopa |
| (N04BA02) Levodopa and decarboxylase inhibitor |
| (N04BA03) Levodopa, decarboxylase inhibitor and COMT inhibitor |
| (N04BA04) Melevodopa |
| (N04BA05) Melevodopa and decarboxylase inhibitor |
| (N04BA06) Etilevodopa and decarboxylase inhibitor |
| (N04BB) Adamantane derivatives |
| (N04BB01) Amantadine |
| (N04BC) Dopamine agonists |
| (N04BC01) Bromocriptine |
| (N04BC02) Pergolide |
| (N04BC03) Dihydroergocryptine mesylate |
| (N04BC04) Ropinirole |
| (N04BC05) Pramipexole |
| (N04BC06) Cabergoline |
| (N04BC07) Apomorphine |
| (N04BD) Monoamine oxidase B inhibitors |
| (N04BD01) Selegiline |
| (N04BX) Other dopaminergic agents |
| (N04BX01) Tolcapone |
| (N04BX02) Entacapone |
| (N04BX03) Budipine |
| (N05) PSYCHOLEPTICS |
| (N05A) ANTIPSYCHOTICS |
| (N05AA) Phenothiazines with aliphatic side-chain |
| (N05AA01) Chlorpromazine |
| (N05AA02) Levomepromazine |
| (N05AA03) Promazine |
| (N05AA04) Acepromazine |
| (N05AA05) Triflupromazine |
| (N05AA06) Cyamemazine |
| (N05AA07) Chlorproethazine |
| (N05AB) Phenothiazines with piperazine structure |
| (N05AB01) Dixyrazine |
| (N05AB02) Fluphenazine |
| (N05AB03) Perphenazine |
| (N05AB04) Prochlorperazine |
| (N05AB05) Thiopropazate |
| (N05AB06) Trifluoperazine |
| (N05AB07) Acetophenazine |
| (N05AB08) Thioproperazine |
| (N05AB09) Butaperazine |
| (N05AB10) Perazine |
| (N05AC) Phenothiazines with piperidine structure |
| (N05AC01) Periciazine |
| (N05AC02) Thioridazine |
| (N05AC03) Mesoridazine |
| (N05AC04) Pipotiazine |
| (N05AD) Butyrophenone derivatives |
| (N05AD01) Haloperidol |
| (N05AD02) Trifluperidol |
| (N05AD03) Melperone |
| (N05AD04) Moperone |
| (N05AD05) Pipamperone |
| (N05AD06) Bromperidol |
| (N05AD07) Benperidol |
| (N05AD08) Droperidol |
| (N05AD09) Fluanisone |
| (N05AE) Indole derivatives |
| (N05AE01) Oxypertine |
| (N05AE02) Molindone |
| (N05AE03) Sertindole |
| (N05AE04) Ziprasidone |
| (N05AF) Thioxanthene derivatives |
| (N05AF01) Flupentixol |
| (N05AF02) Clopenthixol |
| (N05AF03) Chlorprothixene |
| (N05AF04) Tiotixene |
| (N05AF05) Zuclopenthixol |
| (N05AG) Diphenylbutylpiperidine derivatives |
| (N05AG01) Fluspirilene |
| (N05AG02) Pimozide |
| (N05AG03) Penfluridol |
| (N05AH) Diazepines, oxazepines and thiazepines |
| (N05AH01) Loxapine |
| (N05AH02) Clozapine |
| (N05AH03) Olanzapine |
| (N05AH04) Quetiapine |
| (N05AK) Neuroleptics, in tardive dyskinesia |
| (N05AK01) Tetrabenazine |
| (N05AL) Benzamides |
| (N05AL01) Sulpiride |
| (N05AL02) Sultopride |
| (N05AL03) Tiapride |
| (N05AL04) Remoxipride |
| (N05AL05) Amisulpride |
| (N05AL06) Veralipride |
| (N05AL07) Levosulpiride |
| (N05AN) Lithium |
| (N05AN01) Lithium |
| (N05AX) Other antipsychotics |
| (N05AX07) Prothipendyl |
| (N05AX08) Risperidone |
| (N05AX09) Clotiapine |
| (N05AX10) Mosapramine |
| (N05AX11) Zotepine |
| (N05AX12) Aripiprazole |
| (N05AX13) Paliperidone |
| (N05B) ANXIOLYTICS |
| (N05BA) Benzodiazepine derivatives |
| (N05BA01) Diazepam |
| (N05BA02) Chlordiazepoxide |
| (N05BA03) Medazepam |
| (N05BA04) Oxazepam |
| (N05BA05) Potassium clorazepate |
| (N05BA06) Lorazepam |
| (N05BA07) Adinazolam |
| (N05BA08) Bromazepam |
| (N05BA09) Clobazam |
| (N05BA10) Ketazolam |
| (N05BA11) Prazepam |
| (N05BA12) Alprazolam |
| (N05BA13) Halazepam |
| (N05BA14) Pinazepam |
| (N05BA15) Camazepam |
| (N05BA16) Nordazepam |
| (N05BA17) Fludiazepam |
| (N05BA18) Ethyl loflazepate |
| (N05BA19) Etizolam |
| (N05BA21) Clotiazepam |
| (N05BA22) Cloxazolam |
| (N05BA23) Tofisopam |
| (N05BA56) Lorazepam, combinations |
| (N05BB) Diphenylmethane derivatives |
| (N05BB01) Hydroxyzine |
| (N05BB02) Captodiame |
| (N05BB51) Hydroxyzine, combinations |
| (N05BC) Carbamates |
| (N05BC01) Meprobamate |
| (N05BC03) Emylcamate |
| (N05BC04) Mebutamate |
| (N05BC51) Meprobamate, combinations |
| (N05BD) Dibenzo-bicyclo-octadiene derivatives |
| (N05BD01) Benzoctamine |
| (N05BE) Azaspirodecanedione derivatives |
| (N05BE01) Buspirone |
| (N05BX) Other anxiolytics |
| (N05BX01) Mephenoxalone |
| (N05BX02) Gedocarnil |
| (N05BX03) Etifoxine |
| (N05C) HYPNOTICS AND SEDATIVES |
| (N05CA) Barbiturates, plain |
| (N05CA01) Pentobarbital |
| (N05CA02) Amobarbital |
| (N05CA03) Butobarbital |
| (N05CA04) Barbital |
| (N05CA05) Aprobarbital |
| (N05CA06) Secobarbital |
| (N05CA07) Talbutal |
| (N05CA08) Vinylbital |
| (N05CA09) Vinbarbital |
| (N05CA10) Cyclobarbital |
| (N05CA11) Heptabarbital |
| (N05CA12) Reposal |
| (N05CA15) Methohexital |
| (N05CA16) Hexobarbital |
| (N05CA19) Thiopental |
| (N05CA20) Etallobarbital |
| (N05CA21) Allobarbital |
| (N05CA22) Proxibarbal |
| (N05CB) Barbiturates, combinations |
| (N05CB01) Combinations of barbiturates |
| (N05CB02) Barbiturates in combination with other drugs |
| (N05CC) Aldehydes and derivatives |
| (N05CC01) Chloral hydrate |
| (N05CC02) Chloralodol |
| (N05CC03) Acetylglycinamide chloral hydrate |
| (N05CC04) Dichloralphenazone |
| (N05CC05) Paraldehyde |
| (N05CD) Benzodiazepine derivatives |
| (N05CD01) Flurazepam |
| (N05CD02) Nitrazepam |
| (N05CD03) Flunitrazepam |
| (N05CD04) Estazolam |
| (N05CD05) Triazolam |
| (N05CD06) Lormetazepam |
| (N05CD07) Temazepam |
| (N05CD08) Midazolam |
| (N05CD09) Brotizolam |
| (N05CD10) Quazepam |
| (N05CD11) Loprazolam |
| (N05CD12) Doxefazepam |
| (N05CD13) Cinolazepam |
| (N05CE) Piperidinedione derivatives |
| (N05CE01) Glutethimide |
| (N05CE02) Methyprylon |
| (N05CE03) Pyrithyldione |
| (N05CF) Benzodiazepine related drugs |
| (N05CF01) Zopiclone |
| (N05CF02) Zolpidem |
| (N05CF03) Zaleplon |
| (N05CM) Other hypnotics and sedatives |
| (N05CM01) Methaqualone |
| (N05CM02) Clomethiazole |
| (N05CM03) Bromisoval |
| (N05CM04) Carbromal |
| (N05CM05) Scopolamine |
| (N05CM06) Propiomazine |
| (N05CM07) Triclofos |
| (N05CM08) Ethchlorvynol |
| (N05CM09) Valerian |
| (N05CM10) Hexapropymate |
| (N05CM11) Bromides |
| (N05CM12) Apronal |
| (N05CM13) Valnoctamide |
| (N05CM15) Methylpentynol |
| (N05CM16) Niaprazine |
| (N05CX) Hypnotics and sedatives in combination, excl. barbiturates |
| (N05CX01) Meprobamate, combinations |
| (N05CX02) Methaqualone, combinations |
| (N05CX03) Methylpentynol, combinations |
| (N05CX04) Clomethiazole, combinations |
| (N05CX05) Emepronium, combinations |
| (N05CX06) Dipiperonylaminoethanol, combinations |
| (N06) PSYCHOANALEPTICS |
| (N06A) ANTIDEPRESSANTS |
| (N06AA) Non-selective monoamine reuptake inhibitors |
| (N06AA01) Desipramine |
| (N06AA02) Imipramine |
| (N06AA03) Imipramine oxide |
| (N06AA04) Clomipramine |
| (N06AA05) Opipramol |
| (N06AA06) Trimipramine |
| (N06AA07) Lofepramine |
| (N06AA08) Dibenzepin |
| (N06AA09) Amitriptyline |
| (N06AA10) Nortriptyline |
| (N06AA11) Protriptyline |
| (N06AA12) Doxepin |
| (N06AA13) Iprindole |
| (N06AA14) Melitracen |
| (N06AA15) Butriptyline |
| (N06AA16) Dosulepin |
| (N06AA17) Amoxapine |
| (N06AA18) Dimetacrine |
| (N06AA19) Amineptine |
| (N06AA21) Maprotiline |
| (N06AA23) Quinupramine |
| (N06AB) Selective serotonin reuptake inhibitors |
| (N06AB02) Zimeldine |
| (N06AB03) Fluoxetine |
| (N06AB04) Citalopram |
| (N06AB05) Paroxetine |
| (N06AB06) Sertraline |
| (N06AB07) Alaproclate |
| (N06AB08) Fluvoxamine |
| (N06AB09) Etoperidone |
| (N06AB10) Escitalopram |
| (N06AF) Monoamine oxidase inhibitors, non-selective |
| (N06AF01) Isocarboxazid |
| (N06AF02) Nialamide |
| (N06AF03) Phenelzine |
| (N06AF04) Tranylcypromine |
| (N06AF05) Iproniazide |
| (N06AF06) Iproclozide |
| (N06AG) Monoamine oxidase A inhibitors |
| (N06AG02) Moclobemide |
| (N06AG03) Toloxatone |
| (N06AX) Other antidepressants |
| (N06AX01) Oxitriptan |
| (N06AX02) Tryptophan |
| (N06AX03) Mianserin |
| (N06AX04) Nomifensine |
| (N06AX05) Trazodone |
| (N06AX06) Nefazodone |
| (N06AX07) Minaprine |
| (N06AX08) Bifemelane |
| (N06AX09) Viloxazine |
| (N06AX10) Oxaflozane |
| (N06AX11) Mirtazapine |
| (N06AX13) Medifoxamine |
| (N06AX14) Tianeptine |
| (N06AX15) Pivagabine |
| (N06AX16) Venlafaxine |
| (N06AX17) Milnacipran |
| (N06AX18) Reboxetine |
| (N06AX19) Gepirone |
| (N06AX21) Duloxetine |
| (N06AX22) Agomelatine |
| (N06AX23) Desvenlafaxine |
| (N06B) PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS |
| (N06BA) Centrally acting sympathomimetics |
| (N06BA01) Amfetamine |
| (N06BA02) Dexamfetamine |
| (N06BA03) Metamfetamine |
| (N06BA04) Methylphenidate |
| (N06BA05) Pemoline |
| (N06BA06) Fencamfamin |
| (N06BA07) Modafinil |
| (N06BA08) Fenozolone |
| (N06BA09) Atomoxetine |
| (N06BC) Xanthine derivatives |
| (N06BC01) Caffeine |
| (N06BC02) Propentofylline |
| (N06BX) Other psychostimulants and nootropics |
| (N06BX01) Meclofenoxate |
| (N06BX02) Pyritinol |
| (N06BX03) Piracetam |
| (N06BX04) Deanol |
| (N06BX05) Fipexide |
| (N06BX06) Citicoline |
| (N06BX07) Oxiracetam |
| (N06BX08) Pirisudanol |
| (N06BX09) Linopirdine |
| (N06BX10) Nizofenone |
| (N06BX11) Aniracetam |
| (N06BX12) Acetylcarnitine |
| (N06BX13) Idebenone |
| (N06BX14) Prolintane |
| (N06BX15) Pipradrol |
| (N06BX16) Pramiracetam |
| (N06BX17) Adrafinil |
| (N06BX18) Vinpocetine |
| (N06C) PSYCHOLEPTICS AND PSYCHOANALEPTICS IN COMBINATION |
| (N06CA) Antidepressants in combination with psycholeptics |
| (N06CA01) Amitriptyline and psycholeptics |
| (N06CA02) Melitracen and psycholeptics |
| (N06CB) Psychostimulants in combination with psycholeptics |
| (N06D) ANTI-DEMENTIA DRUGS |
| (N06DA) Anticholinesterases |
| (N06DA01) Tacrine |
| (N06DA02) Donepezil |
| (N06DA03) Rivastigmine |
| (N06DA04) Galantamine |
| (N06DX) Other anti-dementia drugs |
| (N06DX01) Memantine |
| (N06DX02) Ginkgo biloba |
| (N07) OTHER NERVOUS SYSTEM DRUGS |
| (N07A) PARASYMPATHOMIMETICS |
| (N07AA) Anticholinesterases |
| (N07AA01) Neostigmine |
| (N07AA02) Pyridostigmine |
| (N07AA03) Distigmine |
| (N07AA30) Ambenonium |
| (N07AA51) Neostigmine, combinations |
| (N07AB) Choline esters |
| (N07AB01) Carbachol |
| (N07AB02) Bethanechol |
| (N07AX) Other parasympathomimetics |
| (N07AX01) Pilocarpine |
| (N07AX02) Choline alfoscerate |
| (N07AX03) Cevimeline |
| (N07B) DRUGS USED IN ADDICTIVE DISORDERS |
| (N07BA) Drugs used in nicotine dependence |
| (N07BA01) Nicotine |
| (N07BA02) Bupropion |
| (N07BA03) Vareniclin |
| (N07BB) Drugs used in alcohol dependence |
| (N07BB01) Disulfiram |
| (N07BB02) Calcium carbimide |
| (N07BB03) Acamprosate |
| (N07BB04) Naltrexone |
| (N07BC) Drugs used in opioid dependence |
| (N07BC01) Buprenorphine |
| (N07BC02) Methadone |
| (N07BC03) Levacetylmethadol |
| (N07BC04) Lofexidine |
| (N07C) ANTIVERTIGO PREPARATIONS |
| (N07CA) Antivertigo preparations |
| (N07CA01) Betahistine |
| (N07CA02) Cinnarizine |
| (N07CA03) Flunarizine |
| (N07CA04) Acetylleucine |
| (N07CA52) Cinnarizine, combinations |
| (N07X) OTHER NERVOUS SYSTEM DRUGS |
| (N07XA) Gangliosides and ganglioside derivatives |
| (N07XX) Other nervous system drugs |
| (N07XX01) Tirilazad |
| (N07XX02) Riluzole |
| (N07XX03) Xaliproden |
| (P) ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS |
| (P01) ANTIPROTOZOALS |
| (P01A) AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES |
| (P01AA) Hydroxyquinoline derivatives |
| (P01AA01) Broxyquinoline |
| (P01AA02) Clioquinol |
| (P01AA04) Chlorquinaldol |
| (P01AA05) Tilbroquinol |
| (P01AA52) Clioquinol, combinations |
| (P01AB) Nitroimidazole derivatives |
| (P01AB01) Metronidazole |
| (P01AB02) Tinidazole |
| (P01AB03) Ornidazole |
| (P01AB04) Azanidazole |
| (P01AB05) Propenidazole |
| (P01AB06) Nimorazole |
| (P01AB07) Secnidazole |
| (P01AC) Dichloroacetamide derivatives |
| (P01AC01) Diloxanide |
| (P01AC02) Clefamide |
| (P01AC03) Etofamide |
| (P01AC04) Teclozan |
| (P01AR) Arsenic compounds |
| (P01AR01) Arsthinol |
| (P01AR02) Difetarsone |
| (P01AR03) Glycobiarsol |
| (P01AR53) Glycobiarsol, combinations |
| (P01AX) Other agents against amoebiasis and other protozoal diseases |
| (P01AX01) Chiniofon |
| (P01AX02) Emetine |
| (P01AX04) Phanquinone |
| (P01AX05) Mepacrine |
| (P01AX06) Atovaquone |
| (P01AX07) Trimetrexate |
| (P01AX08) Tenonitrozole |
| (P01AX09) Dihydroemetine |
| (P01AX52) Emetine, combinations |
| (P01B) ANTIMALARIALS |
| (P01BA) Aminoquinolines |
| (P01BA01) Chloroquine |
| (P01BA02) Hydroxychloroquine |
| (P01BA03) Primaquine |
| (P01BA06) Amodiaquine |
| (P01BB) Biguanides |
| (P01BB01) Proguanil |
| (P01BB02) Cycloguanil embonate |
| (P01BB51) Proguanil, combinations |
| (P01BC) Methanolquinolines |
| (P01BC01) Quinine |
| (P01BC02) Mefloquine |
| (P01BD) Diaminopyrimidines |
| (P01BD01) Pyrimethamine |
| (P01BD51) Pyrimethamine, combinations |
| (P01BE) Artemisinin and derivatives |
| (P01BE01) Artemisinin |
| (P01BE02) Artemether |
| (P01BE03) Artesunate |
| (P01BE04) Artemotil |
| (P01BE05) Artenimol |
| (P01BE52) Artemether, combinations |
| (P01BX) Other antimalarials |
| (P01BX01) Halofantrine |
| (P01C) AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS |
| (P01CA) Nitroimidazole derivatives |
| (P01CA02) Benznidazole |
| (P01CB) Antimony compounds |
| (P01CB01) Meglumine antimonate |
| (P01CB02) Sodium stibogluconate |
| (P01CC) Nitrofuran derivatives |
| (P01CC01) Nifurtimox |
| (P01CC02) Nitrofural |
| (P01CD) Arsenic compounds |
| (P01CD01) Melarsoprol |
| (P01CD02) Acetarsol |
| (P01CX) Other agents against leishmaniasis and trypanosomiasis |
| (P01CX01) Pentamidine isethionate |
| (P01CX02) Suramin sodium |
| (P01CX03) Eflornithine |
| (P02) ANTHELMINTICS |
| (P02B) ANTITREMATODALS |
| (P02BA) Quinoline derivatives and related substances |
| (P02BA01) Praziquantel |
| (P02BA02) Oxamniquine |
| (P02BB) Organophosphorous compounds |
| (P02BB01) Metrifonate |
| (P02BX) Other antitrematodal agents |
| (P02BX01) Bithionol |
| (P02BX02) Niridazole |
| (P02BX03) Stibophen |
| (P02BX04) Triclabendazole |
| (P02C) ANTINEMATODAL AGENTS |
| (P02CA) Benzimidazole derivatives |
| (P02CA01) Mebendazole |
| (P02CA02) Tiabendazole |
| (P02CA03) Albendazole |
| (P02CA04) Ciclobendazole |
| (P02CA05) Flubendazole |
| (P02CA06) Fenbendazole |
| (P02CA51) Mebendazole, combinations |
| (P02CB) Piperazine and derivatives |
| (P02CB01) Piperazine |
| (P02CB02) Diethylcarbamazine |
| (P02CC) Tetrahydropyrimidine derivatives |
| (P02CC01) Pyrantel |
| (P02CC02) Oxantel |
| (P02CE) Imidazothiazole derivatives |
| (P02CE01) Levamisole |
| (P02CF) Avermectines |
| (P02CF01) Ivermectin |
| (P02CX) Other antinematodals |
| (P02CX01) Pyrvinium |
| (P02CX02) Bephenium |
| (P02D) ANTICESTODALS |
| (P02DA) Salicylic acid derivatives |
| (P02DA01) Niclosamide |
| (P02DX) Other anticestodals |
| (P02DX01) Desaspidin |
| (P02DX02) Dichlorophen |
| (P03) ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS |
| (P03A) ECTOPARASITICIDES, INCL. SCABICIDES |
| (P03AA) Sulfur containing products |
| (P03AA01) Dixanthogen |
| (P03AA02) Potassium polysulfide |
| (P03AA03) Mesulfen |
| (P03AA04) Disulfiram |
| (P03AA05) Thiram |
| (P03AA54) Disulfiram, combinations |
| (P03AB) Chlorine containing products |
| (P03AB01) Clofenotane |
| (P03AB02) Lindane |
| (P03AB51) Clofenotane, combinations |
| (P03AC) Pyrethrines, incl. synthetic compounds |
| (P03AC01) Pyrethrum |
| (P03AC02) Bioallethrin |
| (P03AC03) Phenothrin |
| (P03AC04) Permethrin |
| (P03AC51) Pyrethrum, combinations |
| (P03AC52) Bioallethrin, combinations |
| (P03AC53) Phenothrin, combinations |
| (P03AC54) Permethrin, combinations |
| (P03AX) Other ectoparasiticides, incl. scabicides |
| (P03AX01) Benzyl benzoate |
| (P03AX02) Copper oleinate |
| (P03AX03) Malathion |
| (P03AX04) Quassia |
| (P03B) INSECTICIDES AND REPELLENTS |
| (P03BA) Pyrethrines |
| (P03BA01) Cyfluthrin |
| (P03BA02) Cypermethrin |
| (P03BA03) Decamethrin |
| (P03BA04) Tetramethrin |
| (P03BX) Other insecticides and repellents |
| (P03BX01) Diethyltoluamide |
| (P03BX02) Dimethylphthalate |
| (P03BX03) Dibutylphthalate |
| (P03BX04) Dibutylsuccinate |
| (P03BX05) Dimethylcarbate |
| (P03BX06) Etohexadiol |
| (R) RESPIRATORY SYSTEM |
| (R01) NASAL PREPARATIONS |
| (R01A) DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE |
| (R01AA) Sympathomimetics, plain |
| (R01AA02) Cyclopentamine |
| (R01AA03) Ephedrine |
| (R01AA04) Phenylephrine |
| (R01AA05) Oxymetazoline |
| (R01AA06) Tetryzoline |
| (R01AA07) Xylometazoline |
| (R01AA08) Naphazoline |
| (R01AA09) Tramazoline |
| (R01AA10) Metizoline |
| (R01AA11) Tuaminoheptane |
| (R01AA12) Fenoxazoline |
| (R01AA13) Tymazoline |
| (R01AA14) Epinephrine |
| (R01AB) Sympathomimetics, combinations excl. corticosteroids |
| (R01AB01) Phenylephrine |
| (R01AB02) Naphazoline |
| (R01AB03) Tetryzoline |
| (R01AB05) Ephedrine |
| (R01AB06) Xylometazoline |
| (R01AB07) Oxymetazoline |
| (R01AB08) Tuaminoheptane |
| (R01AC) Antiallergic agents, excl. corticosteroids |
| (R01AC01) Cromoglicic acid |
| (R01AC02) Levocabastine |
| (R01AC03) Azelastine |
| (R01AC04) Antazoline |
| (R01AC05) Spaglumic acid |
| (R01AC06) Thonzylamine |
| (R01AC07) Nedocromil |
| (R01AC51) Cromoglicic acid, combinations |
| (R01AD) Corticosteroids |
| (R01AD01) Beclometasone |
| (R01AD02) Prednisolone |
| (R01AD03) Dexamethasone |
| (R01AD04) Flunisolide |
| (R01AD05) Budesonide |
| (R01AD06) Betamethasone |
| (R01AD07) Tixocortol |
| (R01AD08) Fluticasone |
| (R01AD09) Mometasone |
| (R01AD11) Triamcinolone |
| (R01AD52) Prednisolone, combinations |
| (R01AD53) Dexamethasone, combinations |
| (R01AD57) Tixocortol, combinations |
| (R01AD60) Hydrocortisone, combinations |
| (R01AX) Other nasal preparations |
| (R01AX01) Calcium hexamine thiocyanate |
| (R01AX02) Retinol |
| (R01AX03) Ipratropium bromide |
| (R01AX05) Ritiometan |
| (R01AX06) Mupirocin |
| (R01AX07) Hexamidine |
| (R01AX08) Framycetin |
| (R01AX10) Various |
| (R01AX30) Combinations |
| (R01B) NASAL DECONGESTANTS FOR SYSTEMIC USE |
| (R01BA) Sympathomimetics |
| (R01BA01) Phenylpropanolamine |
| (R01BA02) Pseudoephedrine |
| (R01BA03) Phenylephrine |
| (R01BA51) Phenylpropanolamine, combinations |
| (R01BA52) Pseudoephedrine, combinations |
| (R01BA53) Phenylephrine, combinations |
| (R02) THROAT PREPARATIONS |
| (R02A) THROAT PREPARATIONS |
| (R02AA) Antiseptics |
| (R02AA01) Ambazone |
| (R02AA02) Dequalinium |
| (R02AA03) Dichlorobenzyl alcohol |
| (R02AA05) Chlorhexidine |
| (R02AA06) Cetylpyridinium |
| (R02AA09) Benzethonium |
| (R02AA10) Myristyl-benzalkonium |
| (R02AA11) Chlorquinaldol |
| (R02AA12) Hexylresorcinol |
| (R02AA13) Acriflavinium chloride |
| (R02AA14) Oxyquinoline |
| (R02AA15) Povidone-iodine |
| (R02AA16) Benzalkonium |
| (R02AA17) Cetrimonium |
| (R02AA18) Hexamidine |
| (R02AA19) Phenol |
| (R02AA20) Various |
| (R02AB) Antibiotics |
| (R02AB01) Neomycin |
| (R02AB02) Tyrothricin |
| (R02AB03) Fusafungine |
| (R02AB04) Bacitracin |
| (R02AB30) Gramicidin |
| (R02AD) Anesthetics, local |
| (R02AD01) Benzocaine |
| (R02AD02) Lidocaine |
| (R02AD03) Cocaine |
| (R02AD04) Dyclonine |
| (R03) DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| (R03A) ADRENERGICS, INHALANTS |
| (R03AA) Alpha- and beta-adrenoreceptor agonists |
| (R03AA01) Epinephrine |
| (R03AB) Non-selective beta-adrenoreceptor agonists |
| (R03AB02) Isoprenaline |
| (R03AB03) Orciprenaline |
| (R03AC) Selective beta-2-adrenoreceptor agonists |
| (R03AC02) Salbutamol |
| (R03AC03) Terbutaline |
| (R03AC04) Fenoterol |
| (R03AC05) Rimiterol |
| (R03AC06) Hexoprenaline |
| (R03AC07) Isoetarine |
| (R03AC08) Pirbuterol |
| (R03AC09) Tretoquinol |
| (R03AC10) Carbuterol |
| (R03AC11) Tulobuterol |
| (R03AC12) Salmeterol |
| (R03AC13) Formoterol |
| (R03AC14) Clenbuterol |
| (R03AC15) Reproterol |
| (R03AC16) Procaterol |
| (R03AC17) Bitolterol |
| (R03AH) Combinations of adrenergics |
| (R03AK) Adrenergics and other drugs for obstructive airway diseases |
| (R03AK01) Epinephrine and other drugs for obstructive airway diseases |
| (R03AK02) Isoprenaline and other drugs for obstructive airway diseases |
| (R03AK03) Fenoterol and other drugs for obstructive airway diseases |
| (R03AK04) Salbutamol and other drugs for obstructive airway diseases |
| (R03AK05) Reproterol and other drugs for obstructive airway diseases |
| (R03AK06) Salmeterol and other drugs for obstructive airway diseases |
| (R03AK07) Formoterol and other drugs for obstructive airway diseases |
| (R03B) OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| (R03BA) Glucocorticoids |
| (R03BA01) Beclometasone |
| (R03BA02) Budesonide |
| (R03BA03) Flunisolide |
| (R03BA04) Betamethasone |
| (R03BA05) Fluticasone |
| (R03BA06) Triamcinolone |
| (R03BA07) Mometasone |
| (R03BA08) Ciclesonide |
| (R03BB) Anticholinergics |
| (R03BB01) Ipratropium bromide |
| (R03BB02) Oxitropium bromide |
| (R03BB03) Stramoni preparations |
| (R03BB04) Tiotropium bromide |
| (R03BC) Antiallergic agents, excl. corticosteroids |
| (R03BC01) Cromoglicic acid |
| (R03BC03) Nedocromil |
| (R03BX) Other drugs for obstructive airway diseases, inhalants |
| (R03BX01) Fenspiride |
| (R03C) ADRENERGICS FOR SYSTEMIC USE |
| (R03CA) Alpha- and beta-adrenoreceptor agonists |
| (R03CA02) Ephedrine |
| (R03CB) Non-selective beta-adrenoreceptor agonists |
| (R03CB01) Isoprenaline |
| (R03CB02) Methoxyphenamine |
| (R03CB03) Orciprenaline |
| (R03CB51) Isoprenaline, combinations |
| (R03CB53) Orciprenaline, combinations |
| (R03CC) Selective beta-2-adrenoreceptor agonists |
| (R03CC02) Salbutamol |
| (R03CC03) Terbutaline |
| (R03CC04) Fenoterol |
| (R03CC05) Hexoprenaline |
| (R03CC06) Isoetarine |
| (R03CC07) Pirbuterol |
| (R03CC08) Procaterol |
| (R03CC09) Tretoquinol |
| (R03CC10) Carbuterol |
| (R03CC11) Tulobuterol |
| (R03CC12) Bambuterol |
| (R03CC13) Clenbuterol |
| (R03CC14) Reproterol |
| (R03CC53) Terbutaline, combinations |
| (R03CK) Adrenergics and other drugs for obstructive airway diseases |
| (R03D) OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES |
| (R03DA) Xanthines |
| (R03DA01) Diprophylline |
| (R03DA02) Choline theophyllinate |
| (R03DA03) Proxyphylline |
| (R03DA04) Theophylline |
| (R03DA05) Aminophylline |
| (R03DA06) Etamiphylline |
| (R03DA07) Theobromine |
| (R03DA08) Bamifylline |
| (R03DA09) Acefylline piperazine |
| (R03DA10) Bufylline |
| (R03DA11) Doxofylline |
| (R03DA20) Combinations of xanthines |
| (R03DA51) Diprophylline, combinations |
| (R03DA54) Theophylline, combinations excl. psycholeptics |
| (R03DA55) Aminophylline, combinations |
| (R03DA57) Theobromine, combinations |
| (R03DA74) Theophylline, combinations with psycholeptics |
| (R03DB) Xanthines and adrenergics |
| (R03DB01) Diprophylline and adrenergics |
| (R03DB02) Choline theophyllinate and adrenergics |
| (R03DB03) Proxyphylline and adrenergics |
| (R03DB04) Theophylline and adrenergics |
| (R03DB05) Aminophylline and adrenergics |
| (R03DB06) Etamiphylline and adrenergics |
| (R03DC) Leukotriene receptor antagonists |
| (R03DC01) Zafirlukast |
| (R03DC02) Pranlukast |
| (R03DC03) Montelukast |
| (R03DC04) Ibudilast |
| (R03DX) Other systemic drugs for obstructive airway diseases |
| (R03DX01) Amlexanox |
| (R03DX02) Eprozinol |
| (R03DX03) Fenspiride |
| (R03DX05) Omalizumab |
| (R03DX06) Seratrodast |
| (R05) COUGH AND COLD PREPARATIONS |
| (R05C) EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS |
| (R05CA) Expectorants |
| (R05CA01) Tyloxapol |
| (R05CA02) Potassium iodide |
| (R05CA03) Guaifenesin |
| (R05CA04) Ipecacuanha |
| (R05CA05) Althea root |
| (R05CA06) Senega |
| (R05CA07) Antimony pentasulfide |
| (R05CA08) Creosote |
| (R05CA09) Guaiacolsulfonate |
| (R05CA10) Combinations |
| (R05CA11) Levoverbenone |
| (R05CB) Mucolytics |
| (R05CB01) Acetylcysteine |
| (R05CB02) Bromhexine |
| (R05CB03) Carbocisteine |
| (R05CB04) Eprazinone |
| (R05CB05) Mesna |
| (R05CB06) Ambroxol |
| (R05CB07) Sobrerol |
| (R05CB08) Domiodol |
| (R05CB09) Letosteine |
| (R05CB10) Combinations |
| (R05CB11) Stepronin |
| (R05CB12) Tiopronin |
| (R05CB13) Dornase alfa (desoxyribonuclease) |
| (R05CB14) Neltenexine |
| (R05CB15) Erdosteine |
| (R05D) COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS |
| (R05DA) Opium alkaloids and derivatives |
| (R05DA01) Ethylmorphine |
| (R05DA03) Hydrocodone |
| (R05DA04) Codeine |
| (R05DA05) Opium alkaloids with morphine |
| (R05DA06) Normethadone |
| (R05DA07) Noscapine |
| (R05DA08) Pholcodine |
| (R05DA09) Dextromethorphan |
| (R05DA10) Thebacon |
| (R05DA11) Dimemorfan |
| (R05DA20) Combinations |
| (R05DB) Other cough suppressants |
| (R05DB01) Benzonatate |
| (R05DB02) Benproperine |
| (R05DB03) Clobutinol |
| (R05DB04) Isoaminile |
| (R05DB05) Pentoxyverine |
| (R05DB07) Oxolamine |
| (R05DB09) Oxeladin |
| (R05DB10) Clofedanol |
| (R05DB11) Pipazetate |
| (R05DB12) Bibenzonium bromide |
| (R05DB13) Butamirate |
| (R05DB14) Fedrilate |
| (R05DB15) Zipeprol |
| (R05DB16) Dibunate |
| (R05DB17) Droxypropine |
| (R05DB18) Prenoxdiazine |
| (R05DB19) Dropropizine |
| (R05DB20) Combinations |
| (R05DB21) Cloperastine |
| (R05DB22) Meprotixol |
| (R05DB23) Piperidione |
| (R05DB24) Tipepidine |
| (R05DB25) Morclofone |
| (R05DB26) Nepinalone |
| (R05DB27) Levodropropizine |
| (R05F) COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS |
| (R05FA) Opium derivatives and expectorants |
| (R05FA01) Opium derivatives and mucolytics |
| (R05FA02) Opium derivatives and expectorants |
| (R05FB) Other cough suppressants and expectorants |
| (R05FB01) Cough suppressants and mucolytics |
| (R05FB02) Cough suppressants and expectorants |
| (R05X) OTHER COLD COMBINATION PREPARATIONS |
| (R06) ANTIHISTAMINES FOR SYSTEMIC USE |
| (R06A) ANTIHISTAMINES FOR SYSTEMIC USE |
| (R06AA) Aminoalkyl ethers |
| (R06AA01) Bromazine |
| (R06AA02) Diphenhydramine |
| (R06AA04) Clemastine |
| (R06AA06) Chlorphenoxamine |
| (R06AA07) Diphenylpyraline |
| (R06AA08) Carbinoxamine |
| (R06AA09) Doxylamine |
| (R06AA52) Diphenhydramine, combinations |
| (R06AA54) Clemastine, combinations |
| (R06AA56) Chlorphenoxamine, combinations |
| (R06AA57) Diphenylpyraline, combinations |
| (R06AB) Substituted alkylamines |
| (R06AB01) Brompheniramine |
| (R06AB02) Dexchlorpheniramine |
| (R06AB03) Dimetindene |
| (R06AB04) Chlorphenamine |
| (R06AB05) Pheniramine |
| (R06AB06) Dexbrompheniramine |
| (R06AB07) Talastine |
| (R06AB51) Brompheniramine, combinations |
| (R06AB52) Dexchlorpheniramine, combinations |
| (R06AB54) Chlorphenamine, combinations |
| (R06AB56) Dexbrompheniramine, combinations |
| (R06AC) Substituted ethylene diamines |
| (R06AC01) Mepyramine |
| (R06AC02) Histapyrrodine |
| (R06AC03) Chloropyramine |
| (R06AC04) Tripelennamine |
| (R06AC05) Methapyrilene |
| (R06AC06) Thonzylamine |
| (R06AC52) Histapyrrodine, combinations |
| (R06AC53) Chloropyramine, combinations |
| (R06AD) Phenothiazine derivatives |
| (R06AD01) Alimemazine |
| (R06AD02) Promethazine |
| (R06AD03) Thiethylperazine |
| (R06AD04) Methdilazine |
| (R06AD05) Hydroxyethylpromethazine |
| (R06AD06) Thiazinam |
| (R06AD07) Mequitazine |
| (R06AD08) Oxomemazine |
| (R06AD09) Isothipendyl |
| (R06AD52) Promethazine, combinations |
| (R06AD55) Hydroxyethylpromethazine, combinations |
| (R06AE) Piperazine derivatives |
| (R06AE01) Buclizine |
| (R06AE03) Cyclizine |
| (R06AE04) Chlorcyclizine |
| (R06AE05) Meclozine |
| (R06AE06) Oxatomide |
| (R06AE07) Cetirizine |
| (R06AE09) Levocetirizine |
| (R06AE51) Buclizine, combinations |
| (R06AE53) Cyclizine, combinations |
| (R06AE55) Meclozine, combinations |
| (R06AK) Combinations of antihistamines |
| (R06AX) Other antihistamines for systemic use |
| (R06AX01) Bamipine |
| (R06AX02) Cyproheptadine |
| (R06AX03) Thenalidine |
| (R06AX04) Phenindamine |
| (R06AX05) Antazoline |
| (R06AX07) Triprolidine |
| (R06AX08) Pyrrobutamine |
| (R06AX09) Azatadine |
| (R06AX11) Astemizole |
| (R06AX12) Terfenadine |
| (R06AX13) Loratadine |
| (R06AX15) Mebhydrolin |
| (R06AX16) Deptropine |
| (R06AX17) Ketotifen |
| (R06AX18) Acrivastine |
| (R06AX19) Azelastine |
| (R06AX21) Tritoqualine |
| (R06AX22) Ebastine |
| (R06AX23) Pimethixene |
| (R06AX24) Epinastine |
| (R06AX25) Mizolastine |
| (R06AX26) Fexofenadine |
| (R06AX27) Desloratadine |
| (R06AX28) Rupatadine |
| (R06AX53) Thenalidine, combinations |
| (R06AX58) Pyrrobutamine, combinations |
| (R07) OTHER RESPIRATORY SYSTEM PRODUCTS |
| (R07A) OTHER RESPIRATORY SYSTEM PRODUCTS |
| (R07AA) Lung surfactants |
| (R07AA01) Colfosceril palmitate |
| (R07AA02) Natural phospholipids |
| (R07AA30) Combinations |
| (R07AB) Respiratory stimulants |
| (R07AB01) Doxapram |
| (R07AB02) Nikethamide |
| (R07AB03) Pentetrazol |
| (R07AB04) Etamivan |
| (R07AB05) Bemegride |
| (R07AB06) Prethcamide |
| (R07AB07) Almitrine |
| (R07AB08) Dimefline |
| (R07AB09) Mepixanox |
| (R07AB52) Nikethamide, combinations |
| (R07AB53) Pentetrazol, combinations |
| (R07AX) Other respiratory system products |
| (R07AX01) Nitric oxide |
| (S) SENSORY ORGANS |
| (S01) OPHTHALMOLOGICALS |
| (S01A) ANTIINFECTIVES |
| (S01AA) Antibiotics |
| (S01AA01) Chloramphenicol |
| (S01AA02) Chlortetracycline |
| (S01AA03) Neomycin |
| (S01AA04) Oxytetracycline |
| (S01AA05) Tyrothricin |
| (S01AA07) Framycetin |
| (S01AA09) Tetracycline |
| (S01AA10) Natamycin |
| (S01AA11) Gentamicin |
| (S01AA12) Tobramycin |
| (S01AA13) Fusidic acid |
| (S01AA14) Benzylpenicillin |
| (S01AA15) Dihydrostreptomycin |
| (S01AA16) Rifamycine |
| (S01AA17) Erythromycin |
| (S01AA18) Polymyxin B |
| (S01AA19) Ampicillin |
| (S01AA20) Antibiotics in combination with other drugs |
| (S01AA21) Amikacin |
| (S01AA22) Micronomicin |
| (S01AA23) Netilmicin |
| (S01AA24) Kanamycin |
| (S01AA25) Azidamfenicol |
| (S01AA30) Combinations of different antibiotics |
| (S01AB) Sulfonamides |
| (S01AB01) Sulfamethizole |
| (S01AB02) Sulfafurazole |
| (S01AB03) Sulfadicramide |
| (S01AB04) Sulfacetamide |
| (S01AB05) Sulfafenazol |
| (S01AD) Antivirals |
| (S01AD01) Idoxuridine |
| (S01AD02) Trifluridine |
| (S01AD03) Aciclovir |
| (S01AD05) Interferon |
| (S01AD06) Vidarabine |
| (S01AD07) Famciclovir |
| (S01AD08) Fomivirsen |
| (S01AD09) Ganciclovir |
| (S01AX) Other antiinfectives |
| (S01AX01) Mercury compounds |
| (S01AX02) Silver compounds |
| (S01AX03) Zinc compounds |
| (S01AX04) Nitrofural |
| (S01AX05) Bibrocathol |
| (S01AX06) Resorcinol |
| (S01AX07) Sodium borate |
| (S01AX08) Hexamidine |
| (S01AX09) Chlorhexidine |
| (S01AX10) Sodium propionate |
| (S01AX11) Ofloxacin |
| (S01AX12) Norfloxacin |
| (S01AX13) Ciprofloxacin |
| (S01AX14) Dibrompropamidine |
| (S01AX15) Propamidine |
| (S01AX16) Picloxydine |
| (S01AX17) Lomefloxacin |
| (S01AX18) Povidone-iodine |
| (S01AX19) Levofloxacin |
| (S01B) ANTIINFLAMMATORY AGENTS |
| (S01BA) Corticosteroids, plain |
| (S01BA01) Dexamethasone |
| (S01BA02) Hydrocortisone |
| (S01BA03) Cortisone |
| (S01BA04) Prednisolone |
| (S01BA05) Triamcinolone |
| (S01BA06) Betamethasone |
| (S01BA07) Fluorometholone |
| (S01BA08) Medrysone |
| (S01BA09) Clobetasone |
| (S01BA10) Alclometasone |
| (S01BA11) Desonide |
| (S01BA12) Formocortal |
| (S01BA13) Rimexolone |
| (S01BB) Corticosteroids and mydriatics in combination |
| (S01BB01) Hydrocortisone and mydriatics |
| (S01BB02) Prednisolone and mydriatics |
| (S01BB03) Fluorometholone and mydriatics |
| (S01BB04) Betamethasone and mydriatics |
| (S01BC) Antiinflammatory agents, non-steroids |
| (S01BC01) Indometacin |
| (S01BC02) Oxyphenbutazone |
| (S01BC03) Diclofenac |
| (S01BC04) Flurbiprofen |
| (S01BC05) Ketorolac |
| (S01BC06) Piroxicam |
| (S01BC07) Bendazac |
| (S01BC08) Salicylic acid |
| (S01BC09) Pranoprofen |
| (S01C) ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION |
| (S01CA) Corticosteroids and antiinfectives in combination |
| (S01CA01) Dexamethasone and antiinfectives |
| (S01CA02) Prednisolone and antiinfectives |
| (S01CA03) Hydrocortisone and antiinfectives |
| (S01CA04) Fluocortolone and antiinfectives |
| (S01CA05) Betamethasone and antiinfectives |
| (S01CA06) Fludrocortisone and antiinfectives |
| (S01CA07) Fluorometholone and antiinfectives |
| (S01CA08) Methylprednisolone and antiinfectives |
| (S01CA09) Chloroprednisone and antiinfectives |
| (S01CA10) Fluocinolone acetonide and antiinfectives |
| (S01CA11) Clobetasone and antiinfectives |
| (S01CB) Corticosteroids/antiinfectives/mydriatics in combination |
| (S01CB01) Dexamethasone |
| (S01CB02) Prednisolone |
| (S01CB03) Hydrocortisone |
| (S01CB04) Betamethasone |
| (S01CB05) Fluorometholone |
| (S01CC) Antiinflammatory agents, non-steroids and antiinfectives in combination |
| (S01CC01) Diclofenac and antiinfectives |
| (S01E) ANTIGLAUCOMA PREPARATIONS AND MIOTICS1) |
| (S01EA) Sympathomimetics in glaucoma therapy |
| (S01EA01) Epinephrine |
| (S01EA02) Dipivefrine |
| (S01EA03) Apraclonidine |
| (S01EA04) Clonidine |
| (S01EA05) Brimonidine |
| (S01EA51) Epinephrine, combinations |
| (S01EB) Parasympathomimetics |
| (S01EB01) Pilocarpine |
| (S01EB02) Carbachol |
| (S01EB03) Ecothiopate |
| (S01EB04) Demecarium |
| (S01EB05) Physostigmine |
| (S01EB06) Neostigmine |
| (S01EB07) Fluostigmine |
| (S01EB08) Aceclidine |
| (S01EB09) Acetylcholine |
| (S01EB10) Paraoxon |
| (S01EB51) Pilocarpine, combinations |
| (S01EB58) Aceclidine, combinations |
| (S01EC) Carbonic anhydrase inhibitors |
| (S01EC01) Acetazolamide |
| (S01EC02) Diclofenamide |
| (S01EC03) Dorzolamide |
| (S01EC04) Brinzolamide |
| (S01ED) Beta blocking agents |
| (S01ED01) Timolol |
| (S01ED02) Betaxolol |
| (S01ED03) Levobunolol |
| (S01ED04) Metipranolol |
| (S01ED05) Carteolol |
| (S01ED06) Befunolol |
| (S01ED51) Timolol, combinations |
| (S01ED52) Betaxolol, combinations |
| (S01ED54) Metipranolol, combinations |
| (S01EE) Prostaglandin analogues |
| (S01EE01) Latanoprost |
| (S01EE02) Unoprostone |
| (S01EE03) Bimatoprost |
| (S01EE04) Travoprost |
| (S01EX) Other antiglaucoma preparations |
| (S01EX01) Guanethidine |
| (S01EX02) Dapiprazole |
| (S01F) MYDRIATICS AND CYCLOPLEGICS |
| (S01FA) Anticholinergics |
| (S01FA01) Atropine |
| (S01FA02) Scopolamine |
| (S01FA03) Methylscopolamine |
| (S01FA04) Cyclopentolate |
| (S01FA05) Homatropine |
| (S01FA06) Tropicamide |
| (S01FA56) Tropicamide, combinations |
| (S01FB) Sympathomimetics excl. antiglaucoma preparations |
| (S01FB01) Phenylephrine |
| (S01FB02) Ephedrine |
| (S01FB03) Ibopamine |
| (S01G) DECONGESTANTS AND ANTIALLERGICS |
| (S01GA) Sympathomimetics used as decongestants |
| (S01GA01) Naphazoline |
| (S01GA02) Tetryzoline |
| (S01GA03) Xylometazoline |
| (S01GA04) Oxymetazoline |
| (S01GA05) Phenylephrine |
| (S01GA06) Oxedrine |
| (S01GA51) Naphazoline, combinations |
| (S01GA52) Tetryzoline, combinations |
| (S01GA53) Xylometazoline, combinations |
| (S01GA55) Phenylephrine, combinations |
| (S01GA56) Oxedrine, combinations |
| (S01GX) Other antiallergics |
| (S01GX01) Cromoglicic acid |
| (S01GX02) Levocabastine |
| (S01GX03) Spaglumic acid |
| (S01GX04) Nedocromil |
| (S01GX05) Lodoxamide |
| (S01GX06) Emedastine |
| (S01GX07) Azelastine |
| (S01GX08) Ketotifen |
| (S01GX09) Olopatadine |
| (S01GX10) Epinastine |
| (S01GX51) Cromoglicic acid, combinations |
| (S01H) LOCAL ANESTHETICS |
| (S01HA) Local anesthetics |
| (S01HA01) Cocaine |
| (S01HA02) Oxybuprocaine |
| (S01HA03) Tetracaine |
| (S01HA04) Proxymetacaine |
| (S01HA05) Procaine |
| (S01HA06) Cinchocaine |
| (S01HA07) Lidocaine |
| (S01HA30) Combinations |
| (S01J) DIAGNOSTIC AGENTS |
| (S01JA) Colouring agents |
| (S01JA01) Fluorescein |
| (S01JA02) Rose bengal sodium |
| (S01JA51) Fluorescein, combinations |
| (S01JX) Other ophthalmological diagnostic agents |
| (S01K) SURGICAL AIDS |
| (S01KA) Viscoelastic substances |
| (S01KA01) Hyaluronic acid |
| (S01KA02) Hypromellose |
| (S01KA51) Hyaluronic acid, combinations |
| (S01KX) Other surgical aids |
| (S01KX01) Chymotrypsin |
| (S01X) OTHER OPHTHALMOLOGICALS |
| (S01XA) Other ophthalmologicals |
| (S01XA01) Guaiazulen |
| (S01XA02) Retinol |
| (S01XA03) Sodium chloride, hypertonic |
| (S01XA04) Potassium iodide |
| (S01XA05) Sodium edetate |
| (S01XA06) Ethylmorphine |
| (S01XA07) Alum |
| (S01XA08) Acetylcysteine |
| (S01XA09) Iodoheparinate |
| (S01XA10) Inosine |
| (S01XA11) Nandrolone |
| (S01XA12) Dexpanthenol |
| (S01XA13) Alteplase |
| (S01XA14) Heparin |
| (S01XA15) Ascorbic acid |
| (S01XA20) Artificial tears and other indifferent preparations |
| (S02) OTOLOGICALS |
| (S02A) ANTIINFECTIVES |
| (S02AA) Antiinfectives |
| (S02AA01) Chloramphenicol |
| (S02AA02) Nitrofural |
| (S02AA03) Boric acid |
| (S02AA04) Aluminium acetotartrate |
| (S02AA05) Clioquinol |
| (S02AA06) Hydrogen peroxide |
| (S02AA07) Neomycin |
| (S02AA08) Tetracycline |
| (S02AA09) Chlorhexidine |
| (S02AA10) Acetic acid |
| (S02AA11) Polymyxin B |
| (S02AA12) Rifamycin |
| (S02AA13) Miconazole |
| (S02AA14) Gentamicin |
| (S02AA15) Ciprofloxacin |
| (S02AA16) Ofloxacin |
| (S02AA30) Antiinfectives, combinations |
| (S02B) CORTICOSTEROIDS |
| (S02BA) Corticosteroids |
| (S02BA01) Hydrocortisone |
| (S02BA03) Prednisolone |
| (S02BA06) Dexamethasone |
| (S02BA07) Betamethasone |
| (S02C) CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| (S02CA) Corticosteroids and antiinfectives in combination |
| (S02CA01) Prednisolone and antiinfectives |
| (S02CA02) Flumetasone and antiinfectives |
| (S02CA03) Hydrocortisone and antiinfectives |
| (S02CA04) Triamcinolone and antiinfectives |
| (S02CA05) Fluocinolone acetonide and antiinfectives |
| (S02CA06) Dexamethasone and antiinfectives |
| (S02CA07) Fludrocortisone and antiinfectives |
| (S02D) OTHER OTOLOGICALS |
| (S02DA) Analgesics and anesthetics |
| (S02DA01) Lidocaine |
| (S02DA02) Cocaine |
| (S02DA30) Combinations |
| (S02DC) Indifferent preparations |
| (S03) OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| (S03A) ANTIINFECTIVES |
| (S03AA) Antiinfectives |
| (S03AA01) Neomycin |
| (S03AA02) Tetracycline |
| (S03AA03) Polymyxin B |
| (S03AA04) Chlorhexidine |
| (S03AA05) Hexamidine |
| (S03AA06) Gentamicin |
| (S03AA07) Ciprofloxacin |
| (S03AA08) Chloramphenicol |
| (S03AA30) Antiinfectives, combinations |
| (S03B) CORTICOSTEROIDS |
| (S03BA) Corticosteroids |
| (S03BA01) Dexamethasone |
| (S03BA02) Prednisolone |
| (S03BA03) Betamethasone |
| (S03C) CORTICOSTEROIDS AND ANTIINFECTIVES IN COMBINATION |
| (S03CA) Corticosteroids and antiinfectives in combination |
| (S03CA01) Dexamethasone and antiinfectives |
| (S03CA02) Prednisolone and antiinfectives |
| (S03CA04) Hydrocortisone and antiinfectives |
| (S03CA05) Fludrocortisone and antiinfectives |
| (S03CA06) Betamethasone and antiinfectives |
| (S03D) OTHER OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS |
| (V) VARIOUS |
| (V01) ALLERGENS |
| (V01A) ALLERGENS |
| (V01AA) Allergen extracts |
| (V01AA01) Feather |
| (V01AA02) Grass pollen |
| (V01AA03) House dust |
| (V01AA04) Mould fungus and yeast fungus |
| (V01AA05) Tree pollen |
| (V01AA07) Insects |
| (V01AA08) Food |
| (V01AA09) Textiles |
| (V01AA10) Flowers |
| (V01AA11) Animals |
| (V01AA20) Various |
| (V03) ALL OTHER THERAPEUTIC PRODUCTS |
| (V03A) ALL OTHER THERAPEUTIC PRODUCTS |
| (V03AB) Antidotes |
| (V03AB01) Ipecacuanha |
| (V03AB02) Nalorphine |
| (V03AB03) Edetates |
| (V03AB04) Pralidoxime |
| (V03AB05) Prednisolone and promethazine |
| (V03AB06) Thiosulfate |
| (V03AB08) Sodium nitrite |
| (V03AB09) Dimercaprol |
| (V03AB13) Obidoxime |
| (V03AB14) Protamine |
| (V03AB15) Naloxone |
| (V03AB16) Ethanol |
| (V03AB17) Methylthioninium chloride |
| (V03AB18) Potassium permanganate |
| (V03AB19) Physostigmine |
| (V03AB20) Copper sulfate |
| (V03AB21) Potassium iodide |
| (V03AB22) Amyl nitrite |
| (V03AB23) Acetylcysteine |
| (V03AB24) Digitalis antitoxin |
| (V03AB25) Flumazenil |
| (V03AB26) Methionine |
| (V03AB27) 4-dimethylaminophenol |
| (V03AB29) Cholinesterase |
| (V03AB31) Prussian blue |
| (V03AB32) Glutathione |
| (V03AB33) Hydroxocobalamin |
| (V03AB34) Fomepizole |
| (V03AC) Iron chelating agents |
| (V03AC01) Deferoxamine |
| (V03AC02) Deferiprone |
| (V03AC03) Deferasiro |
| (V03AE) Drugs for treatment of hyperkalemia and hyperphosphatemia |
| (V03AE01) Polystyrene sulfonate |
| (V03AE02) Sevelamer |
| (V03AE03) Lanthanum carbonate |
| (V03AF) Detoxifying agents for antineoplastic treatment |
| (V03AF01) Mesna |
| (V03AF02) Dexrazoxane |
| (V03AF03) Calcium folinate |
| (V03AF04) Calcium levofolinate |
| (V03AF05) Amifostine |
| (V03AF06) Sodium folinate |
| (V03AF07) Rasburicase |
| (V03AG) Drugs for treatment of hypercalcemia |
| (V03AG01) Sodium cellulose phosphate |
| (V03AH) Drugs for treatment of hypoglycemia |
| (V03AH01) Diazoxide |
| (V03AK) Tissue adhesives |
| (V03AM) Drugs for embolisation |
| (V03AN) Medical gases |
| (V03AN01) Oxygen |
| (V03AN02) Carbon dioxide |
| (V03AN03) Helium |
| (V03AN04) Nitrogen |
| (V03AX) Other therapeutic products |
| (V03AZ) Nerve depressants |
| (V03AZ01) Ethanol |
| (V04) DIAGNOSTIC AGENTS |
| (V04B) URINE TESTS |
| (V04C) OTHER DIAGNOSTIC AGENTS |
| (V04CA) Tests for diabetes |
| (V04CA01) Tolbutamide |
| (V04CA02) Glucose |
| (V04CB) Tests for fat absorption |
| (V04CB01) Vitamin A concentrates |
| (V04CC) Tests for bile duct patency |
| (V04CC01) Sorbitol |
| (V04CC02) Magnesium sulfate |
| (V04CC03) Sincalide |
| (V04CC04) Ceruletide |
| (V04CD) Tests for pituitary function |
| (V04CD01) Metyrapone |
| (V04CD03) Sermorelin |
| (V04CD04) Corticorelin |
| (V04CD05) Somatorelin |
| (V04CE) Tests for liver functional capacity |
| (V04CE01) Galactose |
| (V04CE02) Sulfobromophthalein |
| (V04CF) Tuberculosis diagnostics |
| (V04CF01) Tuberculin |
| (V04CG) Tests for gastric secretion |
| (V04CG01) Cation exchange resins |
| (V04CG02) Betazole |
| (V04CG03) Histamine |
| (V04CG04) Pentagastrin |
| (V04CG05) Methylthioninium chloride |
| (V04CG30) Caffeine and sodium benzoate |
| (V04CH) Tests for renal function |
| (V04CH01) Inulin and other polyfructosans |
| (V04CH02) Indigo carmine |
| (V04CH03) Phenolsulfonphthalein |
| (V04CH04) Alsactide |
| (V04CH30) Aminohippuric acid |
| (V04CJ) Tests for thyreoidea function |
| (V04CJ01) Thyrotropin |
| (V04CJ02) Protirelin |
| (V04CK) Tests for pancreatic function |
| (V04CK01) Secretin |
| (V04CK02) Pancreozymin (cholecystokinin) |
| (V04CK03) Bentiromide |
| (V04CL) Tests for allergic diseases |
| (V04CM) Tests for fertility disturbances |
| (V04CM01) Gonadorelin |
| (V04CX) Other diagnostic agents |
| (V06) GENERAL NUTRIENTS |
| (V06A) DIET FORMULATIONS FOR TREATMENT OF OBESITY |
| (V06AA) Low-energy diets |
| (V06B) PROTEIN SUPPLEMENTS |
| (V06C) INFANT FORMULAS |
| (V06CA) Nutrients without phenylalanine |
| (V06D) OTHER NUTRIENTS |
| (V06DA) Carbohydrates/proteins/minerals/vitamins, combinations |
| (V06DB) Fat/carbohydrates/proteins/minerals/vitamins, combinations |
| (V06DC) Carbohydrates |
| (V06DC01) Glucose |
| (V06DC02) Fructose |
| (V06DD) Amino acids, incl. combinations with polypeptides |
| (V06DE) Amino acids/carbohydrates/minerals/vitamins, combinations |
| (V06DF) Milk substitutes |
| (V06DX) Other combinations of nutrients |
| (V07) ALL OTHER NON-THERAPEUTIC PRODUCTS |
| (V07A) ALL OTHER NON-THERAPEUTIC PRODUCTS |
| (V07AA) Plasters |
| (V07AB) Solvents and diluting agents, incl. irrigating solutions |
| (V07AC) Blood transfusion, auxiliary products |
| (V07AD) Blood tests, auxiliary products |
| (V07AN) Incontinence equipment |
| (V07AR) Sensitivity tests, discs and tablets |
| (V07AS) Stomi equipment |
| (V07AT) Cosmetics |
| (V07AV) Technical disinfectants |
| (V07AX) Washing agents etc. |
| (V07AY) Other non-therapeutic auxiliary products |
| (V07AZ) Chemicals and reagents for analysis |
| (V08) CONTRAST MEDIA |
| (V08A) X-RAY CONTRAST MEDIA, IODINATED |
| (V08AA) Watersoluble, nephrotropic, high osmolar X-ray contrast media |
| (V08AA01) Diatrizoic acid |
| (V08AA02) Metrizoic acid |
| (V08AA03) Iodamide |
| (V08AA04) Iotalamic acid |
| (V08AA05) Ioxitalamic acid |
| (V08AA06) Ioglicic acid |
| (V08AA07) Acetrizoic acid |
| (V08AA08) Iocarmic acid |
| (V08AA09) Methiodal |
| (V08AA10) Diodone |
| (V08AB) Watersoluble, nephrotropic, low osmolar X-ray contrast media |
| (V08AB01) Metrizamide |
| (V08AB02) Iohexol |
| (V08AB03) Ioxaglic acid |
| (V08AB04) Iopamidol |
| (V08AB05) Iopromide |
| (V08AB06) Iotrolan |
| (V08AB07) Ioversol |
| (V08AB08) Iopentol |
| (V08AB09) Iodixanol |
| (V08AB10) Iomeprol |
| (V08AB11) Iobitridol |
| (V08AB12) Ioxilan |
| (V08AC) Watersoluble, hepatotropic X-ray contrast media |
| (V08AC01) Iodoxamic acid |
| (V08AC02) Iotroxic acid |
| (V08AC03) Ioglycamic acid |
| (V08AC04) Adipiodone |
| (V08AC05) Iobenzamic acid |
| (V08AC06) Iopanoic acid |
| (V08AC07) Iocetamic acid |
| (V08AC08) Sodium iopodate |
| (V08AC09) Tyropanoic acid |
| (V08AC10) Calcium iopodate |
| (V08AD) Non-watersoluble X-ray contrast media |
| (V08AD01) Ethyl esters of iodised fatty acids |
| (V08AD02) Iopydol |
| (V08AD03) Propyliodone |
| (V08AD04) Iofendylate |
| (V08B) X-RAY CONTRAST MEDIA, NON-IODINATED |
| (V08BA) Barium sulfate containing X-ray contrast media |
| (V08BA01) Barium sulfate with suspending agents |
| (V08BA02) Barium sulfate without suspending agents |
| (V08C) MAGNETIC RESONANCE IMAGING CONTRAST MEDIA |
| (V08CA) Paramagnetic contrast media |
| (V08CA01) Gadopentetic acid |
| (V08CA02) Gadoteric acid |
| (V08CA03) Gadodiamide |
| (V08CA04) Gadoteridol |
| (V08CA05) Mangafodipir |
| (V08CA06) Gadoversetamide |
| (V08CA07) Ferric ammonium citrate |
| (V08CA08) Gadobenic acid |
| (V08CA09) Gadobutrol |
| (V08CB) Superparamagnetic contrast media |
| (V08CB01) Ferumoxsil |
| (V08CB02) Ferristene |
| (V08CB03) Iron oxide, nanoparticles |
| (V08CX) Other magnetic resonance imaging contrast media |
| (V08CX01) Perflubron |
| (V08D) ULTRASOUND CONTRAST MEDIA |
| (V08DA) Ultrasound contrast media |
| (V08DA01) Microspheres of human albumin |
| (V08DA02) Microparticles of galactose |
| (V08DA03) Perflenapent |
| (V08DA04) Microspheres of phospholipids |
| (V08DA05) Sulfur hexafluoride |
| (V09) DIAGNOSTIC RADIOPHARMACEUTICALS |
| (V09A) CENTRAL NERVOUS SYSTEM |
| (V09AA) Technetium (99mTc) compounds |
| (V09AA01) Technetium (99mTc) exametazime |
| (V09AA02) Technetium (99mTc) bicisate |
| (V09AB) Iodine (123I) compounds |
| (V09AB01) Iodine iofetamine (123I) |
| (V09AB02) Iodine iolopride (123I) |
| (V09AB03) Iodine ioflupane (123I) |
| (V09AX) Other central nervous system diagnostic radiopharmaceuticals |
| (V09AX01) Indium (111In) pentetic acid |
| (V09AX02) Fludeoxyglucose (18F) |
| (V09B) SKELETON |
| (V09BA) Technetium (99mTc) compounds |
| (V09BA01) Technetium (99mTc) oxidronic acid |
| (V09BA02) Technetium (99mTc) medronic acid |
| (V09BA03) Technetium (99mTc) pyrophosphate |
| (V09BA04) Technetium (99mTc) butedronic acid |
| (V09C) RENAL SYSTEM |
| (V09CA) Technetium (99mTc) compounds |
| (V09CA01) Technetium (99mTc) pentetic acid |
| (V09CA02) Technetium (99mTc) succimer |
| (V09CA03) Technetium (99mTc) mertiatide |
| (V09CA04) Technetium (99mTc) gluceptate |
| (V09CA05) Technetium (99mTc) gluconate |
| (V09CX) Other renal system diagnostic radiopharmaceuticals |
| (V09CX01) Sodium iodohippurate (123I) |
| (V09CX02) Sodium iodohippurate (131I) |
| (V09CX03) Sodium iothalamate (125I) |
| (V09CX04) Chromium (51Cr) edetate |
| (V09D) HEPATIC AND RETICULO ENDOTHELIAL SYSTEM |
| (V09DA) Technetium (99mTc) compounds |
| (V09DA01) Technetium (99mTc) disofenin |
| (V09DA02) Technetium (99mTc) etifenin |
| (V09DA03) Technetium (99mTc) lidofenin |
| (V09DA04) Technetium (99mTc) mebrofenin |
| (V09DA05) Technetium (99mTc) galtifenin |
| (V09DB) Technetium (99mTc), particles and colloids |
| (V09DB01) Technetium (99mTc) nanocolloid |
| (V09DB02) Technetium (99mTc) microcolloid |
| (V09DB03) Technetium (99mTc) millimicrospheres |
| (V09DB04) Technetium (99mTc) tin colloid |
| (V09DB05) Technetium (99mTc) sulfur colloid |
| (V09DB06) Technetium (99mTc) rheniumsulfide colloid |
| (V09DB07) Technetium (99mTc) phytate |
| (V09DX) Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
| (V09DX01) Selenium (75Se) tauroselcholic acid |
| (V09E) RESPIRATORY SYSTEM |
| (V09EA) Technetium (99mTc), inhalants |
| (V09EA01) Technetium (99mTc) pentetic acid |
| (V09EA02) Technetium (99mTc) technegas |
| (V09EA03) Technetium (99mTc) nanocolloid |
| (V09EB) Technetium (99mTc), particles for injection |
| (V09EB01) Technetium (99mTc) macrosalb |
| (V09EB02) Technetium (99mTc) microspheres |
| (V09EX) Other respiratory system diagnostic radiopharmaceuticals |
| (V09EX01) Krypton (81mKr) gas |
| (V09EX02) Xenon (127Xe) gas |
| (V09EX03) Xenon (133Xe) gas |
| (V09F) THYROID |
| (V09FX) Various thyroid diagnostic radiopharmaceuticals |
| (V09FX01) Technetium (99mTc) pertechnetate |
| (V09FX02) Sodium iodide (123I) |
| (V09FX03) Sodium iodide (131I) |
| (V09G) CARDIOVASCULAR SYSTEM |
| (V09GA) Technetium (99mTc) compounds |
| (V09GA01) Technetium (99mTc) sestamibi |
| (V09GA02) Technetium (99mTc) tetrofosmin |
| (V09GA03) Technetium (99mTc) teboroxime |
| (V09GA04) Technetium (99mTc) human albumin |
| (V09GA05) Technetium (99mTc) furifosmin |
| (V09GA06) Technetium (99mTc) stannous agent labelled cells |
| (V09GA07) Technetium (99mTc) apcitide |
| (V09GB) Iodine (125I) compounds |
| (V09GB01) Fibrinogen (125I) |
| (V09GB02) Iodine (125I) human albumin |
| (V09GX) Other cardiovascular system diagnostic radiopharmaceuticals |
| (V09GX01) Thallium (201Tl) chloride |
| (V09GX02) Indium (111In) imciromab |
| (V09GX03) Chromium (51Cr) chromate labelled cells |
| (V09H) INFLAMMATION AND INFECTION DETECTION |
| (V09HA) Technetium (99mTc) compounds |
| (V09HA01) Technetium (99mTc) human immunoglobulin |
| (V09HA02) Technetium (99mTc) exametazime labelled cells |
| (V09HA03) Technetium (99mTc) antigranulocyte antibody |
| (V09HA04) Technetium (99mTc) sulesomab |
| (V09HB) Indium (111In) compounds |
| (V09HB01) Indium (111In) oxinate labelled cells |
| (V09HB02) Indium (111In) tropolonate labelled cells |
| (V09HX) Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| (V09HX01) Gallium (67Ga) citrate |
| (V09I) TUMOUR DETECTION |
| (V09IA) Technetium (99mTc) compounds |
| (V09IA01) Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody |
| (V09IA02) Technetium (99mTc) antimelanoma antibody |
| (V09IA03) Technetium (99mTc) pentavalent succimer |
| (V09IA04) Technetium (99mTc) votumumab |
| (V09IA05) Technetium (99mTc) depreotide |
| (V09IA06) Technetium (99mTc) arcitumomab |
| (V09IB) Indium (111In) compounds |
| (V09IB01) Indium (111In) pentetreotide |
| (V09IB02) Indium (111In) satumomab pendetide |
| (V09IB03) Indium (111In) antiovariumcarcinoma antibody |
| (V09IB04) Indium (111In) capromab pendetide |
| (V09IX) Other diagnostic radiopharmaceuticals for tumour detection |
| (V09IX01) Iobenguane (123I) |
| (V09IX02) Iobenguane (131I) |
| (V09IX03) Iodine (125I) CC49-monoclonal antibody |
| (V09X) OTHER DIAGNOSTIC RADIOPHARMACEUTICALS |
| (V09XA) Iodine (131I) compounds |
| (V09XA01) Iodine (131I) norcholesterol |
| (V09XA02) Iodocholesterol (131I) |
| (V09XA03) Iodine (131I) human albumin |
| (V09XX) Various diagnostic radiopharmaceuticals |
| (V09XX01) Cobalt (57Co) cyanocobalamine |
| (V09XX02) Cobalt (58Co) cyanocobalamine |
| (V09XX03) Selenium (75Se) norcholesterol |
| (V09XX04) Ferric (59Fe) citrate |
| (V10) THERAPEUTIC RADIOPHARMACEUTICALS |
| (V10A) ANTIINFLAMMATORY AGENTS |
| (V10AA) Yttrium (90Y) compounds |
| (V10AA01) Yttrium (90Y) citrate colloid |
| (V10AA02) Yttrium (90Y) ferrihydroxide colloid |
| (V10AA03) Yttrium (90Y) silicate colloid |
| (V10AX) Other antiinflammatory therapeutic radiopharmaceuticals |
| (V10AX01) Phosphorous (32P) chromicphosphate colloid |
| (V10AX02) Samarium (153Sm) hydroxyapatite colloid |
| (V10AX03) Dysprosium (165Dy) colloid |
| (V10AX04) Erbium (169Er) citrate colloid |
| (V10AX05) Rhenium (186Re) sulfide colloid |
| (V10AX06) Gold (198Au) colloidal |
| (V10B) PAIN PALLIATION (BONE SEEKING AGENTS) |
| (V10BX) Various pain palliation radiopharmaceuticals |
| (V10BX01) Strontium (89Sr) chloride |
| (V10BX02) Samarium (153Sm) lexidronam |
| (V10BX03) Rhenium (186Re) etidronic acid |
| (V10X) OTHER THERAPEUTIC RADIOPHARMACEUTICALS |
| (V10XA) Iodine (131I) compounds |
| (V10XA01) Sodium iodide (131I) |
| (V10XA02) Iobenguane (131I) |
| (V10XA53) Tositumomab/iodine (131I) tositumomab |
| (V10XX) Various therapeutic radiopharmaceuticals |
| (V10XX01) Sodium phosphate (32P) |
| (V20) SURGICAL DRESSINGS
|